data_1iv0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1iv0 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.702 0.287 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 12.1 p -140.0 137.88 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.14 130.89 10.1 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.442 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.57 133.26 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.79 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.9 mt -120.38 138.92 53.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 111.194 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 10.1 p-10 -149.9 149.8 30.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.306 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.86 126.62 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.282 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.84 -55.81 2.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.991 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.16 34.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.299 . . . . 0.0 110.826 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 168.53 -48.04 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -105.25 140.41 38.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.43 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 53.5 mt -107.94 128.97 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.493 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.98 141.73 18.69 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.988 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.401 ' CG ' HD21 ' A' ' 31' ' ' LEU . 82.7 mt -118.05 129.71 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -138.75 147.41 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.995 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.426 HG23 ' CZ ' ' A' ' 46' ' ' PHE . 60.4 t -147.24 117.41 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.524 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.091 179.634 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.844 0.354 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.96 -138.28 2.53 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.638 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 p90 179.96 150.05 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.997 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.427 HD23 ' HB ' ' A' ' 13' ' ' ILE . 1.7 pt? -137.18 136.44 38.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.961 0.41 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.0 t -74.28 147.45 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.413 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -54.73 140.96 34.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 60.1 mttm -137.23 -149.79 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.109 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.542 ' CG2' ' H ' ' A' ' 36' ' ' LEU . 1.9 m -87.94 -163.48 0.96 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.572 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.542 ' H ' ' CG2' ' A' ' 35' ' ' THR . 3.9 mp -78.64 -61.03 2.14 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.968 0.413 . . . . 0.0 110.523 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -64.1 -37.17 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 34' ' ' LYS . 5.3 tp10 -57.0 -54.12 50.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.292 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 35' ' ' THR . 46.3 m-20 -52.12 -41.46 62.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.713 0.292 . . . . 0.0 110.631 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.38 -46.12 92.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.408 0.623 . . . . 0.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -55.75 -47.63 76.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.894 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.96 -44.29 85.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 110.533 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 36.8 mt -63.34 -50.03 71.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.341 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 22.1 mt -56.9 -49.88 74.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 37.0 t70 -46.9 -42.07 16.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.69 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.434 ' O ' ' CB ' ' A' ' 50' ' ' GLU . 17.2 t80 -83.75 -57.73 3.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.05 -47.58 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.91 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.568 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 13.9 tpp85 -65.85 -53.95 33.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 58.5 mmt-85 -71.41 -43.45 66.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 40.6 tp10 -63.81 -14.9 56.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.567 0.222 . . . . 0.0 111.37 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.02 40.54 99.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.95 -47.18 66.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . 56.94 32.0 61.91 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.662 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HE3' ' HB ' ' A' ' 3' ' ' VAL . 37.8 ttpt 178.19 130.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 54' ' ' LYS . 1.6 mm? -135.75 133.63 38.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.94 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 p -119.69 135.96 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.144 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 112.059 -179.199 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HD2' HD13 ' A' ' 36' ' ' LEU . 31.9 mtmm . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.791 0.329 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.01 -36.91 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.677 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.465 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 60.2 tp -49.12 -46.84 76.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 97.0 Cg_exo -43.44 -33.0 3.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.649 2.233 . . . . 0.0 112.904 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.457 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 28.2 tp -82.25 -44.92 15.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.41 -36.05 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.311 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 20.4 pt-20 -68.26 -39.11 82.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.352 . . . . 0.0 110.514 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.78 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 0.0 110.529 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.466 ' CD1' HG22 ' A' ' 88' ' ' VAL . 30.3 mt -60.03 -51.0 71.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.058 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -58.23 -44.04 88.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.15 -41.85 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . 0.409 ' NH1' ' CD2' ' A' ' 44' ' ' LEU . 99.1 mtt180 -83.64 15.54 3.13 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.68 37.16 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.36 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.9 t -99.2 132.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.685 0.279 . . . . 0.0 110.786 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 41.4 tp10 -62.61 133.02 54.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.86 0.362 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.466 HG22 ' CD1' ' A' ' 81' ' ' LEU . 61.0 t -157.68 150.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.952 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -163.48 127.92 2.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.708 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.849 0.357 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 9.6 p -133.06 133.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.066 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.45 ' HA3' HD12 ' A' ' 55' ' ' LEU . . . -78.55 139.56 22.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.868 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -130.86 134.71 47.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.378 . . . . 0.0 111.639 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -117.91 137.45 52.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.097 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 8.6 p-10 -140.82 136.2 32.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.73 137.64 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.36 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.27 -44.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.227 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -178.65 105.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.751 0.31 . . . . 0.0 110.784 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . 45.57 30.35 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.281 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -165.86 143.3 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 54.1 mt -112.84 133.73 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.406 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -82.02 133.87 12.47 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.584 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.0 mt -105.11 130.26 53.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.856 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.48 149.06 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.669 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 59.2 t -146.96 127.97 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.151 0.5 . . . . 0.0 111.501 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.217 179.567 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.657 0.265 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.18 -138.38 2.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.825 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.413 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 5.3 p90 -179.72 140.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.748 0.309 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.7 mt -120.22 126.09 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.9 t -71.99 144.12 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.414 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 74.6 mtp180 -55.14 149.27 12.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.959 0.409 . . . . 0.0 111.319 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 61.6 mttm -150.49 -153.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.437 ' CG2' ' H ' ' A' ' 36' ' ' LEU . 1.1 m -86.78 -158.6 0.44 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 37' ' ' GLU . 2.5 pt? -81.54 -48.56 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.123 -0.36 . . . . 0.0 111.0 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.457 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 16.5 pt-20 -66.96 -38.98 87.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 4.1 mm-40 -60.57 -55.42 33.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.33 -48.0 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.499 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 36' ' ' LEU . 5.2 t -60.51 -54.82 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 109.791 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -53.79 -45.82 70.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.48 87.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 97.4 mt -63.89 -44.19 93.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.268 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.0 mt -60.97 -47.58 85.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 110.527 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 48' ' ' ARG . 4.8 t70 -47.29 -41.76 19.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 16.1 t80 -75.06 -40.09 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.01 -53.9 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 8.9 ptt85 -72.06 -62.86 1.28 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 49' ' ' ARG . 11.7 mtp-105 -47.9 -50.52 26.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -75.65 -6.47 50.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.369 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.29 39.45 94.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.666 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.448 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 87.1 mt -72.78 -53.26 12.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.39 42.52 83.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.475 ' O ' HD11 ' A' ' 55' ' ' LEU . 83.3 tttt -178.3 127.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.475 HD11 ' O ' ' A' ' 54' ' ' LYS . 2.4 mm? -141.54 135.96 30.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.786 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 5' ' ' ALA . 13.4 p -117.47 125.69 74.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.074 0.464 . . . . 0.0 111.647 -179.312 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.85 0.357 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.1 -42.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.595 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 59.3 tp -55.93 -43.77 99.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.579 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.8 Cg_exo -46.72 -40.15 24.13 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 0.0 112.392 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.5 tm? -71.44 -38.48 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.616 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -55.03 -36.24 37.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -67.09 -40.02 86.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.886 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.32 92.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.139 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.459 ' CD1' HG21 ' A' ' 88' ' ' VAL . 22.5 mt -59.78 -48.08 83.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -56.83 -41.26 77.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.005 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.14 75.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.194 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mtp85 -84.96 15.28 4.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.739 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.42 38.89 97.08 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.161 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -100.67 134.64 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.654 0.264 . . . . 0.0 111.046 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 4.4 mm-40 -63.79 129.03 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 81' ' ' LEU . 57.3 t -157.52 144.83 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.129 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -168.08 131.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.344 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 pp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.339 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 . . . . . 0 C--O 1.23 0.028 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 3' ' ' VAL . 12.2 p -134.26 139.45 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.834 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.99 140.47 16.4 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.201 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.82 136.79 53.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.8 mt -125.43 142.49 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 10.9 p-10 -145.05 140.15 27.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.643 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.1 m -112.42 134.17 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.27 132.97 2.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.873 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 57.16 49.46 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.235 0.54 . . . . 0.0 111.329 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.434 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 52.29 33.68 13.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.449 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.517 ' NH1' ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -147.66 139.75 24.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 60.9 mt -106.56 128.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.623 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.76 131.89 10.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.824 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.46 130.54 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.95 147.83 28.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.792 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.8 t -150.04 122.84 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.982 0.42 . . . . 0.0 111.063 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.238 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.838 0.351 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.77 -143.96 4.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 179.79 150.47 0.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 111.379 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 1.6 pt? -142.67 135.6 28.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.691 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.23 148.2 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.434 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 74.4 mtm180 -51.64 139.7 20.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.02 0.438 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HD3' ' HG3' ' A' ' 38' ' ' GLU . 66.5 mttm -128.05 -120.3 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.183 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.582 ' O ' ' N ' ' A' ' 38' ' ' GLU . 37.7 p -156.05 128.32 7.62 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.023 0.439 . . . . 0.0 112.113 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 35' ' ' THR . 4.2 mp 0.08 -68.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 38' ' ' GLU . 13.5 pm0 -67.13 -45.71 76.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.0 tp10 -59.86 -50.22 74.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.022 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.409 ' OD2' ' HD2' ' A' ' 73' ' ' LYS . 55.3 m-20 -50.31 -38.82 43.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.11 -46.7 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 109.768 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -56.33 -48.34 76.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.005 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.998 0.428 . . . . 0.0 110.846 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 71.2 mt -63.13 -47.3 83.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.05 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 23.2 mt -59.76 -46.68 88.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 7.4 t70 -46.14 -42.04 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.454 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 18.0 t80 -81.17 -58.01 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -58.12 -48.87 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.07 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.556 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 31.5 tpt85 -65.25 -57.09 9.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 23.1 mmt85 -68.07 -43.43 78.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.4 tp10 -72.34 -3.23 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.661 0.267 . . . . 0.0 111.339 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.76 92.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.674 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.404 HD12 ' CE2' ' A' ' 46' ' ' PHE . 87.9 mt -71.5 -52.54 17.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.903 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 51.18 31.72 27.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.229 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 55' ' ' LEU . 61.5 mttp -162.63 131.02 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.599 0.238 . . . . 0.0 110.614 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 54' ' ' LYS . 2.7 mm? -141.67 136.97 31.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.204 0.526 . . . . 0.0 111.445 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.4 140.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.577 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.064 0.459 . . . . 0.0 111.56 -179.418 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.501 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 10.3 mtmp? . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.739 0.304 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.27 -43.14 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.109 0.481 . . . . 0.0 110.968 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.665 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 51.5 tp -55.42 -48.8 95.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.2 Cg_endo -46.68 -39.45 23.41 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.471 2.114 . . . . 0.0 112.127 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 35.1 tp -66.19 -38.31 87.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.412 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -53.04 -36.94 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.683 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.8 -43.1 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.592 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.09 79.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 26.4 mt -58.7 -47.57 84.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.989 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.72 -42.36 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.44 -46.61 76.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.933 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.6 mtm-85 -87.53 18.87 3.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.28 37.65 92.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.866 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 57.7 t -89.17 131.12 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -62.73 132.15 51.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.8 t -153.05 144.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -148.36 150.84 34.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.327 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.424 ' N ' ' CD2' ' A' ' 90' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.53 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.583 0.23 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 18' ' ' GLY . 14.7 p -132.72 137.36 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.971 0.415 . . . . 0.0 111.188 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.77 126.06 7.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.107 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.28 130.57 49.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.28 139.71 53.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.008 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 8.5 p-10 -147.64 139.17 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 p -113.99 133.51 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.1 126.31 1.27 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.899 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 55.85 45.53 23.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 33' ' ' ARG . . . 75.54 -52.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.669 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.66 140.17 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.502 ' HB ' HD22 ' A' ' 31' ' ' LEU . 60.2 mt -111.23 130.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.835 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.45 140.06 22.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.253 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.445 ' CD1' HD23 ' A' ' 31' ' ' LEU . 74.5 mt -123.99 133.3 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.666 0.27 . . . . 0.0 110.522 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.415 ' O ' ' CG2' ' A' ' 17' ' ' VAL . . . -159.05 -162.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.333 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 28' ' ' ARG . 90.3 t -158.87 142.4 6.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.414 ' O ' ' CG1' ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.242 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.982 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.7 mmp_? . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.485 0.183 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.19 -139.87 5.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.172 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -179.98 151.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.659 0.266 . . . . 0.0 110.796 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.502 HD22 ' HB ' ' A' ' 13' ' ' ILE . 1.5 pt? -133.91 136.17 44.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.9 t -76.08 156.04 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.724 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 64.0 mtp180 -51.84 150.21 4.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.807 0.337 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 56.7 mttp -147.97 -155.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.26 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.455 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -97.13 -158.39 0.66 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.468 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.454 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 2.6 mm? -75.32 -55.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.607 0.241 . . . . 0.0 111.376 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.455 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.9 OUTLIER -70.36 -38.25 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.991 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 34' ' ' LYS . 7.3 mt-10 -57.74 -55.91 28.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 0.0 110.772 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -53.97 -42.31 68.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.794 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 6.1 t -58.98 -55.99 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.415 0.626 . . . . 0.0 110.384 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.66 -46.89 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.422 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.28 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 72.7 mt -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.379 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 76.3 mt -59.52 -48.4 81.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -50.23 -37.78 37.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.708 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 17.9 t80 -77.04 -44.1 32.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.62 -53.77 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -70.78 -60.79 2.04 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -49.6 -50.46 42.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.72 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.6 tp10 -74.25 -10.97 60.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.618 0.247 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.44 39.62 97.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.561 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.412 HD12 ' CE2' ' A' ' 46' ' ' PHE . 89.4 mt -75.09 -49.37 19.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 54.86 26.5 40.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.381 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 53' ' ' GLY . 66.1 mttm -164.26 131.65 3.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 54' ' ' LYS . 2.3 mm? -140.28 131.06 25.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 111.764 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.64 124.24 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.488 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 45.8 t . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.516 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.637 0.256 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.2 t -100.4 -44.35 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.166 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.659 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.9 tm? -54.21 -49.67 88.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.622 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.8 Cg_endo -46.95 -40.27 25.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.565 2.177 . . . . 0.0 112.599 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.8 tm? -71.84 -37.86 70.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.7 -35.62 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.676 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.85 -40.02 91.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.892 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.74 91.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.451 ' HG ' HD11 ' A' ' 77' ' ' LEU . 27.1 mt -61.52 -47.43 85.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 3.6 mmm180 -59.12 -42.27 90.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.19 80.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.377 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -86.89 19.25 3.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.799 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.74 37.88 94.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.985 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 52.9 t -97.28 134.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -65.4 128.09 34.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 81' ' ' LEU . 46.7 t -158.06 145.06 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.55 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -169.71 141.34 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.122 0.487 . . . . 0.0 111.824 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.432 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 2.6 mm? . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.411 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.723 0.297 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 p -124.78 132.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.863 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.87 124.08 6.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.879 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.313 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 99.0 mt -129.27 138.63 51.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 9.5 p-10 -146.33 138.92 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.524 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.6 t -105.5 135.11 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.74 130.41 1.65 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.743 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 17.5 tp10 55.81 52.06 11.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.18 0.514 . . . . 0.0 111.136 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.414 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . 50.5 35.11 10.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.44 ' HD3' ' CG ' ' A' ' 30' ' ' TYR . 38.6 ttm180 -149.24 140.1 22.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.855 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -103.8 128.66 56.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -83.93 130.32 9.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.544 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.11 131.58 52.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.51 147.01 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.901 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.3 t -143.5 119.34 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.197 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.3 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.855 0.359 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.22 -140.77 3.36 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.317 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.44 ' CG ' ' HD3' ' A' ' 12' ' ' ARG . 6.9 p90 179.95 140.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.383 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.7 mt -106.14 123.02 47.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.546 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.8 t -72.68 148.99 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.414 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 81.6 mtm180 -47.08 148.32 1.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.334 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 62.3 mttm -144.79 -121.94 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 38' ' ' GLU . 23.4 p -154.78 128.0 8.36 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 35' ' ' THR . 83.5 mt 5.83 -69.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.4 pt-20 -67.8 -46.88 70.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 111.763 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.1 tp10 -58.55 -50.65 73.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.079 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.4 m-20 -48.67 -46.03 39.7 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.94 0.4 . . . . 0.0 110.315 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 t -61.93 -50.22 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -52.91 -46.85 68.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.093 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.46 93.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.482 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 94.7 mt -67.31 -42.0 84.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.639 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 70.0 mt -59.58 -56.21 24.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.694 0.283 . . . . 0.0 111.066 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -48.55 -38.02 19.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.812 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 16.2 t80 -73.49 -42.59 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.31 -50.12 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -72.89 -62.84 1.32 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.8 mmm-85 -48.0 -51.8 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.074 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.1 tp10 -76.08 -4.88 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.343 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.08 40.68 91.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.425 HD13 ' CD2' ' A' ' 46' ' ' PHE . 86.4 mt -68.22 -54.35 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.99 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.95 40.66 66.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.125 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 55' ' ' LEU . 3.4 tppp? -178.36 128.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 54' ' ' LYS . 2.4 mm? -141.32 133.2 27.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 111.776 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.57 117.83 53.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.341 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.533 -179.428 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 36.6 mtmm . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.77 0.319 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.01 -45.09 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.158 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.501 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 56.3 tp -56.71 -49.82 91.5 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 83.9 Cg_exo -44.06 -38.37 10.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.116 . . . . 0.0 112.38 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.482 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.3 tm? -70.5 -36.31 73.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.693 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.45 -36.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.959 0.409 . . . . 0.0 110.581 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.93 -39.9 83.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.846 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.91 85.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 88' ' ' VAL . 23.6 mt -59.08 -45.29 91.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.026 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -58.3 -44.04 88.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.08 85.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.103 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -83.11 15.55 2.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 38.84 96.65 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.254 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.5 135.24 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.35 . . . . 0.0 111.021 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -69.75 139.35 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 81' ' ' LEU . 44.5 t -155.84 139.72 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.53 130.79 4.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.032 0.444 . . . . 0.0 111.61 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.758 0.313 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.58 136.13 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' A' ' 55' ' ' LEU . . . -79.32 134.69 14.12 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.134 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -121.96 133.92 54.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 111.423 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 98.9 mt -126.43 139.45 53.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.13 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -143.77 139.35 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.31 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -106.71 128.45 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.867 0.365 . . . . 0.0 111.559 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.84 -135.46 6.63 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.79 -44.4 90.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.364 . . . . 0.0 110.746 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.409 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -168.15 32.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.708 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -147.92 144.21 27.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.482 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 55.3 mt -99.61 125.25 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.41 129.34 9.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.631 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -104.81 127.13 52.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 110.937 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.29 148.94 31.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.6 t -151.1 133.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.005 0.431 . . . . 0.0 111.676 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.374 179.695 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.611 0.243 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.66 -151.41 10.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.856 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.4 p90 179.82 141.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.946 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 13' ' ' ILE . 67.0 mt -114.71 124.19 51.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 47.6 t -66.22 146.0 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.562 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 98.6 mtt180 -51.58 147.54 6.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.862 0.363 . . . . 0.0 111.465 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 52.1 mttp -147.17 -125.75 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.052 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 38' ' ' GLU . 16.1 p -157.69 134.79 10.14 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.486 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 5.2 mp 5.27 -72.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -69.75 -48.15 60.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.0 tp10 -57.49 -50.27 73.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.942 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.413 ' OD2' ' CG ' ' A' ' 73' ' ' LYS . 45.5 m-20 -51.31 -42.38 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 2.6 t -60.84 -47.38 93.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.511 0.672 . . . . 0.0 109.779 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.74 -49.58 37.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.436 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.2 -44.3 59.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.257 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.463 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 27.7 mt -61.57 -48.12 82.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.934 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 57.9 mt -57.51 -50.76 72.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -45.28 -40.43 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.968 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 18.0 t80 -77.45 -45.43 25.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.456 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.8 t -57.1 -50.85 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 5.4 ptm180 -71.32 -62.77 1.28 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -51.42 -48.84 62.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.995 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -69.87 -13.41 62.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.547 0.213 . . . . 0.0 111.219 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.88 39.12 95.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.423 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.404 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 86.1 mt -74.1 -49.27 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 54.53 28.21 44.14 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.233 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.46 ' O ' HD13 ' A' ' 55' ' ' LEU . 67.5 mttm -164.14 129.96 2.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.268 0.227 . . . . 0.0 110.399 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 54' ' ' LYS . 2.6 mm? -140.25 121.02 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.503 HG11 ' HA ' ' A' ' 5' ' ' ALA . 8.6 p -99.3 113.93 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.88 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' HB ' ' CB ' ' A' ' 90' ' ' LEU . 48.1 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.735 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 73' ' ' LYS . 2.7 mppt? . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.5 -53.28 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 2.2 tm? -55.38 -50.4 86.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.503 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.2 Cg_exo -42.5 -39.9 7.04 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.494 2.13 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.463 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 42.6 tp -66.52 -41.31 88.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -53.99 -34.88 26.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.86 -43.17 93.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.21 91.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.419 ' CD1' HG22 ' A' ' 88' ' ' VAL . 31.7 mt -59.4 -41.18 88.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.366 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -57.11 -42.73 81.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.281 . . . . 0.0 111.219 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.76 -51.27 69.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.383 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -70.63 -27.3 63.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.99 43.41 4.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.346 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.85 139.95 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.613 0.244 . . . . 0.0 110.754 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -60.43 130.15 45.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 81' ' ' LEU . 60.9 t -151.86 145.2 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -171.86 123.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.481 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.415 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 1.8 pt? . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.682 0.277 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 13.0 p -126.32 132.42 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.08 126.93 7.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.012 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.37 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.696 -0.297 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.0 mt -120.47 136.53 54.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.454 . . . . 0.0 111.249 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -146.97 139.43 24.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.165 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.0 m -108.73 134.23 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.61 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.01 131.52 1.78 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.958 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 40.4 tt0 56.8 53.47 8.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 48.85 35.92 7.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.467 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -151.69 140.97 21.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.68 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 61.8 mt -105.27 127.4 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 134.38 13.42 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.768 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -113.59 133.72 55.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 0.0 110.912 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.38 148.95 29.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.999 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.43 121.96 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.289 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.341 179.841 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.98 -137.58 2.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.67 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -179.93 150.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.927 0.394 . . . . 0.0 110.86 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.452 HD23 ' HB ' ' A' ' 13' ' ' ILE . 1.3 pt? -134.67 135.33 41.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.21 145.07 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 66.1 mtm180 -54.26 151.59 7.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.168 0.509 . . . . 0.0 111.326 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 64.1 mttm -146.61 -122.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.699 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 37' ' ' GLU . 38.4 p -148.58 139.72 23.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.728 0.299 . . . . 0.0 110.903 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -21.96 -43.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.519 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 11.9 pt-20 -73.46 -48.88 30.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG2' ' OG1' ' A' ' 35' ' ' THR . 13.6 mm-40 -61.79 -48.31 81.21 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 23.0 m-20 -45.93 -40.96 10.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.74 -52.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.185 0.517 . . . . 0.0 110.363 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.09 -51.92 66.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.94 93.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 74.0 mt -65.22 -50.31 66.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HB3' ' NH1' ' A' ' 48' ' ' ARG . 61.5 mt -59.1 -48.08 82.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -49.35 -38.91 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 17.9 t80 -77.04 -43.69 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.236 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.9 t -58.06 -51.81 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 44' ' ' LEU . 1.5 ptt-85 -67.81 -63.18 1.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.6 mtp85 -51.35 -49.75 60.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.881 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -72.05 -10.23 59.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.263 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.8 97.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.465 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.36 -52.81 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 0.0 110.897 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.84 36.18 54.77 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.257 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' O ' HD12 ' A' ' 55' ' ' LEU . 37.3 ttpt 178.21 131.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 54' ' ' LYS . 1.6 mm? -137.8 137.45 38.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.748 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -128.19 132.79 68.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.11 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 90' ' ' LEU . 14.8 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.752 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.457 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 37.3 mtmm . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.805 0.336 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.22 -41.15 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.545 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 61.2 tp -54.5 -52.0 73.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.3 Cg_exo -43.94 -40.16 11.52 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.348 2.032 . . . . 0.0 112.219 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.476 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 32.0 tp -63.19 -42.79 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.6 t -52.01 -35.49 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.77 -42.81 94.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.06 66.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 88' ' ' VAL . 24.5 mt -57.94 -50.91 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -58.44 -38.4 77.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.42 -43.74 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.427 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.0 mtm-85 -89.69 20.04 4.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.505 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 39.82 98.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.1 t -95.52 132.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.081 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.85 130.22 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.679 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 81' ' ' LEU . 65.9 t -155.91 144.48 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.96 0.41 . . . . 0.0 111.301 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -172.02 129.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.29 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.402 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 2.5 pp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.693 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.677 0.275 . . . . 0.0 110.672 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.49 131.56 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.092 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . 0.408 ' HA3' HD12 ' A' ' 55' ' ' LEU . . . -87.48 117.56 4.76 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.951 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.22 133.3 42.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.226 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.8 mt -123.73 138.37 54.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -145.34 144.39 30.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.106 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.06 141.18 45.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 111.531 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.78 133.5 2.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.756 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 66.04 -67.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.344 0.257 . . . . 0.0 111.522 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.452 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . -176.19 36.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.844 0.354 . . . . 0.0 111.354 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -156.46 143.9 19.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.3 mt -104.09 130.44 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.708 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.13 138.12 17.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.009 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.481 ' CD2' HD11 ' A' ' 31' ' ' LEU . 52.4 mt -115.39 132.8 56.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.68 145.46 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.058 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.5 t -136.96 125.6 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.115 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.143 179.917 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.406 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.5 mmp_? . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.73 -139.4 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.378 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 5.7 p90 -179.81 143.06 0.17 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 111.311 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.481 HD11 ' CD2' ' A' ' 15' ' ' LEU . 1.3 mp -111.81 127.97 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.029 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 55.2 t -70.61 143.35 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.452 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 mtt180 -50.58 140.23 14.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.824 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 50.3 mttp -138.53 -140.75 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.641 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.459 ' CG2' ' H ' ' A' ' 36' ' ' LEU . 1.2 m -106.16 -158.98 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 37' ' ' GLU . 2.5 pt? -77.17 -49.65 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.148 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.46 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 15.4 pt-20 -70.59 -40.13 73.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.602 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.42 -57.03 13.56 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.333 0.587 . . . . 0.0 110.351 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.6 -44.75 62.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.759 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 3.6 t -60.51 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.428 0.633 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -53.51 -45.52 69.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.128 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.02 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.774 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 92.1 mt -65.86 -45.14 83.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.651 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 22.3 mt -59.29 -57.47 12.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.526 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.817 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 65.8 t0 -43.95 -42.1 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 15.9 t80 -71.05 -42.39 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.152 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.5 t -67.32 -44.57 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.8 ptm180 -64.43 -67.53 0.43 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.817 ' HG2' ' O ' ' A' ' 45' ' ' ASP . 39.7 ptt85 -56.19 -47.75 77.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.0 tp10 -65.35 -16.06 63.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 111.258 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 36.86 90.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.15 -50.64 53.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.74 40.06 69.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.439 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.471 ' O ' HD11 ' A' ' 55' ' ' LEU . 59.7 tttp -177.87 125.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.476 0.179 . . . . 0.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 54' ' ' LYS . 2.4 mm? -140.39 131.68 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.446 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.18 120.05 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.842 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.932 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.474 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 53.8 mtmt . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.624 0.249 . . . . 0.0 111.576 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.31 -45.25 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 2.0 tm? -52.34 -50.12 81.39 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 96.0 Cg_exo -40.85 -33.32 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.834 2.356 . . . . 0.0 112.895 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.7 tm? -80.8 -39.42 26.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.64 -36.8 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 21.3 pt-20 -73.56 -33.91 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.734 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.11 91.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.157 0.503 . . . . 0.0 110.692 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.472 ' CD1' HG23 ' A' ' 88' ' ' VAL . 22.9 mt -60.7 -47.84 84.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.81 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -57.83 -39.59 78.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.94 72.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.376 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -88.19 21.21 2.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.724 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.99 92.73 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.966 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.53 135.78 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.703 0.287 . . . . 0.0 111.063 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 65.5 mm-40 -64.57 125.84 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.792 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 81' ' ' LEU . 57.7 t -158.78 145.97 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -166.92 131.92 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.095 0.474 . . . . 0.0 111.624 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 6.1 tt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.278 179.514 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.689 0.281 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 3' ' ' VAL . 11.9 p -119.42 136.23 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.281 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.47 131.18 10.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.094 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.87 130.76 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 111.112 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.5 mt -123.37 135.95 54.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.041 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 2.9 p30 -140.3 134.86 31.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.625 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -98.95 129.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.637 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.98 -135.48 5.69 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.285 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -62.92 -42.85 99.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . -171.57 39.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -155.33 146.61 22.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -98.95 127.03 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.484 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.47 126.63 7.7 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.447 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.0 mt -99.42 130.41 45.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.918 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.52 145.84 26.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.52 124.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.72 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.505 -179.611 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.93 0.395 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.81 -135.59 1.88 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.252 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 7.2 p90 -178.9 138.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.0 mt -106.43 125.63 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.669 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.23 133.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 52.4 mtp85 -56.94 124.98 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.461 . . . . 0.0 111.048 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 38' ' ' GLU . 96.6 mttt -109.09 -96.96 0.39 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -176.03 127.3 0.22 Allowed 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.416 ' CD1' ' HG3' ' A' ' 76' ' ' PRO . 62.4 tp 16.59 -76.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -67.55 -44.93 77.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.506 ' HB2' ' CB ' ' A' ' 34' ' ' LYS . 4.6 mm-40 -57.69 -51.72 68.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.269 0.557 . . . . 0.0 110.324 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.9 m-20 -49.06 -42.8 39.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.243 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -58.86 -54.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 110.514 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -52.76 -49.53 65.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.346 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.22 89.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.948 0.404 . . . . 0.0 111.201 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.497 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 84.2 mt -65.25 -46.09 81.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.391 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 72.7 mt -60.58 -52.8 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -48.55 -38.41 20.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 18.0 t80 -73.09 -42.09 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.8 t -65.04 -51.94 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -70.79 -62.72 1.29 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -47.61 -51.0 22.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.959 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 5.4 tp10 -77.0 -4.04 42.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 111.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.49 38.55 91.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.657 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.59 -55.55 6.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . 53.0 33.22 43.76 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' HD13 ' A' ' 55' ' ' LEU . 34.2 mmtp -161.91 128.1 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.225 0.21 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 54' ' ' LYS . 2.8 mm? -143.16 133.05 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.367 0.603 . . . . 0.0 111.65 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -131.02 122.44 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.2 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 25.0 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.589 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.824 0.345 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.4 -43.17 10.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.074 0.464 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.667 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 59.7 tp -53.5 -48.86 91.42 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 1.4 Cg_endo -43.19 -39.78 8.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.767 2.311 . . . . 0.0 112.718 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.497 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.5 tm? -76.07 -36.87 58.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -55.44 -36.18 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.678 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -66.23 -39.55 89.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.51 -44.9 93.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' HG22 ' A' ' 88' ' ' VAL . 24.1 mt -60.15 -48.39 81.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.056 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -58.81 -43.57 90.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.667 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.7 82.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -84.08 17.84 2.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.659 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 37.16 94.15 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.318 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.2 t -106.93 133.38 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 0.0 110.942 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -67.89 132.2 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.927 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 81' ' ' LEU . 43.0 t -157.44 143.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.619 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.95 139.43 6.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.086 0.47 . . . . 0.0 112.054 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.473 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 1.8 mm? . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.994 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 . . . . . 0 C--O 1.23 0.036 0 CA-C-O 120.827 0.346 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -136.67 141.66 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.97 131.84 14.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.448 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.75 137.32 54.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.5 mt -132.17 141.07 48.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.126 0.488 . . . . 0.0 111.609 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 11.6 p-10 -146.2 137.94 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.677 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -103.52 124.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.723 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.56 -136.76 9.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.675 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.1 -42.72 72.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.7 0.286 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.89 40.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.24 0.543 . . . . 0.0 110.899 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -167.59 173.4 8.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 52.1 mt -126.41 134.15 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.74 133.55 11.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.008 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 28' ' ' ARG . 86.0 mt -98.61 131.65 44.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.608 0.242 . . . . 0.0 110.546 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.64 143.8 30.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.775 0.321 . . . . 0.0 111.051 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.8 t -135.79 123.83 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.168 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 179.879 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 15' ' ' LEU . 29.5 tpt180 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 121.067 0.46 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' C ' ' CD1' ' A' ' 30' ' ' TYR . . . -163.0 -154.19 7.53 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.041 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 29' ' ' GLY . 75.0 m-85 -161.05 135.62 7.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.899 0.35 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.4 ' HG ' ' CD1' ' A' ' 15' ' ' LEU . 80.7 mt -121.92 122.28 39.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.117 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.5 t -67.1 145.95 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.513 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -52.64 147.26 8.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.018 0.437 . . . . 0.0 111.28 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HD3' ' HG2' ' A' ' 38' ' ' GLU . 66.7 mttm -147.92 -125.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.118 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 38' ' ' GLU . 42.6 p -145.9 136.31 24.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.026 0.441 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -18.28 -53.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 38' ' ' GLU . 16.5 pt-20 -72.01 -48.83 41.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.356 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 35' ' ' THR . 81.4 tt0 -60.73 -48.97 79.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -49.69 -39.99 38.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.075 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 2.7 t -56.25 -48.52 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.359 0.6 . . . . 0.0 109.867 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -52.41 -47.73 66.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.277 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.1 73.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 61.0 mt -65.05 -47.35 77.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.773 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 61.7 mt -60.33 -49.8 76.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.602 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.2 -39.49 14.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.771 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 16.8 t80 -78.61 -43.86 25.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.244 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -55.58 -53.39 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 4.8 ptm180 -69.69 -61.85 1.62 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -51.52 -49.04 62.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.874 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.9 tp10 -73.22 -12.62 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.43 40.66 99.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.436 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.426 HD12 ' CE2' ' A' ' 46' ' ' PHE . 87.0 mt -74.51 -52.37 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.965 0.412 . . . . 0.0 111.098 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 53.69 29.3 40.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.212 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.495 ' O ' HD11 ' A' ' 55' ' ' LEU . 97.3 mttt -163.62 135.08 4.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.516 0.198 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 ' O ' ' A' ' 54' ' ' LYS . 2.7 mm? -139.82 139.64 36.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 12.4 p -149.66 143.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.962 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 21.6 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 111.969 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 76' ' ' PRO . 36.5 mtmm . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.28 -41.31 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.533 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.582 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 3.0 tm? -54.06 -53.93 53.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.9 Cg_endo -48.79 -35.67 31.34 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.296 1.998 . . . . 0.0 112.069 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 29.0 tp -61.62 -44.07 97.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 110.713 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 41.1 t -55.01 -34.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.432 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -56.58 -43.97 80.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.38 84.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 88' ' ' VAL . 33.5 mt -62.8 -42.83 99.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.383 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 78' ' ' VAL . 25.2 mmm180 -56.22 -43.92 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.693 0.282 . . . . 0.0 111.192 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.77 86.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.915 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -70.77 -30.5 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.929 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.15 42.92 4.2 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.16 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.42 142.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.687 0.28 . . . . 0.0 110.718 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.74 128.7 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.761 0.315 . . . . 0.0 110.63 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 81' ' ' LEU . 62.8 t -152.91 140.08 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 12.6 pm0 -165.42 132.03 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 90' ' ' LEU . 1.3 pt? . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.909 0.385 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -101.08 134.53 43.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.832 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.43 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 12.1 p -140.0 137.88 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.14 130.89 10.1 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.442 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -117.57 133.26 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.79 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 89.9 mt -120.38 138.92 53.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 111.194 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 10.1 p-10 -149.9 149.8 30.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.306 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.86 126.62 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.282 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.84 -55.81 2.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.991 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 178.16 34.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.299 . . . . 0.0 110.826 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 168.53 -48.04 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.084 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -105.25 140.41 38.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.43 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 53.5 mt -107.94 128.97 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.493 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.98 141.73 18.69 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.988 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.401 ' CG ' HD21 ' A' ' 31' ' ' LEU . 82.7 mt -118.05 129.71 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.452 ' HA ' ' HA2' ' A' ' 27' ' ' GLY . . . -138.75 147.41 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.995 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.426 HG23 ' CZ ' ' A' ' 46' ' ' PHE . 60.4 t -147.24 117.41 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.37 -149.88 9.01 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.091 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.456 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 11.7 pt-20 -77.54 148.28 35.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.585 0.231 . . . . 0.0 110.433 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -46.1 -55.38 7.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.241 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -85.72 130.55 9.95 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.195 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 58.9 t -150.2 126.08 5.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.619 0.247 . . . . 0.0 111.044 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.83 -47.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.582 2.188 . . . . 0.0 112.961 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.414 ' C ' ' CD1' ' A' ' 24' ' ' LEU . 2.8 tm? -64.52 -70.98 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.898 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.476 ' O ' ' OG ' ' A' ' 26' ' ' SER . . . 170.66 -42.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.34 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 25' ' ' ALA . 88.6 p 60.19 137.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.819 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.452 ' HA2' ' HA ' ' A' ' 16' ' ' ALA . . . -148.62 -152.66 5.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.632 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 179.17 -43.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.903 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.96 -138.28 2.53 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.638 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 p90 179.96 150.05 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.997 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.427 HD23 ' HB ' ' A' ' 13' ' ' ILE . 1.7 pt? -137.18 136.44 38.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.961 0.41 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.0 t -74.28 147.45 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.413 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 -54.73 140.96 34.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.433 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 60.1 mttm -137.23 -149.79 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.109 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.542 ' CG2' ' H ' ' A' ' 36' ' ' LEU . 1.9 m -87.94 -163.48 0.96 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.572 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.542 ' H ' ' CG2' ' A' ' 35' ' ' THR . 3.9 mp -78.64 -61.03 2.14 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.968 0.413 . . . . 0.0 110.523 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -64.1 -37.17 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.409 ' HG3' ' CD ' ' A' ' 34' ' ' LYS . 5.3 tp10 -57.0 -54.12 50.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.292 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 35' ' ' THR . 46.3 m-20 -52.12 -41.46 62.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.713 0.292 . . . . 0.0 110.631 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.38 -46.12 92.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.408 0.623 . . . . 0.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -55.75 -47.63 76.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.894 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.96 -44.29 85.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 110.533 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 36.8 mt -63.34 -50.03 71.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.341 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 22.1 mt -56.9 -49.88 74.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 37.0 t70 -46.9 -42.07 16.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.69 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.434 ' O ' ' CB ' ' A' ' 50' ' ' GLU . 17.2 t80 -83.75 -57.73 3.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -56.05 -47.58 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.91 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.568 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 13.9 tpp85 -65.85 -53.95 33.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 58.5 mmt-85 -71.41 -43.45 66.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 40.6 tp10 -63.81 -14.9 56.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.567 0.222 . . . . 0.0 111.37 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.02 40.54 99.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -68.95 -47.18 66.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 54' ' ' LYS . . . 56.94 32.0 61.91 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.662 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HE3' ' HB ' ' A' ' 3' ' ' VAL . 37.8 ttpt 178.19 130.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 54' ' ' LYS . 1.6 mm? -135.75 133.63 38.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.94 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 p -119.69 135.96 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.144 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.0 t -148.84 130.48 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 112.059 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -94.8 136.63 13.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.32 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.5 mt -159.59 138.83 8.18 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.5 0.19 . . . . 0.0 110.624 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.66 -47.14 19.91 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.27 1.98 . . . . 0.0 112.138 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.3 tp 62.0 126.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.172 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -75.92 -34.0 59.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.683 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.5 m 69.19 126.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.061 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 t0 178.48 138.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.547 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.35 -56.55 19.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.003 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.507 ' HD3' ' N ' ' A' ' 66' ' ' LYS . 2.5 mppt? -89.07 131.35 35.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.669 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 61.92 145.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.918 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 99.3 p -162.6 -150.73 0.18 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 58.36 40.13 24.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.919 0.39 . . . . 0.0 110.809 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -66.83 128.37 36.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.251 0.548 . . . . 0.0 111.37 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 60.76 135.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.875 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.28 131.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 113.139 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HD2' HD13 ' A' ' 36' ' ' LEU . 31.9 mtmm -86.82 49.38 1.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.932 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.2 t -83.01 -36.91 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.677 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.465 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 60.2 tp -49.12 -46.84 76.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 97.0 Cg_exo -43.44 -33.0 3.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.649 2.233 . . . . 0.0 112.904 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.457 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 28.2 tp -82.25 -44.92 15.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.41 -36.05 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.311 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 20.4 pt-20 -68.26 -39.11 82.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.352 . . . . 0.0 110.514 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.78 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 0.0 110.529 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.466 ' CD1' HG22 ' A' ' 88' ' ' VAL . 30.3 mt -60.03 -51.0 71.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.058 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -58.23 -44.04 88.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.15 -41.85 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . 0.409 ' NH1' ' CD2' ' A' ' 44' ' ' LEU . 99.1 mtt180 -83.64 15.54 3.13 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.68 37.16 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.36 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.9 t -99.2 132.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.685 0.279 . . . . 0.0 110.786 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 41.4 tp10 -62.61 133.02 54.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.86 0.362 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.466 HG22 ' CD1' ' A' ' 81' ' ' LEU . 61.0 t -157.68 150.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.952 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -163.48 127.92 2.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.24 125.25 28.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.708 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -76.88 126.49 31.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.884 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -71.1 -149.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.413 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -64.54 135.14 55.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.936 0.398 . . . . 0.0 110.783 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -63.33 -55.35 25.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.983 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -85.28 138.04 32.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -176.04 129.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.844 0.354 . . . . 0.0 111.342 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.8 m -71.57 136.31 47.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.0 tptt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.839 179.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.9 tpp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -104.15 137.52 41.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.157 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 9.6 p -133.06 133.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.066 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.45 ' HA3' HD12 ' A' ' 55' ' ' LEU . . . -78.55 139.56 22.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.868 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.474 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -130.86 134.71 47.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.378 . . . . 0.0 111.639 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 84.3 mt -117.91 137.45 52.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.097 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.469 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 8.6 p-10 -140.82 136.2 32.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.73 137.64 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.36 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.27 -44.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.227 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -178.65 105.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.751 0.31 . . . . 0.0 110.784 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . 45.57 30.35 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.281 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -165.86 143.3 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 54.1 mt -112.84 133.73 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.406 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.411 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -82.02 133.87 12.47 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.584 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.0 mt -105.11 130.26 53.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.856 179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.48 149.06 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.669 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.445 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 59.2 t -146.96 127.97 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.151 0.5 . . . . 0.0 111.501 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.72 -149.82 8.88 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.217 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -84.87 142.17 29.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 110.645 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -51.49 133.44 29.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.39 53.44 41.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.312 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.419 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 53.4 t -59.67 127.56 85.19 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.479 0.181 . . . . 0.0 111.015 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 22' ' ' VAL . 24.6 Cg_exo -63.05 -45.36 12.81 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.385 2.057 . . . . 0.0 112.31 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.7 mt -159.34 151.99 21.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.029 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 76.52 135.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.668 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.7 p 179.76 131.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.311 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.62 145.38 5.83 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.672 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 mmm180 -155.33 -44.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.657 0.265 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.18 -138.38 2.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.825 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.413 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 5.3 p90 -179.72 140.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.748 0.309 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.7 mt -120.22 126.09 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.9 t -71.99 144.12 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.414 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.424 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 74.6 mtp180 -55.14 149.27 12.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.959 0.409 . . . . 0.0 111.319 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 61.6 mttm -150.49 -153.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.437 ' CG2' ' H ' ' A' ' 36' ' ' LEU . 1.1 m -86.78 -158.6 0.44 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.457 ' HG ' ' N ' ' A' ' 37' ' ' GLU . 2.5 pt? -81.54 -48.56 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.123 -0.36 . . . . 0.0 111.0 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.457 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 16.5 pt-20 -66.96 -38.98 87.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 4.1 mm-40 -60.57 -55.42 33.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.33 -48.0 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.499 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.403 HG21 ' O ' ' A' ' 36' ' ' LEU . 5.2 t -60.51 -54.82 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 109.791 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -53.79 -45.82 70.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.48 87.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 97.4 mt -63.89 -44.19 93.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.268 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.454 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.0 mt -60.97 -47.58 85.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 110.527 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.422 ' HA ' ' CZ ' ' A' ' 48' ' ' ARG . 4.8 t70 -47.29 -41.76 19.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.489 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 16.1 t80 -75.06 -40.09 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.01 -53.9 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.454 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 8.9 ptt85 -72.06 -62.86 1.28 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 49' ' ' ARG . 11.7 mtp-105 -47.9 -50.52 26.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -75.65 -6.47 50.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.369 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.29 39.45 94.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.666 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.448 ' CD1' ' CE2' ' A' ' 46' ' ' PHE . 87.1 mt -72.78 -53.26 12.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.39 42.52 83.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.475 ' O ' HD11 ' A' ' 55' ' ' LEU . 83.3 tttt -178.3 127.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.475 HD11 ' O ' ' A' ' 54' ' ' LYS . 2.4 mm? -141.54 135.96 30.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.786 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 5' ' ' ALA . 13.4 p -117.47 125.69 74.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t -78.45 153.0 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.074 0.464 . . . . 0.0 111.647 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.405 ' O ' ' CD2' ' A' ' 59' ' ' LEU . . . -159.46 130.14 2.39 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.578 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 58' ' ' GLY . 75.0 mt -153.2 136.94 10.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.639 0.257 . . . . 0.0 111.222 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.41 141.18 45.95 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.556 2.171 . . . . 0.0 112.108 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.8 tp -55.88 128.16 33.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -72.65 134.56 45.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.1 p -67.2 130.96 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 p30 45.35 -170.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.502 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 65' ' ' LEU . 5.2 tt -80.44 -43.89 20.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HD3' ' N ' ' A' ' 67' ' ' GLU . 7.8 tmtm? -56.79 137.02 55.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.852 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.464 ' N ' ' HD3' ' A' ' 66' ' ' LYS . 50.8 mt-10 -153.69 132.22 12.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.75 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.1 p -64.8 -58.37 6.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.989 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.24 124.72 34.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -82.4 126.67 32.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 110.914 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 53.2 -135.1 1.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.52 -136.85 2.16 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.217 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -158.79 31.87 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.029 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.1 -42.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.595 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 59.3 tp -55.93 -43.77 99.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.579 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.8 Cg_exo -46.72 -40.15 24.13 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 0.0 112.392 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.5 tm? -71.44 -38.48 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.616 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.5 t -55.03 -36.24 37.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -67.09 -40.02 86.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.886 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.32 92.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.139 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' CD1' HG21 ' A' ' 88' ' ' VAL . 22.5 mt -59.78 -48.08 83.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -56.83 -41.26 77.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.005 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.14 75.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.194 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mtp85 -84.96 15.28 4.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.739 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.42 38.89 97.08 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.161 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -100.67 134.64 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.654 0.264 . . . . 0.0 111.046 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.4 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 4.4 mm-40 -63.79 129.03 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.459 HG21 ' CD1' ' A' ' 81' ' ' LEU . 57.3 t -157.52 144.83 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.129 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -168.08 131.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.344 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.0 pp -82.12 142.63 32.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.339 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.46 ' CD1' ' CG2' ' A' ' 56' ' ' VAL . 11.4 m0 -110.98 137.72 48.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.983 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -174.35 36.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.658 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.49 132.22 34.24 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.057 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.0 mtp85 -156.55 37.27 0.32 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.049 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 60.34 131.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.211 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.411 ' O ' ' CG2' ' A' ' 97' ' ' THR . 8.7 t -68.46 131.55 45.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 96' ' ' THR . 10.2 t 44.39 44.65 7.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.602 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 tttp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.891 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.881 0.372 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -88.68 131.93 34.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.065 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 3' ' ' VAL . 12.2 p -134.26 139.45 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.834 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.99 140.47 16.4 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.201 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -125.82 136.79 53.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.8 mt -125.43 142.49 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 10.9 p-10 -145.05 140.15 27.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.643 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.1 m -112.42 134.17 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.27 132.97 2.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.873 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 57.16 49.46 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.235 0.54 . . . . 0.0 111.329 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.434 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 52.29 33.68 13.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.449 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.517 ' NH1' ' HB2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -147.66 139.75 24.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.559 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 60.9 mt -106.56 128.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.623 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.76 131.89 10.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.824 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 92.7 mt -102.46 130.54 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -149.95 147.83 28.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.792 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.8 t -150.04 122.84 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.982 0.42 . . . . 0.0 111.063 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.56 -149.57 8.76 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.238 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.71 151.09 30.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.665 0.269 . . . . 0.0 110.563 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -46.58 140.41 4.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.205 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.14 46.43 13.1 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.248 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.88 126.31 82.95 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.543 0.211 . . . . 0.0 111.263 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.94 128.6 17.03 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.389 2.059 . . . . 0.0 111.901 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.4 tp 61.8 127.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.001 0.429 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.33 148.31 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.351 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.0 t 66.71 137.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.191 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.21 -47.44 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.259 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -68.61 -41.02 80.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 110.758 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.77 -143.96 4.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 179.79 150.47 0.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 111.379 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.406 ' CD2' ' N ' ' A' ' 31' ' ' LEU . 1.6 pt? -142.67 135.6 28.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.691 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.23 148.2 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.434 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 74.4 mtm180 -51.64 139.7 20.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.02 0.438 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HD3' ' HG3' ' A' ' 38' ' ' GLU . 66.5 mttm -128.05 -120.3 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.183 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.582 ' O ' ' N ' ' A' ' 38' ' ' GLU . 37.7 p -156.05 128.32 7.62 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.023 0.439 . . . . 0.0 112.113 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.449 ' C ' ' O ' ' A' ' 35' ' ' THR . 4.2 mp 0.08 -68.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.489 ' HG2' ' N ' ' A' ' 38' ' ' GLU . 13.5 pm0 -67.13 -45.71 76.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.0 tp10 -59.86 -50.22 74.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.022 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.409 ' OD2' ' HD2' ' A' ' 73' ' ' LYS . 55.3 m-20 -50.31 -38.82 43.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.11 -46.7 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 109.768 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -56.33 -48.34 76.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.005 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.998 0.428 . . . . 0.0 110.846 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.45 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 71.2 mt -63.13 -47.3 83.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.05 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.556 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 23.2 mt -59.76 -46.68 88.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 7.4 t70 -46.14 -42.04 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.454 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 18.0 t80 -81.17 -58.01 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -58.12 -48.87 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.07 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.556 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 31.5 tpt85 -65.25 -57.09 9.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 23.1 mmt85 -68.07 -43.43 78.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.4 tp10 -72.34 -3.23 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.661 0.267 . . . . 0.0 111.339 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.76 92.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.674 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.404 HD12 ' CE2' ' A' ' 46' ' ' PHE . 87.9 mt -71.5 -52.54 17.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.903 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.431 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 51.18 31.72 27.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.229 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 55' ' ' LEU . 61.5 mttp -162.63 131.02 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.599 0.238 . . . . 0.0 110.614 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.467 HD12 ' O ' ' A' ' 54' ' ' LYS . 2.7 mm? -141.67 136.97 31.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.204 0.526 . . . . 0.0 111.445 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.6 p -132.4 140.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.577 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.2 t -153.56 148.67 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.064 0.459 . . . . 0.0 111.56 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -149.35 141.25 8.74 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.921 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.2 mt -144.81 147.6 36.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 111.227 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.11 144.08 81.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.756 2.304 . . . . 0.0 112.155 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.447 ' CD1' ' CZ3' ' A' ' 91' ' ' TRP . 6.9 mp -57.81 129.79 43.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.7 mtm-85 -68.19 134.61 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 9.8 t -82.2 46.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.703 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.36 52.92 5.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 111.475 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -80.53 46.69 0.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.406 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -95.63 31.54 2.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.71 0.291 . . . . 0.0 111.124 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -80.44 -45.06 18.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.616 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -177.79 -46.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.417 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.9 140.33 58.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.774 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -171.34 134.5 0.89 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.271 0.558 . . . . 0.0 111.208 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.26 134.41 14.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.19 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.75 143.39 6.57 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.154 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.501 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 10.3 mtmp? -154.46 28.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 111.211 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.27 -43.14 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.109 0.481 . . . . 0.0 110.968 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.665 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 51.5 tp -55.42 -48.8 95.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.665 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.2 Cg_endo -46.68 -39.45 23.41 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.471 2.114 . . . . 0.0 112.127 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.45 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 35.1 tp -66.19 -38.31 87.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.412 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -53.04 -36.94 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.683 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.8 -43.1 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.592 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.46 -48.09 79.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.414 ' HB3' ' HB ' ' A' ' 86' ' ' VAL . 26.4 mt -58.7 -47.57 84.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.989 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.72 -42.36 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.44 -46.61 76.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.933 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.6 mtm-85 -87.53 18.87 3.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.28 37.65 92.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.866 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 57.7 t -89.17 131.12 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -62.73 132.15 51.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 57.8 t -153.05 144.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -148.36 150.84 34.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.327 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.424 ' N ' ' CD2' ' A' ' 90' ' ' LEU . 1.6 pt? -129.6 157.55 41.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.53 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.447 ' CZ3' ' CD1' ' A' ' 61' ' ' LEU . 23.8 t90 -59.32 144.26 47.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.022 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 68.03 126.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.787 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.09 133.61 44.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.206 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' NH2' ' CZ ' ' A' ' 95' ' ' PHE . 29.6 tpt180 -72.69 134.7 45.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CZ ' ' NH2' ' A' ' 94' ' ' ARG . 5.4 p90 -60.37 142.36 54.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.403 ' O ' ' HB ' ' A' ' 97' ' ' THR . 71.0 m -165.89 -41.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 96' ' ' THR . 51.6 m 72.26 -54.27 0.69 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.622 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.4 tptt . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.372 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -88.5 133.13 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.629 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 18' ' ' GLY . 14.7 p -132.72 137.36 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.971 0.415 . . . . 0.0 111.188 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.77 126.06 7.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.107 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.28 130.57 49.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.28 139.71 53.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.008 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 8.5 p-10 -147.64 139.17 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 p -113.99 133.51 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.1 126.31 1.27 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.899 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 55.85 45.53 23.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' ' HG3' ' A' ' 33' ' ' ARG . . . 75.54 -52.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.669 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.66 140.17 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.502 ' HB ' HD22 ' A' ' 31' ' ' LEU . 60.2 mt -111.23 130.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.835 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.45 140.06 22.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.253 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.445 ' CD1' HD23 ' A' ' 31' ' ' LEU . 74.5 mt -123.99 133.3 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.666 0.27 . . . . 0.0 110.522 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.415 ' O ' ' CG2' ' A' ' 17' ' ' VAL . . . -159.05 -162.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.333 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.425 HG22 ' HG3' ' A' ' 28' ' ' ARG . 90.3 t -158.87 142.4 6.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.414 ' O ' ' CG1' ' A' ' 3' ' ' VAL . . . -171.65 -148.87 6.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.982 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -123.58 116.75 23.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.905 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 47.67 46.75 18.08 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.832 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.62 142.09 0.01 OUTLIER Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.794 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 51.9 t -157.01 137.21 8.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.468 0.175 . . . . 0.0 110.877 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.0 129.71 31.52 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.449 2.099 . . . . 0.0 112.372 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.1 mt 60.89 125.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.192 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 175.45 40.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.127 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -75.66 134.53 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.713 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.81 -45.28 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.287 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.7 mmp_? -58.34 -55.38 35.75 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.843 -0.21 . . . . 0.0 111.355 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.19 -139.87 5.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.172 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -179.98 151.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.659 0.266 . . . . 0.0 110.796 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.502 HD22 ' HB ' ' A' ' 13' ' ' ILE . 1.5 pt? -133.91 136.17 44.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.401 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.9 t -76.08 156.04 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.724 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 64.0 mtp180 -51.84 150.21 4.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.807 0.337 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 56.7 mttp -147.97 -155.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.26 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.455 ' HB ' ' OE2' ' A' ' 37' ' ' GLU . 0.6 OUTLIER -97.13 -158.39 0.66 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.468 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.454 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 2.6 mm? -75.32 -55.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.607 0.241 . . . . 0.0 111.376 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.455 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.9 OUTLIER -70.36 -38.25 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.991 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.431 ' HB2' ' HB3' ' A' ' 34' ' ' LYS . 7.3 mt-10 -57.74 -55.91 28.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 0.0 110.772 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -53.97 -42.31 68.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.794 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 6.1 t -58.98 -55.99 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.415 0.626 . . . . 0.0 110.384 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.66 -46.89 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.422 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.28 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 72.7 mt -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.379 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 76.3 mt -59.52 -48.4 81.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -50.23 -37.78 37.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.708 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.448 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 17.9 t80 -77.04 -44.1 32.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.6 t -56.62 -53.77 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -70.78 -60.79 2.04 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -49.6 -50.46 42.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.72 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.6 tp10 -74.25 -10.97 60.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.618 0.247 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.44 39.62 97.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.561 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.412 HD12 ' CE2' ' A' ' 46' ' ' PHE . 89.4 mt -75.09 -49.37 19.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 54.86 26.5 40.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.381 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.455 ' CG ' ' O ' ' A' ' 53' ' ' GLY . 66.1 mttm -164.26 131.65 3.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 54' ' ' LYS . 2.3 mm? -140.28 131.06 25.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 111.764 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.8 p -118.64 124.24 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.488 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.432 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 45.8 t -78.71 128.49 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.516 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -85.69 139.95 17.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.192 179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 97.5 mt -157.28 129.52 4.13 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.588 0.232 . . . . 0.0 110.943 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.65 -161.16 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.494 2.129 . . . . 0.0 112.234 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.29 134.43 45.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.797 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -64.47 127.37 31.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.887 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.2 p -75.56 -52.39 10.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.173 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 t70 179.5 130.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.65 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -71.62 128.01 34.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.474 ' NZ ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER 178.54 120.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.625 179.668 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 66' ' ' LYS . 66.4 mm-40 59.93 132.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.2 p -62.68 120.05 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.781 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.55 132.96 35.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.01 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -64.86 131.65 47.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 110.784 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.8 134.98 53.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.247 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.46 51.03 2.92 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.748 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER 59.32 20.95 9.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.637 0.256 . . . . 0.0 110.901 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.2 t -100.4 -44.35 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.166 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.659 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.9 tm? -54.21 -49.67 88.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.622 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.659 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.8 Cg_endo -46.95 -40.27 25.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.565 2.177 . . . . 0.0 112.599 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.494 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.8 tm? -71.84 -37.86 70.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.4 t -55.7 -35.62 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.676 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.85 -40.02 91.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.892 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.74 91.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.451 ' HG ' HD11 ' A' ' 77' ' ' LEU . 27.1 mt -61.52 -47.43 85.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.502 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 3.6 mmm180 -59.12 -42.27 90.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.19 80.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.377 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -86.89 19.25 3.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.799 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.74 37.88 94.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.985 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 52.9 t -97.28 134.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.2 tp10 -65.4 128.09 34.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.947 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' A' ' 81' ' ' LEU . 46.7 t -158.06 145.06 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.55 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -169.71 141.34 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.122 0.487 . . . . 0.0 111.824 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.432 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 2.6 mm? -66.46 139.72 57.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.411 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -135.19 136.42 41.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.978 0.418 . . . . 0.0 110.903 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 93' ' ' GLU . 9.9 t70 -62.55 -118.12 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.451 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' O ' ' O ' ' A' ' 94' ' ' ARG . 17.7 tp10 -176.85 138.74 0.27 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.893 0.378 . . . . 0.0 110.991 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' A' ' 93' ' ' GLU . 14.1 ptp180 51.7 138.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.135 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -56.22 139.96 46.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.3 m -165.75 -41.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t -169.15 135.9 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.221 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.84 0.352 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -101.29 134.92 43.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.154 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.7 p -124.78 132.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.863 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.87 124.08 6.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.879 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.313 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 99.0 mt -129.27 138.63 51.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 9.5 p-10 -146.33 138.92 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.524 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.6 t -105.5 135.11 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.74 130.41 1.65 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.743 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.421 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 17.5 tp10 55.81 52.06 11.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.18 0.514 . . . . 0.0 111.136 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.414 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . 50.5 35.11 10.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.44 ' HD3' ' CG ' ' A' ' 30' ' ' TYR . 38.6 ttm180 -149.24 140.1 22.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.855 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -103.8 128.66 56.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -83.93 130.32 9.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.544 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.11 131.58 52.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.51 147.01 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.901 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.3 t -143.5 119.34 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.197 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.44 -149.53 8.76 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.3 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.0 pm0 -69.36 145.87 52.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.6 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -52.24 133.14 34.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.033 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.72 52.47 48.32 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.809 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 47.1 t -59.86 127.36 85.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.485 0.183 . . . . 0.0 111.014 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 22' ' ' VAL . 13.2 Cg_exo -69.39 54.97 1.08 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.794 2.329 . . . . 0.0 112.606 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' CD2' ' C ' ' A' ' 24' ' ' LEU . 5.6 tt -175.93 -41.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.579 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 64.97 137.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.168 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 48.8 m 63.91 130.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.88 45.33 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 -157.32 -45.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 110.791 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.22 -140.77 3.36 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.317 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.44 ' CG ' ' HD3' ' A' ' 12' ' ' ARG . 6.9 p90 179.95 140.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.383 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.7 mt -106.14 123.02 47.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.546 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.457 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.8 t -72.68 148.99 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.414 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 81.6 mtm180 -47.08 148.32 1.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.334 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 62.3 mttm -144.79 -121.94 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 38' ' ' GLU . 23.4 p -154.78 128.0 8.36 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' A' ' 35' ' ' THR . 83.5 mt 5.83 -69.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.4 pt-20 -67.8 -46.88 70.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 111.763 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.1 tp10 -58.55 -50.65 73.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.079 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.4 m-20 -48.67 -46.03 39.7 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.94 0.4 . . . . 0.0 110.315 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 t -61.93 -50.22 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -52.91 -46.85 68.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.093 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.46 93.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.482 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 94.7 mt -67.31 -42.0 84.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.639 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.473 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 70.0 mt -59.58 -56.21 24.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.694 0.283 . . . . 0.0 111.066 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -48.55 -38.02 19.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.812 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.434 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 16.2 t80 -73.49 -42.59 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.31 -50.12 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -72.89 -62.84 1.32 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.8 mmm-85 -48.0 -51.8 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.074 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.1 tp10 -76.08 -4.88 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.343 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.08 40.68 91.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.425 HD13 ' CD2' ' A' ' 46' ' ' PHE . 86.4 mt -68.22 -54.35 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.99 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.95 40.66 66.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.125 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 55' ' ' LEU . 3.4 tppp? -178.36 128.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 54' ' ' LYS . 2.4 mm? -141.32 133.2 27.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 111.776 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 14.8 p -121.57 117.83 53.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.341 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.23 145.42 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.533 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.406 ' O ' ' CD2' ' A' ' 59' ' ' LEU . . . -143.6 125.62 2.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.903 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.406 ' CD2' ' O ' ' A' ' 58' ' ' GLY . 88.5 mt -158.47 134.5 6.19 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.579 0.228 . . . . 0.0 110.747 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.49 129.36 17.75 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.289 1.993 . . . . 0.0 112.123 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' CD1' ' HB ' ' A' ' 63' ' ' THR . 0.6 OUTLIER 62.3 121.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.307 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.505 ' O ' ' CG2' ' A' ' 63' ' ' THR . 19.8 tpp180 -86.38 -40.73 15.12 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 62' ' ' ARG . 8.2 t 50.53 -133.28 1.72 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.107 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -47.49 126.71 10.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.935 0.398 . . . . 0.0 111.298 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.92 -39.9 41.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.366 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -159.63 151.33 20.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.028 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -158.59 -40.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.4 t 65.82 -145.97 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.611 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 59.53 46.63 11.89 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 120.908 0.385 . . . . 0.0 110.727 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 63.63 103.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.666 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 178.74 142.4 0.11 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.117 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.04 131.21 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.591 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 36.6 mtmm -109.64 -29.17 8.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.77 0.319 . . . . 0.0 110.988 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.01 -45.09 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.158 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.501 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 56.3 tp -56.71 -49.82 91.5 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.501 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 83.9 Cg_exo -44.06 -38.37 10.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.116 . . . . 0.0 112.38 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.482 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.3 tm? -70.5 -36.31 73.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.693 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.3 t -54.45 -36.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.959 0.409 . . . . 0.0 110.581 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.93 -39.9 83.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.846 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.91 85.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' HB2' HG23 ' A' ' 88' ' ' VAL . 23.6 mt -59.08 -45.29 91.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.026 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -58.3 -44.04 88.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.08 85.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.103 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -83.11 15.55 2.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 38.84 96.65 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.254 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.5 135.24 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.35 . . . . 0.0 111.021 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -69.75 139.35 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.469 HG23 ' HB2' ' A' ' 81' ' ' LEU . 44.5 t -155.84 139.72 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.53 130.79 4.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.032 0.444 . . . . 0.0 111.61 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.3 pp -83.02 146.81 28.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 12.5 m0 -59.89 151.99 24.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.369 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t0 67.05 135.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.196 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -178.28 127.11 0.12 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.465 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 21.6 tpp180 -172.36 40.04 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.713 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -75.33 -48.05 24.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.762 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t 178.18 136.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.3 p -58.12 133.74 55.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' C ' ' HD2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.779 0.323 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -93.68 133.31 37.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.794 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.4 p -136.58 136.13 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.405 ' HA3' HD11 ' A' ' 55' ' ' LEU . . . -79.32 134.69 14.12 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.134 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HA ' HG11 ' A' ' 56' ' ' VAL . . . -121.96 133.92 54.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 111.423 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 98.9 mt -126.43 139.45 53.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.13 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.498 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -143.77 139.35 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.31 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -106.71 128.45 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.867 0.365 . . . . 0.0 111.559 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.84 -135.46 6.63 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.79 -44.4 90.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.364 . . . . 0.0 110.746 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.409 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -168.15 32.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.708 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 23.6 mmt85 -147.92 144.21 27.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.482 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 55.3 mt -99.61 125.25 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.41 129.34 9.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.631 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -104.81 127.13 52.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 110.937 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -147.29 148.94 31.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.6 t -151.1 133.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.005 0.431 . . . . 0.0 111.676 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.89 -149.89 8.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.374 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -98.62 164.88 12.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.699 0.285 . . . . 0.0 110.973 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -48.75 -45.44 39.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 110.906 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.13 54.72 3.12 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.508 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t -59.95 134.61 90.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.608 0.242 . . . . 0.0 111.026 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.21 -41.15 44.67 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.646 2.23 . . . . 0.0 112.271 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.3 tp -168.83 -42.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.017 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.91 -42.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.245 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.2 t 63.44 127.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.962 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.03 146.82 34.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.682 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -158.03 -47.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.611 0.243 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.66 -151.41 10.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.856 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.4 p90 179.82 141.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.946 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' ' N ' ' A' ' 13' ' ' ILE . 67.0 mt -114.71 124.19 51.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 47.6 t -66.22 146.0 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.562 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.409 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 98.6 mtt180 -51.58 147.54 6.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.862 0.363 . . . . 0.0 111.465 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 52.1 mttp -147.17 -125.75 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.052 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 38' ' ' GLU . 16.1 p -157.69 134.79 10.14 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.486 ' O ' ' CG2' ' A' ' 40' ' ' VAL . 5.2 mp 5.27 -72.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -69.75 -48.15 60.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.0 tp10 -57.49 -50.27 73.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.942 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.413 ' OD2' ' CG ' ' A' ' 73' ' ' LYS . 45.5 m-20 -51.31 -42.38 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 2.6 t -60.84 -47.38 93.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.511 0.672 . . . . 0.0 109.779 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.74 -49.58 37.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.436 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.2 -44.3 59.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.257 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.463 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 27.7 mt -61.57 -48.12 82.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.934 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.502 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 57.9 mt -57.51 -50.76 72.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -45.28 -40.43 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.968 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.476 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 18.0 t80 -77.45 -45.43 25.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.456 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 65.8 t -57.1 -50.85 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 5.4 ptm180 -71.32 -62.77 1.28 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -51.42 -48.84 62.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.995 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -69.87 -13.41 62.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.547 0.213 . . . . 0.0 111.219 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.88 39.12 95.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.423 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.404 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 86.1 mt -74.1 -49.27 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 54.53 28.21 44.14 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.233 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.46 ' O ' HD13 ' A' ' 55' ' ' LEU . 67.5 mttm -164.14 129.96 2.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.268 0.227 . . . . 0.0 110.399 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 54' ' ' LYS . 2.6 mm? -140.25 121.02 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.503 HG11 ' HA ' ' A' ' 5' ' ' ALA . 8.6 p -99.3 113.93 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.88 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' HB ' ' CB ' ' A' ' 90' ' ' LEU . 48.1 t -73.62 157.92 6.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.735 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.457 ' HA3' ' CZ2' ' A' ' 91' ' ' TRP . . . -155.02 129.82 2.66 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.657 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.405 ' CD2' ' O ' ' A' ' 58' ' ' GLY . 91.8 mt -157.58 146.09 14.4 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.603 0.24 . . . . 0.0 110.928 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.1 -26.58 76.34 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.551 2.167 . . . . 0.0 112.148 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 67.8 mt 69.83 -157.2 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.404 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 44.6 -153.78 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.35 0.119 . . . . 0.0 110.758 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 42.1 m 53.34 48.7 21.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 111.031 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -76.55 48.03 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.676 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 5.0 mp -88.47 140.38 29.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.727 0.299 . . . . 0.0 110.825 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -54.76 -41.43 70.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.001 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -59.2 -50.75 72.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.0 m -70.14 131.23 43.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.712 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.71 130.12 38.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.293 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 16.0 mp0 -73.25 133.8 44.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.215 0.531 . . . . 0.0 110.987 179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.413 ' CB ' ' HB2' ' A' ' 75' ' ' LEU . . . 70.13 -55.98 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.678 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.31 -138.78 19.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.282 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 73' ' ' LYS . 2.7 mppt? -81.73 -28.62 33.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.5 -53.28 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 2.2 tm? -55.38 -50.4 86.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.503 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.2 Cg_exo -42.5 -39.9 7.04 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.494 2.13 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.463 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 42.6 tp -66.52 -41.31 88.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 22.0 t -53.99 -34.88 26.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.86 -43.17 93.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.21 91.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.419 ' CD1' HG22 ' A' ' 88' ' ' VAL . 31.7 mt -59.4 -41.18 88.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.366 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 62.1 mtt85 -57.11 -42.73 81.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.281 . . . . 0.0 111.219 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.76 -51.27 69.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.383 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -70.63 -27.3 63.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.99 43.41 4.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.346 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -98.85 139.95 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.613 0.244 . . . . 0.0 110.754 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -60.43 130.15 45.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 81' ' ' LEU . 60.9 t -151.86 145.2 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -171.86 123.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.481 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.415 ' CB ' ' HB ' ' A' ' 57' ' ' VAL . 1.8 pt? -75.68 130.66 39.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.457 ' CZ2' ' HA3' ' A' ' 58' ' ' GLY . 1.5 p90 -77.31 143.1 39.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.573 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -178.13 133.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.795 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 56.64 47.27 18.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' NH2' ' CE1' ' A' ' 95' ' ' PHE . 8.4 ptm180 -177.45 134.04 0.18 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.946 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' ' NH2' ' A' ' 94' ' ' ARG . 2.0 m-85 63.01 137.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t -57.45 139.0 54.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.313 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.6 p -158.47 135.1 9.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 1' ' ' MET . 49.6 ttm . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.822 0.344 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -96.38 132.3 42.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.917 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.425 ' HB ' ' HE3' ' A' ' 54' ' ' LYS . 13.0 p -126.32 132.42 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.08 126.93 7.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.012 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.37 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.696 -0.297 . . . . 0.0 111.098 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 95.0 mt -120.47 136.53 54.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.454 . . . . 0.0 111.249 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.551 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -146.97 139.43 24.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.165 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.0 m -108.73 134.23 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.61 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.01 131.52 1.78 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.958 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 40.4 tt0 56.8 53.47 8.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 48.85 35.92 7.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.467 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -151.69 140.97 21.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.68 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.551 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 61.8 mt -105.27 127.4 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 134.38 13.42 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.768 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 88.0 mt -113.59 133.72 55.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 0.0 110.912 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.38 148.95 29.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.999 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.0 t -140.43 121.96 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.289 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.63 -149.59 8.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.341 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 56.2 mt-10 -65.77 154.79 38.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.724 0.297 . . . . 0.0 110.747 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -65.47 126.84 29.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.964 0.411 . . . . 0.0 111.055 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.67 48.06 86.84 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.712 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.427 ' CG2' ' O ' ' A' ' 19' ' ' GLU . 59.3 t -71.52 132.72 85.36 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 117.095 0.448 . . . . 0.0 110.827 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.408 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 92.3 Cg_endo -83.75 37.72 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.641 2.227 . . . . 0.0 112.732 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 23' ' ' PRO . 94.9 mt -161.8 -42.6 0.04 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.931 0.396 . . . . 0.0 110.6 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 69.46 125.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.0 p -73.09 -37.49 66.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.34 138.79 1.37 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.328 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.1 mmm180 -132.08 -43.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.98 -137.58 2.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.67 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -179.93 150.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.927 0.394 . . . . 0.0 110.86 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.452 HD23 ' HB ' ' A' ' 13' ' ' ILE . 1.3 pt? -134.67 135.33 41.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.21 145.07 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.454 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 66.1 mtm180 -54.26 151.59 7.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.168 0.509 . . . . 0.0 111.326 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 64.1 mttm -146.61 -122.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.699 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 37' ' ' GLU . 38.4 p -148.58 139.72 23.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.728 0.299 . . . . 0.0 110.903 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.523 ' CD1' ' N ' ' A' ' 36' ' ' LEU . 0.0 OUTLIER -21.96 -43.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.519 ' N ' ' CD2' ' A' ' 36' ' ' LEU . 11.9 pt-20 -73.46 -48.88 30.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.453 ' HG2' ' OG1' ' A' ' 35' ' ' THR . 13.6 mm-40 -61.79 -48.31 81.21 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.421 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 23.0 m-20 -45.93 -40.96 10.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.486 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.74 -52.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.185 0.517 . . . . 0.0 110.363 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.09 -51.92 66.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.94 93.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 74.0 mt -65.22 -50.31 66.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.44 ' HB3' ' NH1' ' A' ' 48' ' ' ARG . 61.5 mt -59.1 -48.08 82.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -49.35 -38.91 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.458 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 17.9 t80 -77.04 -43.69 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.236 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.9 t -58.06 -51.81 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.44 ' NH1' ' HB3' ' A' ' 44' ' ' LEU . 1.5 ptt-85 -67.81 -63.18 1.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.6 mtp85 -51.35 -49.75 60.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.881 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.458 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -72.05 -10.23 59.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.263 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.8 97.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.465 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.9 mt -72.36 -52.81 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 0.0 110.897 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.84 36.18 54.77 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.257 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' O ' HD12 ' A' ' 55' ' ' LEU . 37.3 ttpt 178.21 131.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 54' ' ' LYS . 1.6 mm? -137.8 137.45 38.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.748 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.0 p -128.19 132.79 68.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.11 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.402 ' HB ' ' HA ' ' A' ' 90' ' ' LEU . 14.8 t -77.91 141.91 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.752 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -152.48 133.93 4.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.195 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.1 mt -149.56 114.07 3.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.536 0.208 . . . . 0.0 110.584 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.54 -57.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.409 2.073 . . . . 0.0 112.458 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.3 tp -77.27 127.21 32.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.372 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -83.15 133.95 35.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.655 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.5 p -61.44 127.45 31.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.59 -57.92 3.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -66.03 125.61 25.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.456 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -84.35 133.92 34.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.763 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 68' ' ' SER . 12.6 pt-20 -177.62 -163.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.674 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 67' ' ' GLU . 91.6 p 56.33 130.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.056 0.455 . . . . 0.0 111.547 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.74 98.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -178.24 130.83 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.271 0.558 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.48 -144.15 0.56 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.946 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' O ' ' CD ' ' A' ' 76' ' ' PRO . . . -179.64 -135.44 2.43 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.374 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.457 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 37.3 mtmm -64.22 -25.26 67.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 111.383 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.22 -41.15 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.545 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 61.2 tp -54.5 -52.0 73.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.3 Cg_exo -43.94 -40.16 11.52 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.348 2.032 . . . . 0.0 112.219 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.476 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 32.0 tp -63.19 -42.79 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.6 t -52.01 -35.49 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.77 -42.81 94.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.06 66.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.446 ' CD1' HG22 ' A' ' 88' ' ' VAL . 24.5 mt -57.94 -50.91 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -58.44 -38.4 77.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.42 -43.74 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.427 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 68.0 mtm-85 -89.69 20.04 4.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.505 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 39.82 98.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.1 t -95.52 132.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.081 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.85 130.22 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.679 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 81' ' ' LEU . 65.9 t -155.91 144.48 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.96 0.41 . . . . 0.0 111.301 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -172.02 129.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.29 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.402 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 2.5 pp -78.0 149.61 34.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.693 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -157.87 137.55 12.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.069 0.461 . . . . 0.0 111.602 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 93' ' ' GLU . 2.8 p30 -177.96 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.314 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.405 ' N ' ' OD1' ' A' ' 92' ' ' ASP . 52.7 mt-10 -70.2 132.74 46.22 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -164.41 -47.87 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.332 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -177.99 130.13 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.728 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 97' ' ' THR . 37.7 m -91.11 42.83 1.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.277 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' THR . 65.7 p 56.33 133.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.767 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.33 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.985 0.422 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.485 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 1.0 OUTLIER -87.59 135.91 33.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.672 179.515 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.7 p -121.49 131.56 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.092 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.408 ' HA3' HD12 ' A' ' 55' ' ' LEU . . . -87.48 117.56 4.76 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.951 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -97.22 133.3 42.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.226 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 83.8 mt -123.73 138.37 54.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.581 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -145.34 144.39 30.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.106 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.06 141.18 45.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 111.531 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.78 133.5 2.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.756 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 66.04 -67.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.344 0.257 . . . . 0.0 111.522 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.452 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . -176.19 36.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.844 0.354 . . . . 0.0 111.354 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -156.46 143.9 19.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.3 mt -104.09 130.44 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.708 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.13 138.12 17.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.009 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.481 ' CD2' HD11 ' A' ' 31' ' ' LEU . 52.4 mt -115.39 132.8 56.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -154.68 145.46 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.058 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 57.5 t -136.96 125.6 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.115 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.63 -149.42 8.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.143 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' O ' ' CG2' ' A' ' 22' ' ' VAL . 42.2 tp10 -73.56 160.02 32.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.338 . . . . 0.0 110.53 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.401 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 94.2 mt-10 -67.7 130.08 41.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.944 0.402 . . . . 0.0 111.402 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.02 46.06 95.35 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.182 -0.532 . . . . 0.0 113.767 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 19' ' ' GLU . 94.7 t -80.14 133.49 57.39 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.896 0.348 . . . . 0.0 110.979 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.05 134.39 29.36 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.482 2.121 . . . . 0.0 111.767 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.417 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.5 mm? 60.22 52.85 4.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.863 0.363 . . . . 0.0 110.343 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.453 ' O ' ' OG ' ' A' ' 26' ' ' SER . . . -60.17 -138.63 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.608 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 25' ' ' ALA . 97.8 p 58.45 122.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.967 0.413 . . . . 0.0 111.017 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.91 51.55 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.406 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.5 mmp_? -151.39 -50.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.73 -139.4 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.378 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.525 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 5.7 p90 -179.81 143.06 0.17 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 111.311 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.481 HD11 ' CD2' ' A' ' 15' ' ' LEU . 1.3 mp -111.81 127.97 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.029 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.473 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 55.2 t -70.61 143.35 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.452 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 mtt180 -50.58 140.23 14.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.824 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 50.3 mttp -138.53 -140.75 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.641 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.459 ' CG2' ' H ' ' A' ' 36' ' ' LEU . 1.2 m -106.16 -158.98 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.46 ' HG ' ' N ' ' A' ' 37' ' ' GLU . 2.5 pt? -77.17 -49.65 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.148 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.46 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 15.4 pt-20 -70.59 -40.13 73.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.602 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.42 -57.03 13.56 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.333 0.587 . . . . 0.0 110.351 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.6 -44.75 62.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.759 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 3.6 t -60.51 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.428 0.633 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -53.51 -45.52 69.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.128 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.68 -47.02 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.774 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.441 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 92.1 mt -65.86 -45.14 83.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.651 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 22.3 mt -59.29 -57.47 12.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.526 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.817 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 65.8 t0 -43.95 -42.1 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 15.9 t80 -71.05 -42.39 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.152 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 83.5 t -67.32 -44.57 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.651 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.8 ptm180 -64.43 -67.53 0.43 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.817 ' HG2' ' O ' ' A' ' 45' ' ' ASP . 39.7 ptt85 -56.19 -47.75 77.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.0 tp10 -65.35 -16.06 63.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 111.258 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 36.86 90.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 89.8 mt -68.15 -50.64 53.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.74 40.06 69.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.439 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.471 ' O ' HD11 ' A' ' 55' ' ' LEU . 59.7 tttp -177.87 125.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.476 0.179 . . . . 0.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.471 HD11 ' O ' ' A' ' 54' ' ' LYS . 2.4 mm? -140.39 131.68 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.446 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.18 120.05 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.842 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 t -92.27 153.73 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.407 ' O ' ' CD2' ' A' ' 59' ' ' LEU . . . -152.31 130.72 3.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.003 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.407 ' CD2' ' O ' ' A' ' 58' ' ' GLY . 93.1 mt -156.83 138.15 9.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.643 0.258 . . . . 0.0 110.993 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.96 149.05 82.9 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.703 2.268 . . . . 0.0 112.312 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.9 mt 68.13 139.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -55.47 138.78 45.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.082 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 t -58.35 134.34 56.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.301 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.99 141.65 58.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -59.94 137.0 58.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.753 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt 63.48 136.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.719 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -62.0 121.56 13.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.779 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.8 p -81.76 134.9 35.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.08 78.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.781 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -70.2 132.31 45.56 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.287 0.565 . . . . 0.0 110.83 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.25 -146.9 0.5 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.801 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 76' ' ' PRO . . . 54.94 43.04 82.18 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.302 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.474 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 53.8 mtmt -76.96 -25.31 52.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.624 0.249 . . . . 0.0 111.576 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.31 -45.25 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.524 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 2.0 tm? -52.34 -50.12 81.39 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 96.0 Cg_exo -40.85 -33.32 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.834 2.356 . . . . 0.0 112.895 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.7 tm? -80.8 -39.42 26.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.3 t -53.64 -36.8 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 21.3 pt-20 -73.56 -33.91 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.734 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.12 -45.11 91.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.157 0.503 . . . . 0.0 110.692 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.472 ' CD1' HG23 ' A' ' 88' ' ' VAL . 22.9 mt -60.7 -47.84 84.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.81 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -57.83 -39.59 78.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.94 72.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.376 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -88.19 21.21 2.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.724 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.99 92.73 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.966 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.53 135.78 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.703 0.287 . . . . 0.0 111.063 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 65.5 mm-40 -64.57 125.84 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.792 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG23 ' CD1' ' A' ' 81' ' ' LEU . 57.7 t -158.78 145.97 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -166.92 131.92 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.095 0.474 . . . . 0.0 111.624 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 91' ' ' TRP . 6.1 tt -72.27 142.38 48.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.278 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.415 ' N ' HD21 ' A' ' 90' ' ' LEU . 21.0 t-105 -146.86 141.99 27.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 0.0 111.042 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -164.28 -43.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.761 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -175.21 127.32 0.27 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.185 0.516 . . . . 0.0 111.121 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 3.0 tpm_? -91.74 -44.2 9.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.923 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.47 57.82 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.503 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.2 m -62.51 -43.46 98.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.899 0.381 . . . . 0.0 110.796 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 77.6 m 63.72 132.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.052 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 47.0 mmtm . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 179.889 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 121.029 0.443 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -104.74 140.26 38.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.782 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.414 ' O ' HG13 ' A' ' 3' ' ' VAL . 11.9 p -119.42 136.23 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.281 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.47 131.18 10.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.094 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -113.87 130.76 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 111.112 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 96.5 mt -123.37 135.95 54.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.041 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 2.9 p30 -140.3 134.86 31.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.625 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -98.95 129.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.637 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.98 -135.48 5.69 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.285 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -62.92 -42.85 99.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . -171.57 39.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -155.33 146.61 22.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -98.95 127.03 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.484 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.47 126.63 7.7 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.447 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 86.0 mt -99.42 130.41 45.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.918 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -150.52 145.84 26.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.52 124.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.72 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.64 151.67 10.05 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.505 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -59.86 148.59 34.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.637 0.256 . . . . 0.0 110.404 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -42.07 134.98 2.6 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.537 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.29 45.97 52.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.455 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.29 127.53 92.2 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.519 0.199 . . . . 0.0 111.102 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.426 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 23.6 Cg_exo -63.91 134.38 43.08 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.358 2.039 . . . . 0.0 111.699 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HB3' ' O ' ' A' ' 23' ' ' PRO . 54.8 tp 69.69 -51.54 0.62 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.533 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 71.1 137.55 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.981 0.419 . . . . 0.0 111.256 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.7 p -173.71 129.92 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.623 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.44 132.77 27.67 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.789 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -65.52 -35.63 81.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 110.676 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.81 -135.59 1.88 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.252 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 7.2 p90 -178.9 138.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.0 mt -106.43 125.63 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.669 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.23 133.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.431 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 52.4 mtp85 -56.94 124.98 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.461 . . . . 0.0 111.048 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' CB ' ' HB2' ' A' ' 38' ' ' GLU . 96.6 mttt -109.09 -96.96 0.39 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.9 OUTLIER -176.03 127.3 0.22 Allowed 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.416 ' CD1' ' HG3' ' A' ' 76' ' ' PRO . 62.4 tp 16.59 -76.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -67.55 -44.93 77.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.506 ' HB2' ' CB ' ' A' ' 34' ' ' LYS . 4.6 mm-40 -57.69 -51.72 68.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.269 0.557 . . . . 0.0 110.324 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.9 m-20 -49.06 -42.8 39.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.243 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 3.2 t -58.86 -54.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 110.514 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -52.76 -49.53 65.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.346 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.22 89.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.948 0.404 . . . . 0.0 111.201 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.497 ' CD1' ' HG ' ' A' ' 77' ' ' LEU . 84.2 mt -65.25 -46.09 81.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.391 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.477 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 72.7 mt -60.58 -52.8 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -48.55 -38.41 20.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.437 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 18.0 t80 -73.09 -42.09 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 69.8 t -65.04 -51.94 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -70.79 -62.72 1.29 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -47.61 -51.0 22.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.959 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.437 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 5.4 tp10 -77.0 -4.04 42.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 111.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.49 38.55 91.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.657 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.0 mt -72.59 -55.55 6.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.41 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . 53.0 33.22 43.76 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' O ' HD13 ' A' ' 55' ' ' LEU . 34.2 mmtp -161.91 128.1 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.225 0.21 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 54' ' ' LYS . 2.8 mm? -143.16 133.05 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.367 0.603 . . . . 0.0 111.65 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 11.1 p -131.02 122.44 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.2 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 25.0 t -97.23 141.76 15.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.589 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.44 109.99 0.65 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.983 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.42 131.37 84.84 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.525 0.203 . . . . 0.0 110.898 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.4 42.03 1.26 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.586 2.191 . . . . 0.0 112.862 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.463 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.5 pt? 179.67 129.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.758 0.314 . . . . 0.0 110.864 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -71.85 -51.45 22.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.744 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -76.5 142.16 41.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.245 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.68 132.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.446 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -171.24 41.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.237 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm 64.75 146.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.675 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -154.52 -42.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.28 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.5 t -169.13 135.01 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.932 0.396 . . . . 0.0 111.261 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 62.25 126.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.42 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -75.3 136.05 40.89 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.97 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.33 127.85 8.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.441 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.64 129.5 1.09 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.127 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -179.39 34.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.287 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.4 -43.17 10.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.074 0.464 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.667 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 59.7 tp -53.5 -48.86 91.42 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 1.4 Cg_endo -43.19 -39.78 8.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.767 2.311 . . . . 0.0 112.718 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.497 ' HG ' ' CD1' ' A' ' 43' ' ' LEU . 2.5 tm? -76.07 -36.87 58.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -55.44 -36.18 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.678 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -66.23 -39.55 89.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.51 -44.9 93.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' HG22 ' A' ' 88' ' ' VAL . 24.1 mt -60.15 -48.39 81.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.056 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -58.81 -43.57 90.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.667 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.7 82.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -84.08 17.84 2.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.659 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 37.16 94.15 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.318 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.2 t -106.93 133.38 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 0.0 110.942 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -67.89 132.2 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.927 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.446 HG22 ' HB2' ' A' ' 81' ' ' LEU . 43.0 t -157.44 143.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.619 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.95 139.43 6.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.086 0.47 . . . . 0.0 112.054 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.473 ' CD1' ' HB ' ' A' ' 57' ' ' VAL . 1.8 mm? -80.56 119.9 23.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.994 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.446 ' CZ2' ' HB2' ' A' ' 93' ' ' GLU . 15.3 t-105 179.9 159.35 0.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 110.972 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -151.73 -44.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.574 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . 65.9 mm-40 -58.37 128.89 39.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.231 0.539 . . . . 0.0 111.195 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 94' ' ' ARG . 2.8 ptp180 -84.79 145.53 27.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.384 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.415 ' CE2' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -166.01 45.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.348 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.8 t -177.49 -143.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.7 m 64.07 133.96 0.02 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.909 0.385 . . . . 0.0 111.004 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.981 0.42 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -119.18 142.18 48.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.896 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.3 p -136.67 141.66 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.97 131.84 14.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.448 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -121.75 137.32 54.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.132 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 94.5 mt -132.17 141.07 48.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.126 0.488 . . . . 0.0 111.609 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 11.6 p-10 -146.2 137.94 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.677 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 p -103.52 124.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.723 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.56 -136.76 9.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.675 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.1 -42.72 72.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.7 0.286 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -158.89 40.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.24 0.543 . . . . 0.0 110.899 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -167.59 173.4 8.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 52.1 mt -126.41 134.15 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.74 133.55 11.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.008 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' O ' ' N ' ' A' ' 28' ' ' ARG . 86.0 mt -98.61 131.65 44.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.608 0.242 . . . . 0.0 110.546 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -145.64 143.8 30.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.775 0.321 . . . . 0.0 111.051 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.8 t -135.79 123.83 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.168 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.64 -149.41 8.63 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -64.99 145.22 56.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.724 0.297 . . . . 0.0 110.535 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -46.14 133.43 9.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.89 0.376 . . . . 0.0 111.245 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.84 47.72 53.39 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.631 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.25 129.6 92.38 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.538 0.208 . . . . 0.0 110.978 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.5 41.21 0.95 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.582 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 33.4 tp 56.5 44.42 24.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.999 0.428 . . . . 0.0 110.785 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.41 93.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.1 m -165.42 127.4 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.462 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.77 124.6 8.69 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.137 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 15' ' ' LEU . 29.5 tpt180 -75.29 -37.79 60.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.067 0.46 . . . . 0.0 110.155 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' C ' ' CD1' ' A' ' 30' ' ' TYR . . . -163.0 -154.19 7.53 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.041 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 29' ' ' GLY . 75.0 m-85 -161.05 135.62 7.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.899 0.35 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.4 ' HG ' ' CD1' ' A' ' 15' ' ' LEU . 80.7 mt -121.92 122.28 39.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.117 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.447 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.5 t -67.1 145.95 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.513 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -52.64 147.26 8.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.018 0.437 . . . . 0.0 111.28 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.453 ' HD3' ' HG2' ' A' ' 38' ' ' GLU . 66.7 mttm -147.92 -125.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.118 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 38' ' ' GLU . 42.6 p -145.9 136.31 24.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.026 0.441 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.505 ' CD2' ' N ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -18.28 -53.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 38' ' ' GLU . 16.5 pt-20 -72.01 -48.83 41.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.356 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.469 ' N ' ' O ' ' A' ' 35' ' ' THR . 81.4 tt0 -60.73 -48.97 79.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -49.69 -39.99 38.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.075 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 36' ' ' LEU . 2.7 t -56.25 -48.52 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.359 0.6 . . . . 0.0 109.867 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -52.41 -47.73 66.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.277 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.1 73.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.477 ' CD1' ' CD2' ' A' ' 77' ' ' LEU . 61.0 mt -65.05 -47.35 77.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.773 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.474 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 61.7 mt -60.33 -49.8 76.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.602 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.2 -39.49 14.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.771 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 16.8 t80 -78.61 -43.86 25.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.244 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 62.1 t -55.58 -53.39 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 4.8 ptm180 -69.69 -61.85 1.62 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -51.52 -49.04 62.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.874 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.9 tp10 -73.22 -12.62 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.43 40.66 99.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.436 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.426 HD12 ' CE2' ' A' ' 46' ' ' PHE . 87.0 mt -74.51 -52.37 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.965 0.412 . . . . 0.0 111.098 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 53.69 29.3 40.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.212 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.495 ' O ' HD11 ' A' ' 55' ' ' LEU . 97.3 mttt -163.62 135.08 4.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.516 0.198 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD11 ' O ' ' A' ' 54' ' ' LYS . 2.7 mm? -139.82 139.64 36.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 89' ' ' GLU . 12.4 p -149.66 143.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.962 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.403 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 21.6 t -144.86 129.73 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 111.969 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.06 108.31 3.46 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.341 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 59' ' ' LEU . 2.3 mm? -85.49 138.6 35.98 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.731 0.3 . . . . 0.0 111.493 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -62.51 -40.84 35.97 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.643 2.229 . . . . 0.0 112.822 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.428 HD13 ' CZ2' ' A' ' 91' ' ' TRP . 65.1 tp 65.64 159.64 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.337 . . . . 0.0 110.82 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 62' ' ' ARG . 27.8 tpt180 76.1 42.55 0.19 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.633 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.0 t -74.4 144.14 44.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.761 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.95 126.16 17.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.876 0.369 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.55 134.13 48.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.194 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.467 ' NZ ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -178.14 -68.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 73.5 mm-40 -161.3 -54.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.02 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.0 p -71.07 132.97 45.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 175.76 -49.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.249 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -83.74 52.34 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.628 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 179.4 137.28 0.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.793 0.33 . . . . 0.0 111.647 179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 74' ' ' VAL . . . -168.51 25.66 0.12 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.84 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 76' ' ' PRO . 36.5 mtmm 66.56 -19.55 0.11 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.478 ' H ' ' C ' ' A' ' 72' ' ' GLY . 48.9 t -79.28 -41.31 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.533 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.582 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 3.0 tm? -54.06 -53.93 53.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.9 Cg_endo -48.79 -35.67 31.34 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.296 1.998 . . . . 0.0 112.069 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.477 ' CD2' ' CD1' ' A' ' 43' ' ' LEU . 29.0 tp -61.62 -44.07 97.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 110.713 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.406 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 41.1 t -55.01 -34.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.432 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -56.58 -43.97 80.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.3 -47.38 84.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.439 ' CD1' HG23 ' A' ' 88' ' ' VAL . 33.5 mt -62.8 -42.83 99.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.383 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 78' ' ' VAL . 25.2 mmm180 -56.22 -43.92 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.693 0.282 . . . . 0.0 111.192 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.77 86.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.915 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -70.77 -30.5 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.929 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.15 42.92 4.2 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.16 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.42 142.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.687 0.28 . . . . 0.0 110.718 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.74 128.7 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.761 0.315 . . . . 0.0 110.63 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.439 HG23 ' CD1' ' A' ' 81' ' ' LEU . 62.8 t -152.91 140.08 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.443 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 12.6 pm0 -165.42 132.03 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 90' ' ' LEU . 1.3 pt? -154.47 124.44 6.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TRP . . . . . 0.428 ' CZ2' HD13 ' A' ' 61' ' ' LEU . 31.3 t-105 -179.23 148.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -47.11 132.17 12.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.847 0.356 . . . . 0.0 110.745 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 15.4 pt-20 -57.6 114.12 2.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.201 0.524 . . . . 0.0 111.507 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 22.5 mmt85 -161.02 32.7 0.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.49 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' O ' ' CG ' ' A' ' 95' ' ' PHE . 17.2 t80 52.33 39.11 26.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.915 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.0 m -68.46 127.99 34.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.007 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.1 t -74.1 -46.06 45.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.142 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 179.962 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.702 0.287 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.1 p -140.0 137.88 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.14 130.89 10.1 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.442 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -117.57 133.26 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.79 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.58 ' HB2' HG22 ' A' ' 57' ' ' VAL . 89.9 mt -120.38 138.92 53.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 111.194 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.1 p-10 -149.9 149.8 30.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.306 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.0 p -149.86 126.62 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.84 -55.81 2.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.991 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 178.16 34.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.299 . . . . 0.0 110.826 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . 168.53 -48.04 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -105.25 140.41 38.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.43 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 7' ' ' ASP . 53.5 mt -107.94 128.97 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.493 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.98 141.73 18.69 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.988 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.61 HD21 HD22 ' A' ' 31' ' ' LEU . 82.7 mt -118.05 129.71 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -138.75 147.41 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.995 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.616 HG21 ' CZ ' ' A' ' 46' ' ' PHE . 60.4 t -147.24 117.41 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.448 -0.524 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.091 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.844 0.354 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.96 -138.28 2.53 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.638 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 p90 179.96 150.05 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.997 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.685 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.7 pt? -137.18 136.44 38.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.961 0.41 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.0 t -74.28 147.45 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.413 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 83.2 mtm180 -54.73 140.96 34.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 60.1 mttm -137.23 -149.79 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.109 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.875 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.9 m -87.94 -163.48 0.96 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.572 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.875 ' H ' HG22 ' A' ' 35' ' ' THR . 3.9 mp -78.64 -61.03 2.14 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.968 0.413 . . . . 0.0 110.523 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -64.1 -37.17 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HG3' ' CD ' ' A' ' 34' ' ' LYS . 5.3 tp10 -57.0 -54.12 50.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.292 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 35' ' ' THR . 46.3 m-20 -52.12 -41.46 62.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.713 0.292 . . . . 0.0 110.631 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.38 -46.12 92.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.408 0.623 . . . . 0.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -55.75 -47.63 76.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.894 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.96 -44.29 85.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 110.533 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.017 HD13 ' CD2' ' A' ' 77' ' ' LEU . 36.8 mt -63.34 -50.03 71.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.341 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.592 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 22.1 mt -56.9 -49.88 74.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 37.0 t70 -46.9 -42.07 16.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.69 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.616 ' CZ ' HG21 ' A' ' 17' ' ' VAL . 17.2 t80 -83.75 -57.73 3.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.55 HG11 HD21 ' A' ' 55' ' ' LEU . 59.5 t -56.05 -47.58 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 13.9 tpp85 -65.85 -53.95 33.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 58.5 mmt-85 -71.41 -43.45 66.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 40.6 tp10 -63.81 -14.9 56.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.567 0.222 . . . . 0.0 111.37 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.02 40.54 99.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.408 HD21 ' HG2' ' A' ' 50' ' ' GLU . 85.5 mt -68.95 -47.18 66.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.94 32.0 61.91 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.662 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.934 ' O ' HD13 ' A' ' 55' ' ' LEU . 37.8 ttpt 178.19 130.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.6 mm? -135.75 133.63 38.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.94 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 p -119.69 135.96 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.144 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 6' ' ' LEU . 43.0 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 112.059 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 31.9 mtmm . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.791 0.329 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.401 HG11 HG11 ' A' ' 57' ' ' VAL . 46.2 t -83.01 -36.91 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.677 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 60.2 tp -49.12 -46.84 76.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 97.0 Cg_exo -43.44 -33.0 3.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.649 2.233 . . . . 0.0 112.904 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.017 ' CD2' HD13 ' A' ' 43' ' ' LEU . 28.2 tp -82.25 -44.92 15.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.41 -36.05 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.311 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 20.4 pt-20 -68.26 -39.11 82.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.352 . . . . 0.0 110.514 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.78 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 0.0 110.529 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.853 HD13 HD23 ' A' ' 55' ' ' LEU . 30.3 mt -60.03 -51.0 71.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.058 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -58.23 -44.04 88.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.15 -41.85 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.452 ' NH1' HD22 ' A' ' 44' ' ' LEU . 99.1 mtt180 -83.64 15.54 3.13 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.68 37.16 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.36 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.9 t -99.2 132.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.685 0.279 . . . . 0.0 110.786 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 41.4 tp10 -62.61 133.02 54.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.86 0.362 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 81' ' ' LEU . 61.0 t -157.68 150.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.952 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -163.48 127.92 2.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.708 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.849 0.357 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.882 HG23 ' HG2' ' A' ' 54' ' ' LYS . 9.6 p -133.06 133.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.066 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.642 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -78.55 139.56 22.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.868 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.86 134.71 47.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.378 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.68 HD11 HD22 ' A' ' 43' ' ' LEU . 84.3 mt -117.91 137.45 52.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.097 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 8.6 p-10 -140.82 136.2 32.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.73 137.64 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.36 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.27 -44.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.227 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -178.65 105.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.751 0.31 . . . . 0.0 110.784 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . 45.57 30.35 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.281 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -165.86 143.3 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 54.1 mt -112.84 133.73 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.406 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.403 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -82.02 133.87 12.47 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.584 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 ' HG ' ' A' ' 31' ' ' LEU . 92.0 mt -105.11 130.26 53.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.856 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.48 149.06 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.669 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 59.2 t -146.96 127.97 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.151 0.5 . . . . 0.0 111.501 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.793 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.449 -0.451 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.217 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HG3' HG23 ' A' ' 17' ' ' VAL . 26.8 mmm180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.657 0.265 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.18 -138.38 2.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.825 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.413 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 5.3 p90 -179.72 140.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.748 0.309 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.651 ' HG ' HD11 ' A' ' 15' ' ' LEU . 80.7 mt -120.22 126.09 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.9 t -71.99 144.12 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.414 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 74.6 mtp180 -55.14 149.27 12.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.959 0.409 . . . . 0.0 111.319 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 61.6 mttm -150.49 -153.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.1 m -86.78 -158.6 0.44 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.5 pt? -81.54 -48.56 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.123 -0.36 . . . . 0.0 111.0 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 16.5 pt-20 -66.96 -38.98 87.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 4.1 mm-40 -60.57 -55.42 33.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.33 -48.0 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.499 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 36' ' ' LEU . 5.2 t -60.51 -54.82 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 109.791 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -53.79 -45.82 70.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.48 87.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.718 ' O ' HG23 ' A' ' 47' ' ' VAL . 97.4 mt -63.89 -44.19 93.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.268 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.0 mt -60.97 -47.58 85.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 110.527 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 48' ' ' ARG . 4.8 t70 -47.29 -41.76 19.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.739 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.1 t80 -75.06 -40.09 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 43' ' ' LEU . 60.3 t -63.01 -53.9 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 8.9 ptt85 -72.06 -62.86 1.28 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 49' ' ' ARG . 11.7 mtp-105 -47.9 -50.52 26.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -75.65 -6.47 50.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.369 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.29 39.45 94.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.666 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.739 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.1 mt -72.78 -53.26 12.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.39 42.52 83.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.882 ' HG2' HG23 ' A' ' 3' ' ' VAL . 83.3 tttt -178.3 127.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.011 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -141.54 135.96 30.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.786 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 4' ' ' GLY . 13.4 p -117.47 125.69 74.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.074 0.464 . . . . 0.0 111.647 -179.312 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.85 0.357 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.1 -42.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.595 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 59.3 tp -55.93 -43.77 99.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.579 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.8 Cg_exo -46.72 -40.15 24.13 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 0.0 112.392 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.663 ' C ' HD13 ' A' ' 77' ' ' LEU . 2.5 tm? -71.44 -38.48 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.616 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.819 HG13 HG11 ' A' ' 88' ' ' VAL . 61.5 t -55.03 -36.24 37.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -67.09 -40.02 86.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.886 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.32 92.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.139 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.011 HD13 HD23 ' A' ' 55' ' ' LEU . 22.5 mt -59.78 -48.08 83.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -56.83 -41.26 77.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.005 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.14 75.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.194 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mtp85 -84.96 15.28 4.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.739 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.42 38.89 97.08 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.161 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -100.67 134.64 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.654 0.264 . . . . 0.0 111.046 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.41 ' C ' HG23 ' A' ' 88' ' ' VAL . 4.4 mm-40 -63.79 129.03 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.819 HG11 HG13 ' A' ' 78' ' ' VAL . 57.3 t -157.52 144.83 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.129 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' VAL . 16.1 pt-20 -168.08 131.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.344 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.898 ' O ' HD12 ' A' ' 90' ' ' LEU . 3.0 pp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.339 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.72 ' NE ' HG12 ' A' ' 17' ' ' VAL . 9.6 tpt180 . . . . . 0 C--O 1.23 0.028 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.818 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.2 p -134.26 139.45 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.834 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.798 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -87.99 140.47 16.4 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.201 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -125.82 136.79 53.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.625 HD11 HD22 ' A' ' 43' ' ' LEU . 92.8 mt -125.43 142.49 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 10.9 p-10 -145.05 140.15 27.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.643 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 13' ' ' ILE . 35.1 m -112.42 134.17 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.27 132.97 2.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.873 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 57.16 49.46 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.235 0.54 . . . . 0.0 111.329 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 52.29 33.68 13.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.449 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.877 ' CZ ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -147.66 139.75 24.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.627 HG12 HG12 ' A' ' 8' ' ' VAL . 60.9 mt -106.56 128.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.623 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.76 131.89 10.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.824 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.623 HD21 HD22 ' A' ' 31' ' ' LEU . 92.7 mt -102.46 130.54 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -149.95 147.83 28.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.792 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.72 HG12 ' NE ' ' A' ' 2' ' ' ARG . 46.8 t -150.04 122.84 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.982 0.42 . . . . 0.0 111.063 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.818 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.238 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.838 0.351 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.77 -143.96 4.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 179.79 150.47 0.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 111.379 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 31' ' ' LEU . 1.6 pt? -142.67 135.6 28.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.691 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.877 HG22 ' CZ ' ' A' ' 12' ' ' ARG . 46.5 t -70.23 148.2 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 74.4 mtm180 -51.64 139.7 20.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.02 0.438 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HD3' ' HG3' ' A' ' 38' ' ' GLU . 66.5 mttm -128.05 -120.3 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.183 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.582 ' O ' ' N ' ' A' ' 38' ' ' GLU . 37.7 p -156.05 128.32 7.62 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.023 0.439 . . . . 0.0 112.113 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.835 HD12 ' H ' ' A' ' 36' ' ' LEU . 4.2 mp 0.08 -68.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' A' ' 38' ' ' GLU . 13.5 pm0 -67.13 -45.71 76.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.0 tp10 -59.86 -50.22 74.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.022 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 73' ' ' LYS . 55.3 m-20 -50.31 -38.82 43.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.6 t -59.11 -46.7 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 109.768 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -56.33 -48.34 76.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.005 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.998 0.428 . . . . 0.0 110.846 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.995 HD13 ' CD2' ' A' ' 77' ' ' LEU . 71.2 mt -63.13 -47.3 83.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.05 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 23.2 mt -59.76 -46.68 88.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 7.4 t70 -46.14 -42.04 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.647 ' CE2' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -81.17 -58.01 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.62 HG11 HD21 ' A' ' 55' ' ' LEU . 60.8 t -58.12 -48.87 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.07 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 31.5 tpt85 -65.25 -57.09 9.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 23.1 mmt85 -68.07 -43.43 78.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.4 tp10 -72.34 -3.23 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.661 0.267 . . . . 0.0 111.339 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.76 92.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.674 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.647 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.9 mt -71.5 -52.54 17.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.903 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.516 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 51.18 31.72 27.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.229 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.817 ' C ' HD22 ' A' ' 55' ' ' LEU . 61.5 mttp -162.63 131.02 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.599 0.238 . . . . 0.0 110.614 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.837 HD23 HD13 ' A' ' 81' ' ' LEU . 2.7 mm? -141.67 136.97 31.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.204 0.526 . . . . 0.0 111.445 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 4' ' ' GLY . 10.6 p -132.4 140.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.577 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.064 0.459 . . . . 0.0 111.56 -179.418 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 10.3 mtmp? . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.739 0.304 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.27 -43.14 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.109 0.481 . . . . 0.0 110.968 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.678 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 51.5 tp -55.42 -48.8 95.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.2 Cg_endo -46.68 -39.45 23.41 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.471 2.114 . . . . 0.0 112.127 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.995 ' CD2' HD13 ' A' ' 43' ' ' LEU . 35.1 tp -66.19 -38.31 87.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.412 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -53.04 -36.94 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.683 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.8 -43.1 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.592 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -63.46 -48.09 79.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.837 HD13 HD23 ' A' ' 55' ' ' LEU . 26.4 mt -58.7 -47.57 84.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.989 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.72 -42.36 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.44 -46.61 76.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.933 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.619 HH12 ' HB1' ' A' ' 80' ' ' ALA . 68.6 mtm-85 -87.53 18.87 3.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.28 37.65 92.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.866 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.516 HG13 ' C ' ' A' ' 53' ' ' GLY . 57.7 t -89.17 131.12 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -62.73 132.15 51.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 81' ' ' LEU . 57.8 t -153.05 144.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.633 ' HG3' HG23 ' A' ' 56' ' ' VAL . 16.7 pt-20 -148.36 150.84 34.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.327 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.798 HD23 ' H ' ' A' ' 90' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.53 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.583 0.23 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.934 HG12 ' O ' ' A' ' 18' ' ' GLY . 14.7 p -132.72 137.36 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.971 0.415 . . . . 0.0 111.188 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.77 126.06 7.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.107 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.28 130.57 49.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.613 HD11 HD22 ' A' ' 43' ' ' LEU . 92.8 mt -123.28 139.71 53.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.008 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.69 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.5 p-10 -147.64 139.17 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 p -113.99 133.51 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.1 126.31 1.27 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.899 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 8.4 mp0 55.85 45.53 23.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 10' ' ' GLU . . . 75.54 -52.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.669 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.66 140.17 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 7' ' ' ASP . 60.2 mt -111.23 130.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.835 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.45 140.06 22.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.253 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.828 HD11 HD22 ' A' ' 31' ' ' LEU . 74.5 mt -123.99 133.3 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.666 0.27 . . . . 0.0 110.522 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HA ' ' CG ' ' A' ' 28' ' ' ARG . . . -159.05 -162.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.333 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 16' ' ' ALA . 90.3 t -158.87 142.4 6.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.934 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.242 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.982 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.7 mmp_? . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.485 0.183 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.19 -139.87 5.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.172 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -179.98 151.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.659 0.266 . . . . 0.0 110.796 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 15' ' ' LEU . 1.5 pt? -133.91 136.17 44.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 33' ' ' ARG . 48.9 t -76.08 156.04 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.724 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 64.0 mtp180 -51.84 150.21 4.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.807 0.337 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 56.7 mttp -147.97 -155.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.26 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -97.13 -158.39 0.66 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.468 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.894 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.6 mm? -75.32 -55.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.607 0.241 . . . . 0.0 111.376 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.456 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.9 OUTLIER -70.36 -38.25 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.991 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 34' ' ' LYS . 7.3 mt-10 -57.74 -55.91 28.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 0.0 110.772 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -53.97 -42.31 68.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.794 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 36' ' ' LEU . 6.1 t -58.98 -55.99 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.415 0.626 . . . . 0.0 110.384 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.66 -46.89 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.422 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.28 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 47' ' ' VAL . 72.7 mt -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.379 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.608 ' CD1' HG12 ' A' ' 40' ' ' VAL . 76.3 mt -59.52 -48.4 81.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -50.23 -37.78 37.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.708 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.708 ' CE2' HD11 ' A' ' 52' ' ' LEU . 17.9 t80 -77.04 -44.1 32.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 43' ' ' LEU . 59.6 t -56.62 -53.77 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -70.78 -60.79 2.04 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -49.6 -50.46 42.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.72 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.6 tp10 -74.25 -10.97 60.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.618 0.247 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.44 39.62 97.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.561 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.708 HD11 ' CE2' ' A' ' 46' ' ' PHE . 89.4 mt -75.09 -49.37 19.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 54.86 26.5 40.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.381 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.844 ' O ' HD13 ' A' ' 55' ' ' LEU . 66.1 mttm -164.26 131.65 3.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.968 HD23 HD13 ' A' ' 81' ' ' LEU . 2.3 mm? -140.28 131.06 25.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 111.764 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 56' ' ' VAL . 10.8 p -118.64 124.24 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 90' ' ' LEU . 45.8 t . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.516 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.637 0.256 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.2 t -100.4 -44.35 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.166 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.9 tm? -54.21 -49.67 88.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.622 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.8 Cg_endo -46.95 -40.27 25.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.565 2.177 . . . . 0.0 112.599 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.68 HD23 HG13 ' A' ' 40' ' ' VAL . 2.8 tm? -71.84 -37.86 70.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.617 HG13 HG11 ' A' ' 88' ' ' VAL . 57.4 t -55.7 -35.62 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.676 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.85 -40.02 91.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.892 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.74 91.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.968 HD13 HD23 ' A' ' 55' ' ' LEU . 27.1 mt -61.52 -47.43 85.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 3.6 mmm180 -59.12 -42.27 90.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.19 80.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.377 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -86.89 19.25 3.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.799 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.74 37.88 94.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.985 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 52.9 t -97.28 134.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 41.2 tp10 -65.4 128.09 34.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.947 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 78' ' ' VAL . 46.7 t -158.06 145.06 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.55 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -169.71 141.34 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.122 0.487 . . . . 0.0 111.824 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.692 HD13 ' HB ' ' A' ' 57' ' ' VAL . 2.6 mm? . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.411 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.723 0.297 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.912 HG23 ' HG3' ' A' ' 54' ' ' LYS . 14.7 p -124.78 132.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.863 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.87 124.08 6.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.879 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.313 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.676 HD11 HD22 ' A' ' 43' ' ' LEU . 99.0 mt -129.27 138.63 51.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 9.5 p-10 -146.33 138.92 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.524 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.6 t -105.5 135.11 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.74 130.41 1.65 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.743 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 17.5 tp10 55.81 52.06 11.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.18 0.514 . . . . 0.0 111.136 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . 50.5 35.11 10.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HD3' ' CG ' ' A' ' 30' ' ' TYR . 38.6 ttm180 -149.24 140.1 22.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.855 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -103.8 128.66 56.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -83.93 130.32 9.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.544 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.637 HD11 ' CD2' ' A' ' 31' ' ' LEU . 89.3 mt -105.11 131.58 52.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.51 147.01 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.901 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.3 t -143.5 119.34 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.197 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.908 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.3 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.855 0.359 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.22 -140.77 3.36 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.317 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.442 ' CG ' ' HD3' ' A' ' 12' ' ' ARG . 6.9 p90 179.95 140.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.383 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 15' ' ' LEU . 75.7 mt -106.14 123.02 47.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.546 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.8 t -72.68 148.99 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 81.6 mtm180 -47.08 148.32 1.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.334 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HD3' ' CG ' ' A' ' 38' ' ' GLU . 62.3 mttm -144.79 -121.94 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 38' ' ' GLU . 23.4 p -154.78 128.0 8.36 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.817 ' O ' HG23 ' A' ' 40' ' ' VAL . 83.5 mt 5.83 -69.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.4 pt-20 -67.8 -46.88 70.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 111.763 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.1 tp10 -58.55 -50.65 73.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.079 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.4 m-20 -48.67 -46.03 39.7 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.94 0.4 . . . . 0.0 110.315 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 36' ' ' LEU . 3.8 t -61.93 -50.22 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -52.91 -46.85 68.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.093 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.46 93.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.832 ' O ' HG23 ' A' ' 47' ' ' VAL . 94.7 mt -67.31 -42.0 84.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.639 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 70.0 mt -59.58 -56.21 24.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.694 0.283 . . . . 0.0 111.066 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -48.55 -38.02 19.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.812 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.686 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.2 t80 -73.49 -42.59 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 43' ' ' LEU . 59.5 t -63.31 -50.12 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -72.89 -62.84 1.32 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.8 mmm-85 -48.0 -51.8 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.074 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.1 tp10 -76.08 -4.88 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.343 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.08 40.68 91.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 46' ' ' PHE . 86.4 mt -68.22 -54.35 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.99 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.95 40.66 66.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.125 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.912 ' HG3' HG23 ' A' ' 3' ' ' VAL . 3.4 tppp? -178.36 128.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.02 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -141.32 133.2 27.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 111.776 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 89' ' ' GLU . 14.8 p -121.57 117.83 53.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.533 -179.428 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.747 ' HG2' HD23 ' A' ' 36' ' ' LEU . 36.6 mtmm . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.77 0.319 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.01 -45.09 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.158 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.523 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 56.3 tp -56.71 -49.82 91.5 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 83.9 Cg_exo -44.06 -38.37 10.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.116 . . . . 0.0 112.38 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.689 HD23 HG13 ' A' ' 40' ' ' VAL . 2.3 tm? -70.5 -36.31 73.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.693 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.96 HG13 HG11 ' A' ' 88' ' ' VAL . 61.3 t -54.45 -36.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.959 0.409 . . . . 0.0 110.581 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.93 -39.9 83.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.846 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.91 85.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.02 HD13 HD23 ' A' ' 55' ' ' LEU . 23.6 mt -59.08 -45.29 91.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.026 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -58.3 -44.04 88.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.08 85.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.103 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -83.11 15.55 2.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 38.84 96.65 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.254 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.6 t -108.5 135.24 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.35 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -69.75 139.35 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.96 HG11 HG13 ' A' ' 78' ' ' VAL . 44.5 t -155.84 139.72 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -161.53 130.79 4.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.032 0.444 . . . . 0.0 111.61 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.861 ' O ' HD12 ' A' ' 90' ' ' LEU . 2.3 pp . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.758 0.313 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 54' ' ' LYS . 14.4 p -136.58 136.13 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -79.32 134.69 14.12 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.134 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -121.96 133.92 54.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 111.423 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.614 HD11 HD22 ' A' ' 43' ' ' LEU . 98.9 mt -126.43 139.45 53.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -143.77 139.35 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.31 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -106.71 128.45 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.867 0.365 . . . . 0.0 111.559 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.84 -135.46 6.63 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.79 -44.4 90.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.364 . . . . 0.0 110.746 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -168.15 32.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.708 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' CD ' HG22 ' A' ' 32' ' ' VAL . 23.6 mmt85 -147.92 144.21 27.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.482 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 55.3 mt -99.61 125.25 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.41 129.34 9.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.631 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.668 HD11 ' HG ' ' A' ' 31' ' ' LEU . 85.5 mt -104.81 127.13 52.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 110.937 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -147.29 148.94 31.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.432 HG22 ' HA2' ' A' ' 4' ' ' GLY . 55.6 t -151.1 133.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.005 0.431 . . . . 0.0 111.676 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.374 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.611 0.243 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.66 -151.41 10.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.856 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.4 p90 179.82 141.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.946 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HG ' HD11 ' A' ' 15' ' ' LEU . 67.0 mt -114.71 124.19 51.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.495 HG22 ' CD ' ' A' ' 12' ' ' ARG . 47.6 t -66.22 146.0 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.562 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 98.6 mtt180 -51.58 147.54 6.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.862 0.363 . . . . 0.0 111.465 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 35' ' ' THR . 52.1 mttp -147.17 -125.75 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.052 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 34' ' ' LYS . 16.1 p -157.69 134.79 10.14 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.842 HD12 ' H ' ' A' ' 36' ' ' LEU . 5.2 mp 5.27 -72.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -69.75 -48.15 60.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.0 tp10 -57.49 -50.27 73.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.942 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.413 ' OD2' ' CG ' ' A' ' 73' ' ' LYS . 45.5 m-20 -51.31 -42.38 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.6 t -60.84 -47.38 93.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.511 0.672 . . . . 0.0 109.779 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.74 -49.58 37.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.436 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.2 -44.3 59.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.257 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.994 ' CD1' HD22 ' A' ' 77' ' ' LEU . 27.7 mt -61.57 -48.12 82.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.934 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' HG12 ' A' ' 40' ' ' VAL . 57.9 mt -57.51 -50.76 72.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -45.28 -40.43 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.968 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CE2' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -77.45 -45.43 25.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.456 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' LEU . 65.8 t -57.1 -50.85 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 5.4 ptm180 -71.32 -62.77 1.28 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -51.42 -48.84 62.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.995 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -69.87 -13.41 62.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.547 0.213 . . . . 0.0 111.219 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.88 39.12 95.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.423 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.572 HD11 ' CE2' ' A' ' 46' ' ' PHE . 86.1 mt -74.1 -49.27 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.507 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 54.53 28.21 44.14 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.233 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.796 ' O ' HD13 ' A' ' 55' ' ' LEU . 67.5 mttm -164.14 129.96 2.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.268 0.227 . . . . 0.0 110.399 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 54' ' ' LYS . 2.6 mm? -140.25 121.02 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 56' ' ' VAL . 8.6 p -99.3 113.93 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.88 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.475 HG13 ' CG1' ' A' ' 74' ' ' VAL . 48.1 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.735 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 2.7 mppt? . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.475 ' CG1' HG13 ' A' ' 57' ' ' VAL . 40.3 t -61.5 -53.28 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.61 ' O ' HD13 ' A' ' 75' ' ' LEU . 2.2 tm? -55.38 -50.4 86.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.503 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.2 Cg_exo -42.5 -39.9 7.04 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.494 2.13 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.994 HD22 ' CD1' ' A' ' 43' ' ' LEU . 42.6 tp -66.52 -41.31 88.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.717 HG13 HG11 ' A' ' 88' ' ' VAL . 22.0 t -53.99 -34.88 26.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.86 -43.17 93.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.21 91.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.635 HD13 HD23 ' A' ' 55' ' ' LEU . 31.7 mt -59.4 -41.18 88.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.366 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.692 ' NH1' HG12 ' A' ' 78' ' ' VAL . 62.1 mtt85 -57.11 -42.73 81.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.281 . . . . 0.0 111.219 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.76 -51.27 69.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.383 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -70.63 -27.3 63.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.99 43.41 4.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.346 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.507 HG13 ' C ' ' A' ' 53' ' ' GLY . 59.1 t -98.85 139.95 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.613 0.244 . . . . 0.0 110.754 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -60.43 130.15 45.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.717 HG11 HG13 ' A' ' 78' ' ' VAL . 60.9 t -151.86 145.2 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 56' ' ' VAL . 24.4 pt-20 -171.86 123.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.481 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.458 ' CD2' ' H ' ' A' ' 90' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.402 ' HB3' ' CG1' ' A' ' 17' ' ' VAL . 99.2 mtt180 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.682 0.277 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 18' ' ' GLY . 13.0 p -126.32 132.42 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.08 126.93 7.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.012 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.723 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -109.37 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.696 -0.297 . . . . 0.0 111.098 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.657 HD11 HD22 ' A' ' 43' ' ' LEU . 95.0 mt -120.47 136.53 54.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.454 . . . . 0.0 111.249 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -146.97 139.43 24.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.165 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.492 HG12 HG12 ' A' ' 13' ' ' ILE . 35.0 m -108.73 134.23 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.61 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.01 131.52 1.78 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.958 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 40.4 tt0 56.8 53.47 8.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 48.85 35.92 7.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.467 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -151.69 140.97 21.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.68 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 61.8 mt -105.27 127.4 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 134.38 13.42 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.768 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.688 HD11 HD22 ' A' ' 31' ' ' LEU . 88.0 mt -113.59 133.72 55.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 0.0 110.912 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.723 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.38 148.95 29.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 28' ' ' ARG . 48.0 t -140.43 121.96 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.289 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.826 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.341 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' A' ' 17' ' ' VAL . 27.1 mmm180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.98 -137.58 2.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.67 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -179.93 150.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.927 0.394 . . . . 0.0 110.86 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.688 HD22 HD11 ' A' ' 15' ' ' LEU . 1.3 pt? -134.67 135.33 41.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.21 145.07 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 66.1 mtm180 -54.26 151.59 7.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.168 0.509 . . . . 0.0 111.326 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.433 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 64.1 mttm -146.61 -122.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.699 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 38' ' ' GLU . 38.4 p -148.58 139.72 23.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.728 0.299 . . . . 0.0 110.903 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.021 HD22 ' N ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -21.96 -43.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 1.021 ' N ' HD22 ' A' ' 36' ' ' LEU . 11.9 pt-20 -73.46 -48.88 30.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HG2' ' OG1' ' A' ' 35' ' ' THR . 13.6 mm-40 -61.79 -48.31 81.21 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 23.0 m-20 -45.93 -40.96 10.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.74 -52.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.185 0.517 . . . . 0.0 110.363 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.09 -51.92 66.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.94 93.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.006 HD13 ' CD2' ' A' ' 77' ' ' LEU . 74.0 mt -65.22 -50.31 66.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.457 ' HB3' ' NH1' ' A' ' 48' ' ' ARG . 61.5 mt -59.1 -48.08 82.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -49.35 -38.91 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 52' ' ' LEU . 17.9 t80 -77.04 -43.69 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.236 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 43' ' ' LEU . 99.9 t -58.06 -51.81 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 44' ' ' LEU . 1.5 ptt-85 -67.81 -63.18 1.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.6 mtp85 -51.35 -49.75 60.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.881 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -72.05 -10.23 59.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.263 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.8 97.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.465 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 46' ' ' PHE . 88.9 mt -72.36 -52.81 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 53.84 36.18 54.77 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.257 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.915 ' O ' HD13 ' A' ' 55' ' ' LEU . 37.3 ttpt 178.21 131.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.111 HD23 HD13 ' A' ' 81' ' ' LEU . 1.6 mm? -137.8 137.45 38.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.748 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 3' ' ' VAL . 15.0 p -128.19 132.79 68.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.11 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 90' ' ' LEU . 14.8 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.752 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 37.3 mtmm . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.805 0.336 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.22 -41.15 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 61.2 tp -54.5 -52.0 73.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.3 Cg_exo -43.94 -40.16 11.52 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.348 2.032 . . . . 0.0 112.219 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.006 ' CD2' HD13 ' A' ' 43' ' ' LEU . 32.0 tp -63.19 -42.79 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.6 t -52.01 -35.49 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.77 -42.81 94.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.06 66.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.111 HD13 HD23 ' A' ' 55' ' ' LEU . 24.5 mt -57.94 -50.91 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -58.44 -38.4 77.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.42 -43.74 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.427 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.425 HH22 HD23 ' A' ' 81' ' ' LEU . 68.0 mtm-85 -89.69 20.04 4.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.505 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 39.82 98.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.501 HG13 ' C ' ' A' ' 53' ' ' GLY . 50.1 t -95.52 132.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.85 130.22 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.679 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 81' ' ' LEU . 65.9 t -155.91 144.48 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.96 0.41 . . . . 0.0 111.301 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.5 pt-20 -172.02 129.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.29 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.815 ' O ' HD12 ' A' ' 90' ' ' LEU . 2.5 pp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.693 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.677 0.275 . . . . 0.0 110.672 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.889 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.7 p -121.49 131.56 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.48 117.56 4.76 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.951 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -97.22 133.3 42.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.226 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.785 HD11 HD22 ' A' ' 43' ' ' LEU . 83.8 mt -123.73 138.37 54.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -145.34 144.39 30.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.106 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.06 141.18 45.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 111.531 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.78 133.5 2.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.756 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 66.04 -67.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.344 0.257 . . . . 0.0 111.522 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . -176.19 36.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.844 0.354 . . . . 0.0 111.354 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -156.46 143.9 19.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.3 mt -104.09 130.44 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.708 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.13 138.12 17.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.009 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 31' ' ' LEU . 52.4 mt -115.39 132.8 56.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -154.68 145.46 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.058 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 28' ' ' ARG . 57.5 t -136.96 125.6 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.115 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.889 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.143 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.635 ' HG3' HG23 ' A' ' 17' ' ' VAL . 4.5 mmp_? . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.73 -139.4 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.378 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 5.7 p90 -179.81 143.06 0.17 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 111.311 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 15' ' ' LEU . 1.3 mp -111.81 127.97 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.029 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 55.2 t -70.61 143.35 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.468 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 mtt180 -50.58 140.23 14.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.824 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 50.3 mttp -138.53 -140.75 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.641 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.736 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.2 m -106.16 -158.98 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.5 pt? -77.17 -49.65 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.148 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 15.4 pt-20 -70.59 -40.13 73.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.602 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 1.7 mm-40 -55.42 -57.03 13.56 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.333 0.587 . . . . 0.0 110.351 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.6 -44.75 62.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.759 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 36' ' ' LEU . 3.6 t -60.51 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.428 0.633 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -53.51 -45.52 69.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.128 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' HD23 ' A' ' 31' ' ' LEU . . . -60.68 -47.02 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.774 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.785 HD22 HD11 ' A' ' 6' ' ' LEU . 92.1 mt -65.86 -45.14 83.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.683 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 22.3 mt -59.29 -57.47 12.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.526 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.823 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 65.8 t0 -43.95 -42.1 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 15.9 t80 -71.05 -42.39 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.152 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 43' ' ' LEU . 83.5 t -67.32 -44.57 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.8 ptm180 -64.43 -67.53 0.43 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 45' ' ' ASP . 39.7 ptt85 -56.19 -47.75 77.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.0 tp10 -65.35 -16.06 63.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 111.258 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 36.86 90.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.454 HD21 ' HG2' ' A' ' 50' ' ' GLU . 89.8 mt -68.15 -50.64 53.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.74 40.06 69.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.439 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.833 ' O ' HD13 ' A' ' 55' ' ' LEU . 59.7 tttp -177.87 125.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.476 0.179 . . . . 0.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.037 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -140.39 131.68 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.446 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 56' ' ' VAL . 10.2 p -111.18 120.05 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.59 HG21 ' CG2' ' A' ' 78' ' ' VAL . 33.2 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.479 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 53.8 mtmt . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.624 0.249 . . . . 0.0 111.576 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.31 -45.25 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 75' ' ' LEU . 2.0 tm? -52.34 -50.12 81.39 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 96.0 Cg_exo -40.85 -33.32 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.834 2.356 . . . . 0.0 112.895 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.664 ' C ' HD13 ' A' ' 77' ' ' LEU . 2.7 tm? -80.8 -39.42 26.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG2' HG21 ' A' ' 57' ' ' VAL . 47.3 t -53.64 -36.8 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 21.3 pt-20 -73.56 -33.91 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.734 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -59.12 -45.11 91.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.157 0.503 . . . . 0.0 110.692 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.037 HD13 HD23 ' A' ' 55' ' ' LEU . 22.9 mt -60.7 -47.84 84.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.81 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -57.83 -39.59 78.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.94 72.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.376 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -88.19 21.21 2.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.724 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.99 92.73 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.966 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.53 135.78 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.703 0.287 . . . . 0.0 111.063 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 65.5 mm-40 -64.57 125.84 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.792 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.563 HG11 HG13 ' A' ' 78' ' ' VAL . 57.7 t -158.78 145.97 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -166.92 131.92 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.095 0.474 . . . . 0.0 111.624 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 90' ' ' LEU . 6.1 tt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.278 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.689 0.281 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 18' ' ' GLY . 11.9 p -119.42 136.23 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.281 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.465 ' HA3' HD13 ' A' ' 55' ' ' LEU . . . -81.47 131.18 10.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.094 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -113.87 130.76 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.663 HD11 HD22 ' A' ' 43' ' ' LEU . 96.5 mt -123.37 135.95 54.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.041 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 2.9 p30 -140.3 134.86 31.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.625 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -98.95 129.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.637 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.98 -135.48 5.69 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.285 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -62.92 -42.85 99.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . -171.57 39.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -155.33 146.61 22.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -98.95 127.03 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.484 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.47 126.63 7.7 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.447 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.658 HD11 ' CD2' ' A' ' 31' ' ' LEU . 86.0 mt -99.42 130.41 45.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.918 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.52 145.84 26.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.52 124.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.72 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.505 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.93 0.395 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.81 -135.59 1.88 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.252 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 7.2 p90 -178.9 138.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.658 ' CD2' HD11 ' A' ' 15' ' ' LEU . 80.0 mt -106.43 125.63 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.669 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.23 133.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 52.4 mtp85 -56.94 124.98 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.461 . . . . 0.0 111.048 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.842 ' O ' HG23 ' A' ' 35' ' ' THR . 96.6 mttt -109.09 -96.96 0.39 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -176.03 127.3 0.22 Allowed 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 40' ' ' VAL . 62.4 tp 16.59 -76.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -67.55 -44.93 77.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 34' ' ' LYS . 4.6 mm-40 -57.69 -51.72 68.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.269 0.557 . . . . 0.0 110.324 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.9 m-20 -49.06 -42.8 39.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.243 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.696 HG13 HD23 ' A' ' 77' ' ' LEU . 3.2 t -58.86 -54.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 110.514 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -52.76 -49.53 65.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.346 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.22 89.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.948 0.404 . . . . 0.0 111.201 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 47' ' ' VAL . 84.2 mt -65.25 -46.09 81.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.391 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.512 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 72.7 mt -60.58 -52.8 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -48.55 -38.41 20.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -73.09 -42.09 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 43' ' ' LEU . 69.8 t -65.04 -51.94 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -70.79 -62.72 1.29 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -47.61 -51.0 22.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.959 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 5.4 tp10 -77.0 -4.04 42.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 111.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.49 38.55 91.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.657 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 46' ' ' PHE . 88.0 mt -72.59 -55.55 6.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . 53.0 33.22 43.76 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.841 ' C ' HD22 ' A' ' 55' ' ' LEU . 34.2 mmtp -161.91 128.1 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.225 0.21 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.952 HD23 HD13 ' A' ' 81' ' ' LEU . 2.8 mm? -143.16 133.05 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.367 0.603 . . . . 0.0 111.65 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.1 p -131.02 122.44 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.2 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 25.0 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.589 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.824 0.345 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.4 -43.17 10.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.074 0.464 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 59.7 tp -53.5 -48.86 91.42 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 1.4 Cg_endo -43.19 -39.78 8.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.767 2.311 . . . . 0.0 112.718 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.696 HD23 HG13 ' A' ' 40' ' ' VAL . 2.5 tm? -76.07 -36.87 58.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.814 HG13 HG11 ' A' ' 88' ' ' VAL . 58.5 t -55.44 -36.18 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.678 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -66.23 -39.55 89.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.51 -44.9 93.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.952 HD13 HD23 ' A' ' 55' ' ' LEU . 24.1 mt -60.15 -48.39 81.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.056 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -58.81 -43.57 90.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.667 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.7 82.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -84.08 17.84 2.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.659 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 37.16 94.15 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.318 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.2 t -106.93 133.38 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 0.0 110.942 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 51.0 mm-40 -67.89 132.2 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.814 HG11 HG13 ' A' ' 78' ' ' VAL . 43.0 t -157.44 143.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.619 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.95 139.43 6.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.086 0.47 . . . . 0.0 112.054 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.637 ' N ' HD22 ' A' ' 90' ' ' LEU . 1.8 mm? . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.994 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 . . . . . 0 C--O 1.23 0.036 0 CA-C-O 120.827 0.346 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 18' ' ' GLY . 13.3 p -136.67 141.66 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . 0.468 ' HA3' HD13 ' A' ' 55' ' ' LEU . . . -73.97 131.84 14.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.448 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -121.75 137.32 54.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.85 ' O ' HG13 ' A' ' 57' ' ' VAL . 94.5 mt -132.17 141.07 48.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.126 0.488 . . . . 0.0 111.609 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 11.6 p-10 -146.2 137.94 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.677 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 8' ' ' VAL . 14.7 p -103.52 124.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.723 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.56 -136.76 9.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.675 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.1 -42.72 72.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.7 0.286 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -158.89 40.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.24 0.543 . . . . 0.0 110.899 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -167.59 173.4 8.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 52.1 mt -126.41 134.15 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.74 133.55 11.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.008 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.641 HD21 ' CD1' ' A' ' 31' ' ' LEU . 86.0 mt -98.61 131.65 44.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.608 0.242 . . . . 0.0 110.546 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -145.64 143.8 30.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.775 0.321 . . . . 0.0 111.051 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.8 t -135.79 123.83 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.168 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.9 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 15' ' ' LEU . 29.5 tpt180 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 121.067 0.46 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' C ' ' CD1' ' A' ' 30' ' ' TYR . . . -163.0 -154.19 7.53 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.041 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 29' ' ' GLY . 75.0 m-85 -161.05 135.62 7.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.899 0.35 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.641 ' CD1' HD21 ' A' ' 15' ' ' LEU . 80.7 mt -121.92 122.28 39.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.117 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.5 t -67.1 145.95 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.513 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 99.2 mtt180 -52.64 147.26 8.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.018 0.437 . . . . 0.0 111.28 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HD3' ' HG2' ' A' ' 38' ' ' GLU . 66.7 mttm -147.92 -125.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.118 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 38' ' ' GLU . 42.6 p -145.9 136.31 24.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.026 0.441 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.713 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -18.28 -53.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 38' ' ' GLU . 16.5 pt-20 -72.01 -48.83 41.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.356 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HG2' ' HD3' ' A' ' 34' ' ' LYS . 81.4 tt0 -60.73 -48.97 79.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -49.69 -39.99 38.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.075 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -56.25 -48.52 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.359 0.6 . . . . 0.0 109.867 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -52.41 -47.73 66.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.277 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.1 73.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.017 HD13 ' CD2' ' A' ' 77' ' ' LEU . 61.0 mt -65.05 -47.35 77.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.773 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 61.7 mt -60.33 -49.8 76.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.602 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.2 -39.49 14.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.771 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.727 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.8 t80 -78.61 -43.86 25.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.244 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 43' ' ' LEU . 62.1 t -55.58 -53.39 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 4.8 ptm180 -69.69 -61.85 1.62 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -51.52 -49.04 62.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.874 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.9 tp10 -73.22 -12.62 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.43 40.66 99.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.436 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.727 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.0 mt -74.51 -52.37 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.965 0.412 . . . . 0.0 111.098 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 53.69 29.3 40.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.212 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.82 ' O ' HD13 ' A' ' 55' ' ' LEU . 97.3 mttt -163.62 135.08 4.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.516 0.198 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.936 HD23 HD13 ' A' ' 81' ' ' LEU . 2.7 mm? -139.82 139.64 36.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 89' ' ' GLU . 12.4 p -149.66 143.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.962 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.6 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 111.969 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 76' ' ' PRO . 36.5 mtmm . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.28 -41.31 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.533 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.65 HD13 ' C ' ' A' ' 75' ' ' LEU . 3.0 tm? -54.06 -53.93 53.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.9 Cg_endo -48.79 -35.67 31.34 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.296 1.998 . . . . 0.0 112.069 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.017 ' CD2' HD13 ' A' ' 43' ' ' LEU . 29.0 tp -61.62 -44.07 97.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 110.713 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 41.1 t -55.01 -34.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.432 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -56.58 -43.97 80.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.467 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -62.3 -47.38 84.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.936 HD13 HD23 ' A' ' 55' ' ' LEU . 33.5 mt -62.8 -42.83 99.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.383 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 78' ' ' VAL . 25.2 mmm180 -56.22 -43.92 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.693 0.282 . . . . 0.0 111.192 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.77 86.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.915 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . 0.467 HH12 ' HB1' ' A' ' 80' ' ' ALA . 65.9 mtt85 -70.77 -30.5 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.929 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.15 42.92 4.2 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.16 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.42 142.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.687 0.28 . . . . 0.0 110.718 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.74 128.7 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.761 0.315 . . . . 0.0 110.63 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 81' ' ' LEU . 62.8 t -152.91 140.08 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.6 pm0 -165.42 132.03 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 90' ' ' LEU . 1.3 pt? . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.909 0.385 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -101.08 134.53 43.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.832 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.1 p -140.0 137.88 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.14 130.89 10.1 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.442 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -117.57 133.26 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.79 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.58 ' HB2' HG22 ' A' ' 57' ' ' VAL . 89.9 mt -120.38 138.92 53.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 111.194 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.1 p-10 -149.9 149.8 30.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.306 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.0 p -149.86 126.62 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.84 -55.81 2.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.991 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 178.16 34.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.299 . . . . 0.0 110.826 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . 168.53 -48.04 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -105.25 140.41 38.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.43 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 7' ' ' ASP . 53.5 mt -107.94 128.97 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.493 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.98 141.73 18.69 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.988 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.61 HD21 HD22 ' A' ' 31' ' ' LEU . 82.7 mt -118.05 129.71 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -138.75 147.41 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.995 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG21 ' CZ ' ' A' ' 46' ' ' PHE . 60.4 t -147.24 117.41 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.37 -149.88 9.01 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.091 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 11.7 pt-20 -77.54 148.28 35.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.585 0.231 . . . . 0.0 110.433 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -46.1 -55.38 7.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.241 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -85.72 130.55 9.95 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.195 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 26' ' ' SER . 58.9 t -150.2 126.08 5.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.619 0.247 . . . . 0.0 111.044 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.83 -47.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.582 2.188 . . . . 0.0 112.961 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.8 tm? -64.52 -70.98 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.898 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 24' ' ' LEU . . . 170.66 -42.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.34 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 25' ' ' ALA . 88.6 p 60.19 137.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.819 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 16' ' ' ALA . . . -148.62 -152.66 5.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.632 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 179.17 -43.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.903 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.96 -138.28 2.53 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.638 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 p90 179.96 150.05 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.997 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.685 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.7 pt? -137.18 136.44 38.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.961 0.41 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.0 t -74.28 147.45 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.413 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 83.2 mtm180 -54.73 140.96 34.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 60.1 mttm -137.23 -149.79 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.109 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.875 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.9 m -87.94 -163.48 0.96 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.572 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.875 ' H ' HG22 ' A' ' 35' ' ' THR . 3.9 mp -78.64 -61.03 2.14 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.968 0.413 . . . . 0.0 110.523 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -64.1 -37.17 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HG3' ' CD ' ' A' ' 34' ' ' LYS . 5.3 tp10 -57.0 -54.12 50.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.292 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 35' ' ' THR . 46.3 m-20 -52.12 -41.46 62.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.713 0.292 . . . . 0.0 110.631 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.38 -46.12 92.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.408 0.623 . . . . 0.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -55.75 -47.63 76.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.894 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.96 -44.29 85.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 110.533 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.017 HD13 ' CD2' ' A' ' 77' ' ' LEU . 36.8 mt -63.34 -50.03 71.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.341 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.592 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 22.1 mt -56.9 -49.88 74.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 37.0 t70 -46.9 -42.07 16.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.69 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.616 ' CZ ' HG21 ' A' ' 17' ' ' VAL . 17.2 t80 -83.75 -57.73 3.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.55 HG11 HD21 ' A' ' 55' ' ' LEU . 59.5 t -56.05 -47.58 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 13.9 tpp85 -65.85 -53.95 33.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 58.5 mmt-85 -71.41 -43.45 66.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 40.6 tp10 -63.81 -14.9 56.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.567 0.222 . . . . 0.0 111.37 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.02 40.54 99.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.408 HD21 ' HG2' ' A' ' 50' ' ' GLU . 85.5 mt -68.95 -47.18 66.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.94 32.0 61.91 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.662 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.934 ' O ' HD13 ' A' ' 55' ' ' LEU . 37.8 ttpt 178.19 130.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.6 mm? -135.75 133.63 38.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.94 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 p -119.69 135.96 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.144 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 6' ' ' LEU . 43.0 t -148.84 130.48 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 112.059 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.512 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -94.8 136.63 13.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.32 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 58' ' ' GLY . 96.5 mt -159.59 138.83 8.18 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.5 0.19 . . . . 0.0 110.624 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.66 -47.14 19.91 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.27 1.98 . . . . 0.0 112.138 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.3 tp 62.0 126.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.172 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -75.92 -34.0 59.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.683 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.5 m 69.19 126.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.061 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 t0 178.48 138.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.547 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.35 -56.55 19.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.003 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 66' ' ' LYS . 2.5 mppt? -89.07 131.35 35.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.669 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 61.92 145.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.918 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 99.3 p -162.6 -150.73 0.18 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.874 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . . . 58.36 40.13 24.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.919 0.39 . . . . 0.0 110.809 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -66.83 128.37 36.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.251 0.548 . . . . 0.0 111.37 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 60.76 135.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.875 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.28 131.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 113.139 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 31.9 mtmm -86.82 49.38 1.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.932 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.401 HG11 HG11 ' A' ' 57' ' ' VAL . 46.2 t -83.01 -36.91 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.677 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.874 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 60.2 tp -49.12 -46.84 76.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 97.0 Cg_exo -43.44 -33.0 3.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.649 2.233 . . . . 0.0 112.904 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.017 ' CD2' HD13 ' A' ' 43' ' ' LEU . 28.2 tp -82.25 -44.92 15.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.41 -36.05 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.311 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 20.4 pt-20 -68.26 -39.11 82.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.352 . . . . 0.0 110.514 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.78 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 0.0 110.529 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.853 HD13 HD23 ' A' ' 55' ' ' LEU . 30.3 mt -60.03 -51.0 71.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.058 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -58.23 -44.04 88.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.15 -41.85 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.452 ' NH1' HD22 ' A' ' 44' ' ' LEU . 99.1 mtt180 -83.64 15.54 3.13 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.68 37.16 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.36 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.9 t -99.2 132.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.685 0.279 . . . . 0.0 110.786 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 41.4 tp10 -62.61 133.02 54.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.86 0.362 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 81' ' ' LEU . 61.0 t -157.68 150.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.952 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -163.48 127.92 2.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.24 125.25 28.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.708 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -76.88 126.49 31.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.884 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -71.1 -149.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.413 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -64.54 135.14 55.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.936 0.398 . . . . 0.0 110.783 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -63.33 -55.35 25.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.983 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -85.28 138.04 32.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -176.04 129.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.844 0.354 . . . . 0.0 111.342 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.8 m -71.57 136.31 47.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.0 tptt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.839 179.907 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.9 tpp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -104.15 137.52 41.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.157 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.882 HG23 ' HG2' ' A' ' 54' ' ' LYS . 9.6 p -133.06 133.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.066 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.642 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -78.55 139.56 22.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.868 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.86 134.71 47.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.378 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.68 HD11 HD22 ' A' ' 43' ' ' LEU . 84.3 mt -117.91 137.45 52.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.097 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 8.6 p-10 -140.82 136.2 32.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.73 137.64 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.36 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.27 -44.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.227 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -178.65 105.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.751 0.31 . . . . 0.0 110.784 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . 45.57 30.35 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.281 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -165.86 143.3 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 54.1 mt -112.84 133.73 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.406 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.403 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -82.02 133.87 12.47 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.584 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 ' HG ' ' A' ' 31' ' ' LEU . 92.0 mt -105.11 130.26 53.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.856 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.48 149.06 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.669 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 59.2 t -146.96 127.97 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.151 0.5 . . . . 0.0 111.501 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.793 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.72 -149.82 8.88 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.217 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -84.87 142.17 29.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 110.645 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -51.49 133.44 29.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.39 53.44 41.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.312 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 53.4 t -59.67 127.56 85.19 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.479 0.181 . . . . 0.0 111.015 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.505 ' O ' HD23 ' A' ' 24' ' ' LEU . 24.6 Cg_exo -63.05 -45.36 12.81 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.385 2.057 . . . . 0.0 112.31 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 96.7 mt -159.34 151.99 21.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.029 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 24' ' ' LEU . . . 76.52 135.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.668 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.7 p 179.76 131.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.311 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.62 145.38 5.83 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.672 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HG3' HG23 ' A' ' 17' ' ' VAL . 26.8 mmm180 -155.33 -44.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.657 0.265 . . . . 0.0 110.862 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.18 -138.38 2.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.825 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.413 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 5.3 p90 -179.72 140.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.748 0.309 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.651 ' HG ' HD11 ' A' ' 15' ' ' LEU . 80.7 mt -120.22 126.09 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.9 t -71.99 144.12 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.414 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 74.6 mtp180 -55.14 149.27 12.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.959 0.409 . . . . 0.0 111.319 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 61.6 mttm -150.49 -153.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.1 m -86.78 -158.6 0.44 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.5 pt? -81.54 -48.56 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.123 -0.36 . . . . 0.0 111.0 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 16.5 pt-20 -66.96 -38.98 87.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 4.1 mm-40 -60.57 -55.42 33.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.33 -48.0 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.499 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 36' ' ' LEU . 5.2 t -60.51 -54.82 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 109.791 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -53.79 -45.82 70.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.48 87.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.718 ' O ' HG23 ' A' ' 47' ' ' VAL . 97.4 mt -63.89 -44.19 93.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.268 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.0 mt -60.97 -47.58 85.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 110.527 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 48' ' ' ARG . 4.8 t70 -47.29 -41.76 19.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.739 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.1 t80 -75.06 -40.09 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 43' ' ' LEU . 60.3 t -63.01 -53.9 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 8.9 ptt85 -72.06 -62.86 1.28 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' HB3' ' CZ ' ' A' ' 49' ' ' ARG . 11.7 mtp-105 -47.9 -50.52 26.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -75.65 -6.47 50.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.369 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.29 39.45 94.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.666 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.739 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.1 mt -72.78 -53.26 12.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.39 42.52 83.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.882 ' HG2' HG23 ' A' ' 3' ' ' VAL . 83.3 tttt -178.3 127.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.011 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -141.54 135.96 30.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.786 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 4' ' ' GLY . 13.4 p -117.47 125.69 74.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 58' ' ' GLY . 21.9 t -78.45 153.0 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.074 0.464 . . . . 0.0 111.647 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.641 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -159.46 130.14 2.39 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.578 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 58' ' ' GLY . 75.0 mt -153.2 136.94 10.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.639 0.257 . . . . 0.0 111.222 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.41 141.18 45.95 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.556 2.171 . . . . 0.0 112.108 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.8 tp -55.88 128.16 33.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -72.65 134.56 45.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.1 p -67.2 130.96 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 p30 45.35 -170.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.502 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 65' ' ' LEU . 5.2 tt -80.44 -43.89 20.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 67' ' ' GLU . 7.8 tmtm? -56.79 137.02 55.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.852 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' N ' ' HD3' ' A' ' 66' ' ' LYS . 50.8 mt-10 -153.69 132.22 12.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.75 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.1 p -64.8 -58.37 6.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.989 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.24 124.72 34.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -82.4 126.67 32.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 110.914 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 53.2 -135.1 1.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.52 -136.85 2.16 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.217 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -158.79 31.87 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.029 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.1 -42.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.595 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 59.3 tp -55.93 -43.77 99.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.579 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.8 Cg_exo -46.72 -40.15 24.13 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 0.0 112.392 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.663 ' C ' HD13 ' A' ' 77' ' ' LEU . 2.5 tm? -71.44 -38.48 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.616 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.819 HG13 HG11 ' A' ' 88' ' ' VAL . 61.5 t -55.03 -36.24 37.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -67.09 -40.02 86.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.886 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.32 92.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.139 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.011 HD13 HD23 ' A' ' 55' ' ' LEU . 22.5 mt -59.78 -48.08 83.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -56.83 -41.26 77.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.005 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.14 75.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.194 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mtp85 -84.96 15.28 4.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.739 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.42 38.89 97.08 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.161 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -100.67 134.64 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.654 0.264 . . . . 0.0 111.046 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.41 ' C ' HG23 ' A' ' 88' ' ' VAL . 4.4 mm-40 -63.79 129.03 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.819 HG11 HG13 ' A' ' 78' ' ' VAL . 57.3 t -157.52 144.83 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.129 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' VAL . 16.1 pt-20 -168.08 131.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.344 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.898 ' O ' HD12 ' A' ' 90' ' ' LEU . 3.0 pp -82.12 142.63 32.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.339 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.46 ' CD1' ' CG2' ' A' ' 56' ' ' VAL . 11.4 m0 -110.98 137.72 48.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.983 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -174.35 36.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.658 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.49 132.22 34.24 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.057 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.0 mtp85 -156.55 37.27 0.32 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.049 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 60.34 131.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.211 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.411 ' O ' ' CG2' ' A' ' 97' ' ' THR . 8.7 t -68.46 131.55 45.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 96' ' ' THR . 10.2 t 44.39 44.65 7.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.602 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 tttp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.891 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.881 0.372 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.72 ' NE ' HG12 ' A' ' 17' ' ' VAL . 9.6 tpt180 -88.68 131.93 34.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.065 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.818 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.2 p -134.26 139.45 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.834 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.798 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -87.99 140.47 16.4 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.201 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -125.82 136.79 53.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.625 HD11 HD22 ' A' ' 43' ' ' LEU . 92.8 mt -125.43 142.49 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 10.9 p-10 -145.05 140.15 27.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.643 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 13' ' ' ILE . 35.1 m -112.42 134.17 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.27 132.97 2.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.873 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 57.16 49.46 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.235 0.54 . . . . 0.0 111.329 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 52.29 33.68 13.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.449 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.877 ' CZ ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -147.66 139.75 24.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.627 HG12 HG12 ' A' ' 8' ' ' VAL . 60.9 mt -106.56 128.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.623 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.76 131.89 10.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.824 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.623 HD21 HD22 ' A' ' 31' ' ' LEU . 92.7 mt -102.46 130.54 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -149.95 147.83 28.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.792 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.72 HG12 ' NE ' ' A' ' 2' ' ' ARG . 46.8 t -150.04 122.84 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.982 0.42 . . . . 0.0 111.063 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.818 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.56 -149.57 8.76 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.238 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.71 151.09 30.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.665 0.269 . . . . 0.0 110.563 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -46.58 140.41 4.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.205 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.14 46.43 13.1 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.248 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.88 126.31 82.95 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.543 0.211 . . . . 0.0 111.263 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.94 128.6 17.03 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.389 2.059 . . . . 0.0 111.901 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.4 tp 61.8 127.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.001 0.429 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.33 148.31 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.351 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.0 t 66.71 137.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.191 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.21 -47.44 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.259 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -68.61 -41.02 80.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 110.758 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.77 -143.96 4.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 179.79 150.47 0.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 111.379 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.629 HD23 ' N ' ' A' ' 31' ' ' LEU . 1.6 pt? -142.67 135.6 28.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.691 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.877 HG22 ' CZ ' ' A' ' 12' ' ' ARG . 46.5 t -70.23 148.2 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 74.4 mtm180 -51.64 139.7 20.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.02 0.438 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HD3' ' HG3' ' A' ' 38' ' ' GLU . 66.5 mttm -128.05 -120.3 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.183 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.582 ' O ' ' N ' ' A' ' 38' ' ' GLU . 37.7 p -156.05 128.32 7.62 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.023 0.439 . . . . 0.0 112.113 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.835 HD12 ' H ' ' A' ' 36' ' ' LEU . 4.2 mp 0.08 -68.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' A' ' 38' ' ' GLU . 13.5 pm0 -67.13 -45.71 76.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.0 tp10 -59.86 -50.22 74.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.022 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 73' ' ' LYS . 55.3 m-20 -50.31 -38.82 43.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.6 t -59.11 -46.7 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 109.768 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -56.33 -48.34 76.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.005 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.998 0.428 . . . . 0.0 110.846 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.995 HD13 ' CD2' ' A' ' 77' ' ' LEU . 71.2 mt -63.13 -47.3 83.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.05 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 23.2 mt -59.76 -46.68 88.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 7.4 t70 -46.14 -42.04 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.647 ' CE2' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -81.17 -58.01 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.62 HG11 HD21 ' A' ' 55' ' ' LEU . 60.8 t -58.12 -48.87 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.07 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 31.5 tpt85 -65.25 -57.09 9.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 23.1 mmt85 -68.07 -43.43 78.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.4 tp10 -72.34 -3.23 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.661 0.267 . . . . 0.0 111.339 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.76 92.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.674 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.647 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.9 mt -71.5 -52.54 17.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.903 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.516 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 51.18 31.72 27.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.229 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.817 ' C ' HD22 ' A' ' 55' ' ' LEU . 61.5 mttp -162.63 131.02 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.599 0.238 . . . . 0.0 110.614 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.837 HD23 HD13 ' A' ' 81' ' ' LEU . 2.7 mm? -141.67 136.97 31.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.204 0.526 . . . . 0.0 111.445 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 4' ' ' GLY . 10.6 p -132.4 140.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.577 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.2 t -153.56 148.67 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.064 0.459 . . . . 0.0 111.56 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -149.35 141.25 8.74 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.921 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 58' ' ' GLY . 87.2 mt -144.81 147.6 36.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 111.227 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.11 144.08 81.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.756 2.304 . . . . 0.0 112.155 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 61' ' ' LEU . 6.9 mp -57.81 129.79 43.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.7 mtm-85 -68.19 134.61 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.76 HG22 HD21 ' A' ' 65' ' ' LEU . 9.8 t -82.2 46.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.703 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.36 52.92 5.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 111.475 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.76 HD21 HG22 ' A' ' 63' ' ' THR . 2.6 mm? -80.53 46.69 0.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.406 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -95.63 31.54 2.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.71 0.291 . . . . 0.0 111.124 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -80.44 -45.06 18.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.616 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -177.79 -46.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.417 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.9 140.33 58.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.774 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -171.34 134.5 0.89 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.271 0.558 . . . . 0.0 111.208 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.26 134.41 14.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.19 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.75 143.39 6.57 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.154 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 10.3 mtmp? -154.46 28.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 111.211 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.27 -43.14 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.109 0.481 . . . . 0.0 110.968 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.678 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 51.5 tp -55.42 -48.8 95.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.2 Cg_endo -46.68 -39.45 23.41 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.471 2.114 . . . . 0.0 112.127 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.995 ' CD2' HD13 ' A' ' 43' ' ' LEU . 35.1 tp -66.19 -38.31 87.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.412 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -53.04 -36.94 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.683 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.8 -43.1 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.592 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -63.46 -48.09 79.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.837 HD13 HD23 ' A' ' 55' ' ' LEU . 26.4 mt -58.7 -47.57 84.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.989 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.72 -42.36 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.44 -46.61 76.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.933 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.619 HH12 ' HB1' ' A' ' 80' ' ' ALA . 68.6 mtm-85 -87.53 18.87 3.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.28 37.65 92.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.866 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.516 HG13 ' C ' ' A' ' 53' ' ' GLY . 57.7 t -89.17 131.12 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -62.73 132.15 51.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 81' ' ' LEU . 57.8 t -153.05 144.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.633 ' HG3' HG23 ' A' ' 56' ' ' VAL . 16.7 pt-20 -148.36 150.84 34.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.327 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.798 HD23 ' H ' ' A' ' 90' ' ' LEU . 1.6 pt? -129.6 157.55 41.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.53 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.447 ' CZ3' ' CD1' ' A' ' 61' ' ' LEU . 23.8 t90 -59.32 144.26 47.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.022 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 68.03 126.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.787 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.09 133.61 44.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.206 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' NH2' ' CZ ' ' A' ' 95' ' ' PHE . 29.6 tpt180 -72.69 134.7 45.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CZ ' ' NH2' ' A' ' 94' ' ' ARG . 5.4 p90 -60.37 142.36 54.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 97' ' ' THR . 71.0 m -165.89 -41.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 96' ' ' THR . 51.6 m 72.26 -54.27 0.69 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.622 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.4 tptt . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.372 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -88.5 133.13 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.629 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.934 HG12 ' O ' ' A' ' 18' ' ' GLY . 14.7 p -132.72 137.36 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.971 0.415 . . . . 0.0 111.188 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.77 126.06 7.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.107 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.28 130.57 49.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.613 HD11 HD22 ' A' ' 43' ' ' LEU . 92.8 mt -123.28 139.71 53.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.008 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.69 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.5 p-10 -147.64 139.17 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 p -113.99 133.51 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.1 126.31 1.27 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.899 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 8.4 mp0 55.85 45.53 23.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 10' ' ' GLU . . . 75.54 -52.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.669 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.66 140.17 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 7' ' ' ASP . 60.2 mt -111.23 130.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.835 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.45 140.06 22.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.253 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.828 HD11 HD22 ' A' ' 31' ' ' LEU . 74.5 mt -123.99 133.3 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.666 0.27 . . . . 0.0 110.522 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HA ' ' CG ' ' A' ' 28' ' ' ARG . . . -159.05 -162.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.333 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 16' ' ' ALA . 90.3 t -158.87 142.4 6.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.934 ' O ' HG12 ' A' ' 3' ' ' VAL . . . -171.65 -148.87 6.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.982 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -123.58 116.75 23.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.905 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 47.67 46.75 18.08 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.832 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' C ' HG23 ' A' ' 22' ' ' VAL . . . 62.62 142.09 0.01 OUTLIER Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.794 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.476 HG13 ' HD2' ' A' ' 23' ' ' PRO . 51.9 t -157.01 137.21 8.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.468 0.175 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HD2' HG13 ' A' ' 22' ' ' VAL . 19.3 Cg_endo -60.0 129.71 31.52 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.449 2.099 . . . . 0.0 112.372 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 86.1 mt 60.89 125.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.192 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 24' ' ' LEU . . . 175.45 40.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.127 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -75.66 134.53 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.713 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.81 -45.28 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.287 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.7 mmp_? -58.34 -55.38 35.75 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.843 -0.21 . . . . 0.0 111.355 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.19 -139.87 5.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.172 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -179.98 151.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.659 0.266 . . . . 0.0 110.796 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 15' ' ' LEU . 1.5 pt? -133.91 136.17 44.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 33' ' ' ARG . 48.9 t -76.08 156.04 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.724 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 64.0 mtp180 -51.84 150.21 4.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.807 0.337 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 56.7 mttp -147.97 -155.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.26 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -97.13 -158.39 0.66 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.468 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.894 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.6 mm? -75.32 -55.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.607 0.241 . . . . 0.0 111.376 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.456 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.9 OUTLIER -70.36 -38.25 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.991 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 34' ' ' LYS . 7.3 mt-10 -57.74 -55.91 28.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 0.0 110.772 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -53.97 -42.31 68.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.794 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 36' ' ' LEU . 6.1 t -58.98 -55.99 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.415 0.626 . . . . 0.0 110.384 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.66 -46.89 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.422 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.28 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 47' ' ' VAL . 72.7 mt -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.379 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.608 ' CD1' HG12 ' A' ' 40' ' ' VAL . 76.3 mt -59.52 -48.4 81.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -50.23 -37.78 37.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.708 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.708 ' CE2' HD11 ' A' ' 52' ' ' LEU . 17.9 t80 -77.04 -44.1 32.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 43' ' ' LEU . 59.6 t -56.62 -53.77 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -70.78 -60.79 2.04 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -49.6 -50.46 42.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.72 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.6 tp10 -74.25 -10.97 60.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.618 0.247 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.44 39.62 97.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.561 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.708 HD11 ' CE2' ' A' ' 46' ' ' PHE . 89.4 mt -75.09 -49.37 19.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 54.86 26.5 40.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.381 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.844 ' O ' HD13 ' A' ' 55' ' ' LEU . 66.1 mttm -164.26 131.65 3.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.968 HD23 HD13 ' A' ' 81' ' ' LEU . 2.3 mm? -140.28 131.06 25.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 111.764 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 56' ' ' VAL . 10.8 p -118.64 124.24 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 90' ' ' LEU . 45.8 t -78.71 128.49 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.516 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -85.69 139.95 17.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.192 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 58' ' ' GLY . 97.5 mt -157.28 129.52 4.13 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.588 0.232 . . . . 0.0 110.943 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.65 -161.16 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.494 2.129 . . . . 0.0 112.234 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.29 134.43 45.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.797 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -64.47 127.37 31.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.887 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.2 p -75.56 -52.39 10.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.173 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 t70 179.5 130.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.65 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -71.62 128.01 34.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER 178.54 120.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.625 179.668 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 66' ' ' LYS . 66.4 mm-40 59.93 132.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.2 p -62.68 120.05 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.781 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.55 132.96 35.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.01 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -64.86 131.65 47.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 110.784 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.8 134.98 53.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.247 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.46 51.03 2.92 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.748 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.536 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER 59.32 20.95 9.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.637 0.256 . . . . 0.0 110.901 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.2 t -100.4 -44.35 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.166 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.9 tm? -54.21 -49.67 88.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.622 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.8 Cg_endo -46.95 -40.27 25.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.565 2.177 . . . . 0.0 112.599 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.68 HD23 HG13 ' A' ' 40' ' ' VAL . 2.8 tm? -71.84 -37.86 70.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.617 HG13 HG11 ' A' ' 88' ' ' VAL . 57.4 t -55.7 -35.62 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.676 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.85 -40.02 91.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.892 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.74 91.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.968 HD13 HD23 ' A' ' 55' ' ' LEU . 27.1 mt -61.52 -47.43 85.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 3.6 mmm180 -59.12 -42.27 90.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.19 80.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.377 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -86.89 19.25 3.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.799 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.74 37.88 94.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.985 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 52.9 t -97.28 134.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 41.2 tp10 -65.4 128.09 34.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.947 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 78' ' ' VAL . 46.7 t -158.06 145.06 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.55 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -169.71 141.34 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.122 0.487 . . . . 0.0 111.824 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.692 HD13 ' HB ' ' A' ' 57' ' ' VAL . 2.6 mm? -66.46 139.72 57.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.411 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -135.19 136.42 41.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.978 0.418 . . . . 0.0 110.903 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 93' ' ' GLU . 9.9 t70 -62.55 -118.12 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.451 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' O ' ' O ' ' A' ' 94' ' ' ARG . 17.7 tp10 -176.85 138.74 0.27 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.893 0.378 . . . . 0.0 110.991 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' A' ' 93' ' ' GLU . 14.1 ptp180 51.7 138.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.135 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -56.22 139.96 46.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.3 m -165.75 -41.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t -169.15 135.9 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.221 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.84 0.352 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -101.29 134.92 43.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.154 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.912 HG23 ' HG3' ' A' ' 54' ' ' LYS . 14.7 p -124.78 132.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.863 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.87 124.08 6.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.879 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.313 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.676 HD11 HD22 ' A' ' 43' ' ' LEU . 99.0 mt -129.27 138.63 51.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 9.5 p-10 -146.33 138.92 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.524 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.6 t -105.5 135.11 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.74 130.41 1.65 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.743 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 17.5 tp10 55.81 52.06 11.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.18 0.514 . . . . 0.0 111.136 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . 50.5 35.11 10.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HD3' ' CG ' ' A' ' 30' ' ' TYR . 38.6 ttm180 -149.24 140.1 22.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.855 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -103.8 128.66 56.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -83.93 130.32 9.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.544 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.637 HD11 ' CD2' ' A' ' 31' ' ' LEU . 89.3 mt -105.11 131.58 52.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.93 ' HB2' ' HA ' ' A' ' 26' ' ' SER . . . -150.51 147.01 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.901 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.3 t -143.5 119.34 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.197 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.908 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.44 -149.53 8.76 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.3 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.0 pm0 -69.36 145.87 52.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.6 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.76 ' OE1' HG21 ' A' ' 3' ' ' VAL . 48.3 mm-40 -52.24 133.14 34.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.033 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.72 52.47 48.32 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.809 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 47.1 t -59.86 127.36 85.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.485 0.183 . . . . 0.0 111.014 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 22' ' ' VAL . 13.2 Cg_exo -69.39 54.97 1.08 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.794 2.329 . . . . 0.0 112.606 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 24' ' ' LEU . 5.6 tt -175.93 -41.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.579 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' O ' HD23 ' A' ' 24' ' ' LEU . . . 64.97 137.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.93 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 48.8 m 63.91 130.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.88 45.33 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 -157.32 -45.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 110.791 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.22 -140.77 3.36 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.317 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.442 ' CG ' ' HD3' ' A' ' 12' ' ' ARG . 6.9 p90 179.95 140.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.383 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 15' ' ' LEU . 75.7 mt -106.14 123.02 47.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.546 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.8 t -72.68 148.99 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 81.6 mtm180 -47.08 148.32 1.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.334 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HD3' ' CG ' ' A' ' 38' ' ' GLU . 62.3 mttm -144.79 -121.94 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 38' ' ' GLU . 23.4 p -154.78 128.0 8.36 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.817 ' O ' HG23 ' A' ' 40' ' ' VAL . 83.5 mt 5.83 -69.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.4 pt-20 -67.8 -46.88 70.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 111.763 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.1 tp10 -58.55 -50.65 73.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.079 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.4 m-20 -48.67 -46.03 39.7 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.94 0.4 . . . . 0.0 110.315 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 36' ' ' LEU . 3.8 t -61.93 -50.22 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -52.91 -46.85 68.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.093 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.46 93.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.832 ' O ' HG23 ' A' ' 47' ' ' VAL . 94.7 mt -67.31 -42.0 84.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.639 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 70.0 mt -59.58 -56.21 24.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.694 0.283 . . . . 0.0 111.066 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -48.55 -38.02 19.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.812 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.686 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.2 t80 -73.49 -42.59 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 43' ' ' LEU . 59.5 t -63.31 -50.12 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -72.89 -62.84 1.32 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.8 mmm-85 -48.0 -51.8 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.074 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.1 tp10 -76.08 -4.88 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.343 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.08 40.68 91.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 46' ' ' PHE . 86.4 mt -68.22 -54.35 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.99 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.95 40.66 66.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.125 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.912 ' HG3' HG23 ' A' ' 3' ' ' VAL . 3.4 tppp? -178.36 128.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.02 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -141.32 133.2 27.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 111.776 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 91' ' ' TRP . 14.8 p -121.57 117.83 53.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.23 145.42 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.533 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -143.6 125.62 2.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.903 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 58' ' ' GLY . 88.5 mt -158.47 134.5 6.19 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.579 0.228 . . . . 0.0 110.747 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.49 129.36 17.75 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.289 1.993 . . . . 0.0 112.123 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.569 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.6 OUTLIER 62.3 121.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.307 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.724 ' NH2' HD22 ' A' ' 90' ' ' LEU . 19.8 tpp180 -86.38 -40.73 15.12 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 62' ' ' ARG . 8.2 t 50.53 -133.28 1.72 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.107 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -47.49 126.71 10.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.935 0.398 . . . . 0.0 111.298 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.92 -39.9 41.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.366 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -159.63 151.33 20.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.028 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -158.59 -40.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.4 t 65.82 -145.97 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.611 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 59.53 46.63 11.89 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 120.908 0.385 . . . . 0.0 110.727 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 63.63 103.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.666 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 178.74 142.4 0.11 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.117 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.04 131.21 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.591 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.747 ' HG2' HD23 ' A' ' 36' ' ' LEU . 36.6 mtmm -109.64 -29.17 8.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.77 0.319 . . . . 0.0 110.988 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.01 -45.09 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.158 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.523 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 56.3 tp -56.71 -49.82 91.5 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 83.9 Cg_exo -44.06 -38.37 10.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.116 . . . . 0.0 112.38 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.689 HD23 HG13 ' A' ' 40' ' ' VAL . 2.3 tm? -70.5 -36.31 73.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.693 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.96 HG13 HG11 ' A' ' 88' ' ' VAL . 61.3 t -54.45 -36.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.959 0.409 . . . . 0.0 110.581 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.93 -39.9 83.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.846 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.91 85.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.02 HD13 HD23 ' A' ' 55' ' ' LEU . 23.6 mt -59.08 -45.29 91.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.026 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -58.3 -44.04 88.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.08 85.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.103 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -83.11 15.55 2.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 38.84 96.65 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.254 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.6 t -108.5 135.24 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.35 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -69.75 139.35 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.96 HG11 HG13 ' A' ' 78' ' ' VAL . 44.5 t -155.84 139.72 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -161.53 130.79 4.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.032 0.444 . . . . 0.0 111.61 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.861 ' O ' HD12 ' A' ' 90' ' ' LEU . 2.3 pp -83.02 146.81 28.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.517 ' CD1' HG22 ' A' ' 56' ' ' VAL . 12.5 m0 -59.89 151.99 24.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.369 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t0 67.05 135.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.196 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -178.28 127.11 0.12 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 21.6 tpp180 -172.36 40.04 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.713 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -75.33 -48.05 24.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.762 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t 178.18 136.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.3 p -58.12 133.74 55.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' C ' ' HD2' ' A' ' 98' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.779 0.323 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -93.68 133.31 37.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.794 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 54' ' ' LYS . 14.4 p -136.58 136.13 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -79.32 134.69 14.12 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.134 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -121.96 133.92 54.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 111.423 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.614 HD11 HD22 ' A' ' 43' ' ' LEU . 98.9 mt -126.43 139.45 53.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -143.77 139.35 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.31 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -106.71 128.45 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.867 0.365 . . . . 0.0 111.559 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.84 -135.46 6.63 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.79 -44.4 90.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.364 . . . . 0.0 110.746 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -168.15 32.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.708 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' CD ' HG22 ' A' ' 32' ' ' VAL . 23.6 mmt85 -147.92 144.21 27.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.482 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 55.3 mt -99.61 125.25 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.41 129.34 9.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.631 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.668 HD11 ' HG ' ' A' ' 31' ' ' LEU . 85.5 mt -104.81 127.13 52.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 110.937 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -147.29 148.94 31.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.432 HG22 ' HA2' ' A' ' 4' ' ' GLY . 55.6 t -151.1 133.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.005 0.431 . . . . 0.0 111.676 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.89 -149.89 8.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.374 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -98.62 164.88 12.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.699 0.285 . . . . 0.0 110.973 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -48.75 -45.44 39.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 110.906 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.13 54.72 3.12 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.508 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t -59.95 134.61 90.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.608 0.242 . . . . 0.0 111.026 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.21 -41.15 44.67 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.646 2.23 . . . . 0.0 112.271 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.3 tp -168.83 -42.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.017 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.91 -42.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.245 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.2 t 63.44 127.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.962 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.03 146.82 34.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.682 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -158.03 -47.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.611 0.243 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.66 -151.41 10.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.856 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.4 p90 179.82 141.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.946 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HG ' HD11 ' A' ' 15' ' ' LEU . 67.0 mt -114.71 124.19 51.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.495 HG22 ' CD ' ' A' ' 12' ' ' ARG . 47.6 t -66.22 146.0 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.562 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 98.6 mtt180 -51.58 147.54 6.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.862 0.363 . . . . 0.0 111.465 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 35' ' ' THR . 52.1 mttp -147.17 -125.75 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.052 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 34' ' ' LYS . 16.1 p -157.69 134.79 10.14 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.842 HD12 ' H ' ' A' ' 36' ' ' LEU . 5.2 mp 5.27 -72.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -69.75 -48.15 60.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.0 tp10 -57.49 -50.27 73.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.942 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.413 ' OD2' ' CG ' ' A' ' 73' ' ' LYS . 45.5 m-20 -51.31 -42.38 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.6 t -60.84 -47.38 93.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.511 0.672 . . . . 0.0 109.779 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.74 -49.58 37.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.436 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.2 -44.3 59.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.257 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.994 ' CD1' HD22 ' A' ' 77' ' ' LEU . 27.7 mt -61.57 -48.12 82.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.934 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' HG12 ' A' ' 40' ' ' VAL . 57.9 mt -57.51 -50.76 72.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -45.28 -40.43 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.968 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CE2' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -77.45 -45.43 25.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.456 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' LEU . 65.8 t -57.1 -50.85 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 5.4 ptm180 -71.32 -62.77 1.28 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -51.42 -48.84 62.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.995 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -69.87 -13.41 62.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.547 0.213 . . . . 0.0 111.219 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.88 39.12 95.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.423 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.572 HD11 ' CE2' ' A' ' 46' ' ' PHE . 86.1 mt -74.1 -49.27 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.507 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 54.53 28.21 44.14 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.233 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.796 ' O ' HD13 ' A' ' 55' ' ' LEU . 67.5 mttm -164.14 129.96 2.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.268 0.227 . . . . 0.0 110.399 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 54' ' ' LYS . 2.6 mm? -140.25 121.02 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 56' ' ' VAL . 8.6 p -99.3 113.93 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.88 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 58' ' ' GLY . 48.1 t -73.62 157.92 6.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.735 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -155.02 129.82 2.66 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.657 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.698 HD21 HG21 ' A' ' 74' ' ' VAL . 91.8 mt -157.58 146.09 14.4 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.603 0.24 . . . . 0.0 110.928 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.1 -26.58 76.34 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.551 2.167 . . . . 0.0 112.148 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 67.8 mt 69.83 -157.2 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.404 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 44.6 -153.78 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.35 0.119 . . . . 0.0 110.758 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 63' ' ' THR . 42.1 m 53.34 48.7 21.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 111.031 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -76.55 48.03 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.676 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.577 HD12 ' N ' ' A' ' 65' ' ' LEU . 5.0 mp -88.47 140.38 29.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.727 0.299 . . . . 0.0 110.825 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -54.76 -41.43 70.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.001 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -59.2 -50.75 72.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.0 m -70.14 131.23 43.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.712 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.71 130.12 38.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.293 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 16.0 mp0 -73.25 133.8 44.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.215 0.531 . . . . 0.0 110.987 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.913 ' HB1' ' HB2' ' A' ' 75' ' ' LEU . . . 70.13 -55.98 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.678 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.31 -138.78 19.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.282 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 2.7 mppt? -81.73 -28.62 33.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 59' ' ' LEU . 40.3 t -61.5 -53.28 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.913 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 2.2 tm? -55.38 -50.4 86.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.503 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.2 Cg_exo -42.5 -39.9 7.04 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.494 2.13 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.994 HD22 ' CD1' ' A' ' 43' ' ' LEU . 42.6 tp -66.52 -41.31 88.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.717 HG13 HG11 ' A' ' 88' ' ' VAL . 22.0 t -53.99 -34.88 26.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.86 -43.17 93.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.21 91.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.635 HD13 HD23 ' A' ' 55' ' ' LEU . 31.7 mt -59.4 -41.18 88.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.366 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.692 ' NH1' HG12 ' A' ' 78' ' ' VAL . 62.1 mtt85 -57.11 -42.73 81.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.281 . . . . 0.0 111.219 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.76 -51.27 69.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.383 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -70.63 -27.3 63.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.99 43.41 4.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.346 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.507 HG13 ' C ' ' A' ' 53' ' ' GLY . 59.1 t -98.85 139.95 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.613 0.244 . . . . 0.0 110.754 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -60.43 130.15 45.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.717 HG11 HG13 ' A' ' 78' ' ' VAL . 60.9 t -151.86 145.2 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 56' ' ' VAL . 24.4 pt-20 -171.86 123.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.481 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.458 ' CD2' ' H ' ' A' ' 90' ' ' LEU . 1.8 pt? -75.68 130.66 39.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.476 ' CZ2' ' HA3' ' A' ' 58' ' ' GLY . 1.5 p90 -77.31 143.1 39.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.573 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -178.13 133.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.795 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 56.64 47.27 18.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' NH2' ' CE1' ' A' ' 95' ' ' PHE . 8.4 ptm180 -177.45 134.04 0.18 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.946 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' ' NH2' ' A' ' 94' ' ' ARG . 2.0 m-85 63.01 137.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t -57.45 139.0 54.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.313 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.6 p -158.47 135.1 9.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 1' ' ' MET . 49.6 ttm . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.822 0.344 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.402 ' HB3' ' CG1' ' A' ' 17' ' ' VAL . 99.2 mtt180 -96.38 132.3 42.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.917 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 18' ' ' GLY . 13.0 p -126.32 132.42 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.08 126.93 7.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.012 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.723 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -109.37 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.696 -0.297 . . . . 0.0 111.098 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.657 HD11 HD22 ' A' ' 43' ' ' LEU . 95.0 mt -120.47 136.53 54.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.454 . . . . 0.0 111.249 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -146.97 139.43 24.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.165 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.492 HG12 HG12 ' A' ' 13' ' ' ILE . 35.0 m -108.73 134.23 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.61 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.01 131.52 1.78 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.958 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 10' ' ' GLU . 40.4 tt0 56.8 53.47 8.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 48.85 35.92 7.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.467 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -151.69 140.97 21.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.68 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 61.8 mt -105.27 127.4 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 134.38 13.42 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.768 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.688 HD11 HD22 ' A' ' 31' ' ' LEU . 88.0 mt -113.59 133.72 55.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 0.0 110.912 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.723 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.38 148.95 29.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 28' ' ' ARG . 48.0 t -140.43 121.96 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.289 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.826 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.63 -149.59 8.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.341 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 22' ' ' VAL . 56.2 mt-10 -65.77 154.79 38.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.724 0.297 . . . . 0.0 110.747 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.588 ' HA ' HG11 ' A' ' 3' ' ' VAL . 4.1 tm-20 -65.47 126.84 29.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.964 0.411 . . . . 0.0 111.055 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.67 48.06 86.84 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.712 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 19' ' ' GLU . 59.3 t -71.52 132.72 85.36 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 117.095 0.448 . . . . 0.0 110.827 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.492 ' O ' HD23 ' A' ' 24' ' ' LEU . 92.3 Cg_endo -83.75 37.72 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.641 2.227 . . . . 0.0 112.732 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 23' ' ' PRO . 94.9 mt -161.8 -42.6 0.04 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.931 0.396 . . . . 0.0 110.6 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 24' ' ' LEU . . . 69.46 125.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.095 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.0 p -73.09 -37.49 66.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.34 138.79 1.37 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.328 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' A' ' 17' ' ' VAL . 27.1 mmm180 -132.08 -43.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.98 -137.58 2.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.67 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -179.93 150.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.927 0.394 . . . . 0.0 110.86 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.688 HD22 HD11 ' A' ' 15' ' ' LEU . 1.3 pt? -134.67 135.33 41.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.21 145.07 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 66.1 mtm180 -54.26 151.59 7.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.168 0.509 . . . . 0.0 111.326 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.433 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 64.1 mttm -146.61 -122.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.699 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 38' ' ' GLU . 38.4 p -148.58 139.72 23.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.728 0.299 . . . . 0.0 110.903 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.021 HD22 ' N ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -21.96 -43.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 1.021 ' N ' HD22 ' A' ' 36' ' ' LEU . 11.9 pt-20 -73.46 -48.88 30.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HG2' ' OG1' ' A' ' 35' ' ' THR . 13.6 mm-40 -61.79 -48.31 81.21 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 23.0 m-20 -45.93 -40.96 10.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.74 -52.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.185 0.517 . . . . 0.0 110.363 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.09 -51.92 66.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.94 93.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.006 HD13 ' CD2' ' A' ' 77' ' ' LEU . 74.0 mt -65.22 -50.31 66.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.457 ' HB3' ' NH1' ' A' ' 48' ' ' ARG . 61.5 mt -59.1 -48.08 82.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -49.35 -38.91 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 52' ' ' LEU . 17.9 t80 -77.04 -43.69 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.236 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 43' ' ' LEU . 99.9 t -58.06 -51.81 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 44' ' ' LEU . 1.5 ptt-85 -67.81 -63.18 1.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.6 mtp85 -51.35 -49.75 60.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.881 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -72.05 -10.23 59.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.263 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.8 97.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.465 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 46' ' ' PHE . 88.9 mt -72.36 -52.81 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 53.84 36.18 54.77 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.257 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.915 ' O ' HD13 ' A' ' 55' ' ' LEU . 37.3 ttpt 178.21 131.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.111 HD23 HD13 ' A' ' 81' ' ' LEU . 1.6 mm? -137.8 137.45 38.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.748 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 3' ' ' VAL . 15.0 p -128.19 132.79 68.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.11 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 90' ' ' LEU . 14.8 t -77.91 141.91 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.752 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.733 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -152.48 133.93 4.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.195 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 58' ' ' GLY . 65.1 mt -149.56 114.07 3.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.536 0.208 . . . . 0.0 110.584 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.54 -57.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.409 2.073 . . . . 0.0 112.458 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.3 tp -77.27 127.21 32.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.372 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -83.15 133.95 35.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.655 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.5 p -61.44 127.45 31.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.59 -57.92 3.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.451 HD23 ' N ' ' A' ' 65' ' ' LEU . 1.8 pt? -66.03 125.61 25.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.47 ' HB3' ' NZ ' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -84.35 133.92 34.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.763 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 68' ' ' SER . 12.6 pt-20 -177.62 -163.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.674 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 67' ' ' GLU . 91.6 p 56.33 130.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.056 0.455 . . . . 0.0 111.547 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.74 98.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -178.24 130.83 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.271 0.558 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.48 -144.15 0.56 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.946 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' O ' ' CD ' ' A' ' 76' ' ' PRO . . . -179.64 -135.44 2.43 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.374 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 37.3 mtmm -64.22 -25.26 67.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 111.383 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.22 -41.15 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 61.2 tp -54.5 -52.0 73.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.3 Cg_exo -43.94 -40.16 11.52 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.348 2.032 . . . . 0.0 112.219 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.006 ' CD2' HD13 ' A' ' 43' ' ' LEU . 32.0 tp -63.19 -42.79 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.6 t -52.01 -35.49 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.77 -42.81 94.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.06 66.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.111 HD13 HD23 ' A' ' 55' ' ' LEU . 24.5 mt -57.94 -50.91 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -58.44 -38.4 77.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.42 -43.74 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.427 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.425 HH22 HD23 ' A' ' 81' ' ' LEU . 68.0 mtm-85 -89.69 20.04 4.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.505 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 39.82 98.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG13 ' C ' ' A' ' 53' ' ' GLY . 50.1 t -95.52 132.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.85 130.22 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.679 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 81' ' ' LEU . 65.9 t -155.91 144.48 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.96 0.41 . . . . 0.0 111.301 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.5 pt-20 -172.02 129.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.29 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.815 ' O ' HD12 ' A' ' 90' ' ' LEU . 2.5 pp -78.0 149.61 34.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.693 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -157.87 137.55 12.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.069 0.461 . . . . 0.0 111.602 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' OD1' ' HG3' ' A' ' 93' ' ' GLU . 2.8 p30 -177.96 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.314 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HG3' ' OD1' ' A' ' 92' ' ' ASP . 52.7 mt-10 -70.2 132.74 46.22 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -164.41 -47.87 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.332 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -177.99 130.13 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.728 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.639 ' O ' HG22 ' A' ' 96' ' ' THR . 37.7 m -91.11 42.83 1.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.277 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' THR . 65.7 p 56.33 133.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.767 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.33 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.985 0.422 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 1.0 OUTLIER -87.59 135.91 33.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.672 179.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.889 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.7 p -121.49 131.56 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.48 117.56 4.76 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.951 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -97.22 133.3 42.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.226 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.785 HD11 HD22 ' A' ' 43' ' ' LEU . 83.8 mt -123.73 138.37 54.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -145.34 144.39 30.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.106 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.06 141.18 45.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 111.531 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.78 133.5 2.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.756 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 66.04 -67.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.344 0.257 . . . . 0.0 111.522 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . -176.19 36.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.844 0.354 . . . . 0.0 111.354 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -156.46 143.9 19.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.3 mt -104.09 130.44 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.708 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.13 138.12 17.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.009 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 31' ' ' LEU . 52.4 mt -115.39 132.8 56.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.881 ' HB2' ' HA ' ' A' ' 26' ' ' SER . . . -154.68 145.46 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.058 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 28' ' ' ARG . 57.5 t -136.96 125.6 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.115 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.889 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.63 -149.42 8.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.143 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 22' ' ' VAL . 42.2 tp10 -73.56 160.02 32.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.338 . . . . 0.0 110.53 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.7 130.08 41.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.944 0.402 . . . . 0.0 111.402 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.02 46.06 95.35 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.182 -0.532 . . . . 0.0 113.767 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 19' ' ' GLU . 94.7 t -80.14 133.49 57.39 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.896 0.348 . . . . 0.0 110.979 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.05 134.39 29.36 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.482 2.121 . . . . 0.0 111.767 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.614 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.5 mm? 60.22 52.85 4.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.863 0.363 . . . . 0.0 110.343 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' O ' ' OG ' ' A' ' 26' ' ' SER . . . -60.17 -138.63 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.608 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.881 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 97.8 p 58.45 122.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.967 0.413 . . . . 0.0 111.017 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.91 51.55 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.635 ' HG3' HG23 ' A' ' 17' ' ' VAL . 4.5 mmp_? -151.39 -50.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.73 -139.4 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.378 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 5.7 p90 -179.81 143.06 0.17 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 111.311 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 15' ' ' LEU . 1.3 mp -111.81 127.97 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.029 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 55.2 t -70.61 143.35 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.468 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 mtt180 -50.58 140.23 14.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.824 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 50.3 mttp -138.53 -140.75 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.641 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.736 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.2 m -106.16 -158.98 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.5 pt? -77.17 -49.65 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.148 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 15.4 pt-20 -70.59 -40.13 73.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.602 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 1.7 mm-40 -55.42 -57.03 13.56 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.333 0.587 . . . . 0.0 110.351 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.6 -44.75 62.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.759 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 36' ' ' LEU . 3.6 t -60.51 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.428 0.633 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -53.51 -45.52 69.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.128 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' HD23 ' A' ' 31' ' ' LEU . . . -60.68 -47.02 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.774 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.785 HD22 HD11 ' A' ' 6' ' ' LEU . 92.1 mt -65.86 -45.14 83.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.683 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 22.3 mt -59.29 -57.47 12.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.526 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.823 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 65.8 t0 -43.95 -42.1 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 15.9 t80 -71.05 -42.39 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.152 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 43' ' ' LEU . 83.5 t -67.32 -44.57 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.8 ptm180 -64.43 -67.53 0.43 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 45' ' ' ASP . 39.7 ptt85 -56.19 -47.75 77.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.0 tp10 -65.35 -16.06 63.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 111.258 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 36.86 90.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.454 HD21 ' HG2' ' A' ' 50' ' ' GLU . 89.8 mt -68.15 -50.64 53.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.74 40.06 69.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.439 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.833 ' O ' HD13 ' A' ' 55' ' ' LEU . 59.7 tttp -177.87 125.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.476 0.179 . . . . 0.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.037 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -140.39 131.68 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.446 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.477 HG13 ' O ' ' A' ' 56' ' ' VAL . 10.2 p -111.18 120.05 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.59 HG21 ' CG2' ' A' ' 78' ' ' VAL . 33.2 t -92.27 153.73 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.597 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -152.31 130.72 3.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.003 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 58' ' ' GLY . 93.1 mt -156.83 138.15 9.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.643 0.258 . . . . 0.0 110.993 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.96 149.05 82.9 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.703 2.268 . . . . 0.0 112.312 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.9 mt 68.13 139.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -55.47 138.78 45.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.082 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 t -58.35 134.34 56.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.301 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.99 141.65 58.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.5 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.3 mm? -59.94 137.0 58.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.753 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt 63.48 136.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.719 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -62.0 121.56 13.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.779 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.8 p -81.76 134.9 35.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.08 78.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.781 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -70.2 132.31 45.56 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.287 0.565 . . . . 0.0 110.83 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.25 -146.9 0.5 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.801 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 76' ' ' PRO . . . 54.94 43.04 82.18 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.302 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.479 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 53.8 mtmt -76.96 -25.31 52.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.624 0.249 . . . . 0.0 111.576 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.31 -45.25 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.625 ' O ' HD13 ' A' ' 75' ' ' LEU . 2.0 tm? -52.34 -50.12 81.39 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 96.0 Cg_exo -40.85 -33.32 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.834 2.356 . . . . 0.0 112.895 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.664 ' C ' HD13 ' A' ' 77' ' ' LEU . 2.7 tm? -80.8 -39.42 26.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG2' HG21 ' A' ' 57' ' ' VAL . 47.3 t -53.64 -36.8 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 21.3 pt-20 -73.56 -33.91 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.734 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -59.12 -45.11 91.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.157 0.503 . . . . 0.0 110.692 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.037 HD13 HD23 ' A' ' 55' ' ' LEU . 22.9 mt -60.7 -47.84 84.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.81 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -57.83 -39.59 78.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.94 72.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.376 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -88.19 21.21 2.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.724 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.99 92.73 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.966 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.53 135.78 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.703 0.287 . . . . 0.0 111.063 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 65.5 mm-40 -64.57 125.84 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.792 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.563 HG11 HG13 ' A' ' 78' ' ' VAL . 57.7 t -158.78 145.97 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -166.92 131.92 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.095 0.474 . . . . 0.0 111.624 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.899 HD23 ' N ' ' A' ' 91' ' ' TRP . 6.1 tt -72.27 142.38 48.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.278 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.899 ' N ' HD23 ' A' ' 90' ' ' LEU . 21.0 t-105 -146.86 141.99 27.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 0.0 111.042 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -164.28 -43.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.761 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -175.21 127.32 0.27 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.185 0.516 . . . . 0.0 111.121 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.476 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 3.0 tpm_? -91.74 -44.2 9.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.923 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.47 57.82 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.503 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.2 m -62.51 -43.46 98.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.899 0.381 . . . . 0.0 110.796 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.683 HG22 ' HG2' ' A' ' 98' ' ' LYS . 77.6 m 63.72 132.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.052 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.683 ' HG2' HG22 ' A' ' 97' ' ' THR . 47.0 mmtm . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 121.029 0.443 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -104.74 140.26 38.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.782 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 18' ' ' GLY . 11.9 p -119.42 136.23 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.281 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.465 ' HA3' HD13 ' A' ' 55' ' ' LEU . . . -81.47 131.18 10.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.094 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -113.87 130.76 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.663 HD11 HD22 ' A' ' 43' ' ' LEU . 96.5 mt -123.37 135.95 54.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.041 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 2.9 p30 -140.3 134.86 31.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.625 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -98.95 129.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.637 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.98 -135.48 5.69 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.285 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -62.92 -42.85 99.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . -171.57 39.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -155.33 146.61 22.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -98.95 127.03 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.484 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.47 126.63 7.7 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.447 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.658 HD11 ' CD2' ' A' ' 31' ' ' LEU . 86.0 mt -99.42 130.41 45.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.918 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.52 145.84 26.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.52 124.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.72 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.64 151.67 10.05 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.505 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -59.86 148.59 34.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.637 0.256 . . . . 0.0 110.404 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -42.07 134.98 2.6 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.537 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.29 45.97 52.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.455 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.29 127.53 92.2 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.519 0.199 . . . . 0.0 111.102 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.436 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 23.6 Cg_exo -63.91 134.38 43.08 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.358 2.039 . . . . 0.0 111.699 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 54.8 tp 69.69 -51.54 0.62 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.533 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 24' ' ' LEU . . . 71.1 137.55 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.981 0.419 . . . . 0.0 111.256 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.7 p -173.71 129.92 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.623 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.44 132.77 27.67 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.789 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -65.52 -35.63 81.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 110.676 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.81 -135.59 1.88 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.252 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 7.2 p90 -178.9 138.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.658 ' CD2' HD11 ' A' ' 15' ' ' LEU . 80.0 mt -106.43 125.63 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.669 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.23 133.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 52.4 mtp85 -56.94 124.98 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.461 . . . . 0.0 111.048 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.842 ' O ' HG23 ' A' ' 35' ' ' THR . 96.6 mttt -109.09 -96.96 0.39 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -176.03 127.3 0.22 Allowed 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 40' ' ' VAL . 62.4 tp 16.59 -76.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -67.55 -44.93 77.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 34' ' ' LYS . 4.6 mm-40 -57.69 -51.72 68.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.269 0.557 . . . . 0.0 110.324 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.9 m-20 -49.06 -42.8 39.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.243 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.696 HG13 HD23 ' A' ' 77' ' ' LEU . 3.2 t -58.86 -54.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 110.514 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -52.76 -49.53 65.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.346 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.22 89.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.948 0.404 . . . . 0.0 111.201 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 47' ' ' VAL . 84.2 mt -65.25 -46.09 81.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.391 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.512 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 72.7 mt -60.58 -52.8 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -48.55 -38.41 20.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -73.09 -42.09 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 43' ' ' LEU . 69.8 t -65.04 -51.94 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -70.79 -62.72 1.29 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -47.61 -51.0 22.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.959 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 5.4 tp10 -77.0 -4.04 42.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 111.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.49 38.55 91.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.657 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 46' ' ' PHE . 88.0 mt -72.59 -55.55 6.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . 53.0 33.22 43.76 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.841 ' C ' HD22 ' A' ' 55' ' ' LEU . 34.2 mmtp -161.91 128.1 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.225 0.21 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.952 HD23 HD13 ' A' ' 81' ' ' LEU . 2.8 mm? -143.16 133.05 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.367 0.603 . . . . 0.0 111.65 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.463 HG13 ' O ' ' A' ' 56' ' ' VAL . 11.1 p -131.02 122.44 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.2 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 25.0 t -97.23 141.76 15.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.589 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.44 109.99 0.65 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.983 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.42 131.37 84.84 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.525 0.203 . . . . 0.0 110.898 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.4 42.03 1.26 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.586 2.191 . . . . 0.0 112.862 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 61' ' ' LEU . 1.5 pt? 179.67 129.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.758 0.314 . . . . 0.0 110.864 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -71.85 -51.45 22.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.744 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -76.5 142.16 41.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.245 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.49 ' C ' HD13 ' A' ' 65' ' ' LEU . 2.7 p30 -169.68 132.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.692 ' N ' HD13 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -171.24 41.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.237 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm 64.75 146.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.675 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -154.52 -42.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.28 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.5 t -169.13 135.01 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.932 0.396 . . . . 0.0 111.261 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 62.25 126.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.42 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -75.3 136.05 40.89 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.97 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.33 127.85 8.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.441 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.64 129.5 1.09 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.127 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -179.39 34.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.287 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.4 -43.17 10.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.074 0.464 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 59.7 tp -53.5 -48.86 91.42 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 1.4 Cg_endo -43.19 -39.78 8.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.767 2.311 . . . . 0.0 112.718 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.696 HD23 HG13 ' A' ' 40' ' ' VAL . 2.5 tm? -76.07 -36.87 58.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.814 HG13 HG11 ' A' ' 88' ' ' VAL . 58.5 t -55.44 -36.18 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.678 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -66.23 -39.55 89.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.51 -44.9 93.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.952 HD13 HD23 ' A' ' 55' ' ' LEU . 24.1 mt -60.15 -48.39 81.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.056 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -58.81 -43.57 90.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.667 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.7 82.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -84.08 17.84 2.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.659 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 37.16 94.15 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.318 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.2 t -106.93 133.38 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 0.0 110.942 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 51.0 mm-40 -67.89 132.2 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.814 HG11 HG13 ' A' ' 78' ' ' VAL . 43.0 t -157.44 143.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.619 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.95 139.43 6.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.086 0.47 . . . . 0.0 112.054 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.637 ' N ' HD22 ' A' ' 90' ' ' LEU . 1.8 mm? -80.56 119.9 23.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.994 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.457 ' CZ2' ' HB2' ' A' ' 93' ' ' GLU . 15.3 t-105 179.9 159.35 0.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 110.972 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -151.73 -44.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.574 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . 65.9 mm-40 -58.37 128.89 39.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.231 0.539 . . . . 0.0 111.195 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 94' ' ' ARG . 2.8 ptp180 -84.79 145.53 27.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.384 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.415 ' CE2' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -166.01 45.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.348 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.8 t -177.49 -143.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.7 m 64.07 133.96 0.02 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.909 0.385 . . . . 0.0 111.004 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.981 0.42 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -119.18 142.18 48.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.896 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 18' ' ' GLY . 13.3 p -136.67 141.66 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.468 ' HA3' HD13 ' A' ' 55' ' ' LEU . . . -73.97 131.84 14.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.448 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -121.75 137.32 54.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.85 ' O ' HG13 ' A' ' 57' ' ' VAL . 94.5 mt -132.17 141.07 48.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.126 0.488 . . . . 0.0 111.609 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 11.6 p-10 -146.2 137.94 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.677 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 8' ' ' VAL . 14.7 p -103.52 124.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.723 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.56 -136.76 9.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.675 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.1 -42.72 72.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.7 0.286 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -158.89 40.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.24 0.543 . . . . 0.0 110.899 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -167.59 173.4 8.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 52.1 mt -126.41 134.15 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.74 133.55 11.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.008 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.641 HD21 ' CD1' ' A' ' 31' ' ' LEU . 86.0 mt -98.61 131.65 44.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.608 0.242 . . . . 0.0 110.546 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -145.64 143.8 30.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.775 0.321 . . . . 0.0 111.051 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.8 t -135.79 123.83 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.168 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.9 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.64 -149.41 8.63 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -64.99 145.22 56.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.724 0.297 . . . . 0.0 110.535 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.884 ' HA ' HG11 ' A' ' 3' ' ' VAL . 44.6 tt0 -46.14 133.43 9.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.89 0.376 . . . . 0.0 111.245 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.84 47.72 53.39 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.631 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.25 129.6 92.38 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.538 0.208 . . . . 0.0 110.978 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.5 41.21 0.95 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.582 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 33.4 tp 56.5 44.42 24.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.999 0.428 . . . . 0.0 110.785 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.41 93.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.1 m -165.42 127.4 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.462 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.77 124.6 8.69 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.137 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 15' ' ' LEU . 29.5 tpt180 -75.29 -37.79 60.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.067 0.46 . . . . 0.0 110.155 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' C ' ' CD1' ' A' ' 30' ' ' TYR . . . -163.0 -154.19 7.53 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.041 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 29' ' ' GLY . 75.0 m-85 -161.05 135.62 7.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.899 0.35 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.641 ' CD1' HD21 ' A' ' 15' ' ' LEU . 80.7 mt -121.92 122.28 39.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.117 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.5 t -67.1 145.95 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.513 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 99.2 mtt180 -52.64 147.26 8.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.018 0.437 . . . . 0.0 111.28 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HD3' ' HG2' ' A' ' 38' ' ' GLU . 66.7 mttm -147.92 -125.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.118 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 38' ' ' GLU . 42.6 p -145.9 136.31 24.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.026 0.441 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.713 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -18.28 -53.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 38' ' ' GLU . 16.5 pt-20 -72.01 -48.83 41.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.356 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HG2' ' HD3' ' A' ' 34' ' ' LYS . 81.4 tt0 -60.73 -48.97 79.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -49.69 -39.99 38.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.075 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -56.25 -48.52 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.359 0.6 . . . . 0.0 109.867 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' OE1' ' N ' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -52.41 -47.73 66.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.277 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.1 73.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.017 HD13 ' CD2' ' A' ' 77' ' ' LEU . 61.0 mt -65.05 -47.35 77.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.773 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 61.7 mt -60.33 -49.8 76.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.602 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.2 -39.49 14.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.771 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.727 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.8 t80 -78.61 -43.86 25.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.244 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 43' ' ' LEU . 62.1 t -55.58 -53.39 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 4.8 ptm180 -69.69 -61.85 1.62 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -51.52 -49.04 62.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.874 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.9 tp10 -73.22 -12.62 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.43 40.66 99.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.436 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.727 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.0 mt -74.51 -52.37 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.965 0.412 . . . . 0.0 111.098 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 53.69 29.3 40.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.212 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.82 ' O ' HD13 ' A' ' 55' ' ' LEU . 97.3 mttt -163.62 135.08 4.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.516 0.198 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.936 HD23 HD13 ' A' ' 81' ' ' LEU . 2.7 mm? -139.82 139.64 36.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 89' ' ' GLU . 12.4 p -149.66 143.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.962 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.6 t -144.86 129.73 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 111.969 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.06 108.31 3.46 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.341 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.644 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.3 mm? -85.49 138.6 35.98 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.731 0.3 . . . . 0.0 111.493 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 59' ' ' LEU . 25.3 Cg_exo -62.51 -40.84 35.97 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.643 2.229 . . . . 0.0 112.822 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.479 HD13 ' CH2' ' A' ' 91' ' ' TRP . 65.1 tp 65.64 159.64 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.337 . . . . 0.0 110.82 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 27.8 tpt180 76.1 42.55 0.19 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.633 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.0 t -74.4 144.14 44.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.761 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.95 126.16 17.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.876 0.369 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.55 134.13 48.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.194 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' NZ ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -178.14 -68.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 73.5 mm-40 -161.3 -54.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.02 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 80.0 p -71.07 132.97 45.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 68' ' ' SER . . . 175.76 -49.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.249 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 4.0 mp0 -83.74 52.34 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.628 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 70' ' ' GLN . . . 179.4 137.28 0.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.793 0.33 . . . . 0.0 111.647 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 74' ' ' VAL . . . -168.51 25.66 0.12 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.84 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 76' ' ' PRO . 36.5 mtmm 66.56 -19.55 0.11 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 72' ' ' GLY . 48.9 t -79.28 -41.31 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.533 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.65 HD13 ' C ' ' A' ' 75' ' ' LEU . 3.0 tm? -54.06 -53.93 53.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.9 Cg_endo -48.79 -35.67 31.34 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.296 1.998 . . . . 0.0 112.069 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.017 ' CD2' HD13 ' A' ' 43' ' ' LEU . 29.0 tp -61.62 -44.07 97.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 110.713 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 41.1 t -55.01 -34.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.432 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -56.58 -43.97 80.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.467 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -62.3 -47.38 84.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.936 HD13 HD23 ' A' ' 55' ' ' LEU . 33.5 mt -62.8 -42.83 99.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.383 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 78' ' ' VAL . 25.2 mmm180 -56.22 -43.92 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.693 0.282 . . . . 0.0 111.192 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.77 86.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.915 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . 0.467 HH12 ' HB1' ' A' ' 80' ' ' ALA . 65.9 mtt85 -70.77 -30.5 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.929 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.15 42.92 4.2 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.16 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.42 142.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.687 0.28 . . . . 0.0 110.718 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.74 128.7 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.761 0.315 . . . . 0.0 110.63 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 81' ' ' LEU . 62.8 t -152.91 140.08 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.6 pm0 -165.42 132.03 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.668 HD23 ' N ' ' A' ' 90' ' ' LEU . 1.3 pt? -154.47 124.44 6.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TRP . . . . . 0.479 ' CH2' HD13 ' A' ' 61' ' ' LEU . 31.3 t-105 -179.23 148.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 64.0 t0 -47.11 132.17 12.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.847 0.356 . . . . 0.0 110.745 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 15.4 pt-20 -57.6 114.12 2.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.201 0.524 . . . . 0.0 111.507 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 22.5 mmt85 -161.02 32.7 0.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.49 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' O ' ' CG ' ' A' ' 95' ' ' PHE . 17.2 t80 52.33 39.11 26.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.915 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.0 m -68.46 127.99 34.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.007 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 98' ' ' LYS . 9.1 t -74.1 -46.06 45.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.142 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' N ' HG23 ' A' ' 97' ' ' THR . 39.8 ttmt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.702 0.287 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.1 p -140.0 137.88 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.14 130.89 10.1 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.442 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -117.57 133.26 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.79 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.58 ' HB2' HG22 ' A' ' 57' ' ' VAL . 89.9 mt -120.38 138.92 53.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 111.194 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.1 p-10 -149.9 149.8 30.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.306 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.0 p -149.86 126.62 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.84 -55.81 2.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.991 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 178.16 34.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.299 . . . . 0.0 110.826 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . 168.53 -48.04 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -105.25 140.41 38.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.43 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 7' ' ' ASP . 53.5 mt -107.94 128.97 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.493 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.98 141.73 18.69 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.988 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.61 HD21 HD22 ' A' ' 31' ' ' LEU . 82.7 mt -118.05 129.71 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -138.75 147.41 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.995 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.616 HG21 ' CZ ' ' A' ' 46' ' ' PHE . 60.4 t -147.24 117.41 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.448 -0.524 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.091 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.844 0.354 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.96 -138.28 2.53 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.638 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 p90 179.96 150.05 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.997 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.685 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.7 pt? -137.18 136.44 38.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.961 0.41 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.0 t -74.28 147.45 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.413 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 83.2 mtm180 -54.73 140.96 34.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 60.1 mttm -137.23 -149.79 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.109 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.875 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.9 m -87.94 -163.48 0.96 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.572 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.875 ' H ' HG22 ' A' ' 35' ' ' THR . 3.9 mp -78.64 -61.03 2.14 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.968 0.413 . . . . 0.0 110.523 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -64.1 -37.17 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HG3' ' CD ' ' A' ' 34' ' ' LYS . 5.3 tp10 -57.0 -54.12 50.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.292 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 35' ' ' THR . 46.3 m-20 -52.12 -41.46 62.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.713 0.292 . . . . 0.0 110.631 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.38 -46.12 92.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.408 0.623 . . . . 0.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -55.75 -47.63 76.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.894 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.96 -44.29 85.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 110.533 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.017 HD13 ' CD2' ' A' ' 77' ' ' LEU . 36.8 mt -63.34 -50.03 71.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.341 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.592 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 22.1 mt -56.9 -49.88 74.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 37.0 t70 -46.9 -42.07 16.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.69 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.616 ' CZ ' HG21 ' A' ' 17' ' ' VAL . 17.2 t80 -83.75 -57.73 3.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.55 HG11 HD21 ' A' ' 55' ' ' LEU . 59.5 t -56.05 -47.58 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 13.9 tpp85 -65.85 -53.95 33.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 58.5 mmt-85 -71.41 -43.45 66.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 40.6 tp10 -63.81 -14.9 56.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.567 0.222 . . . . 0.0 111.37 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.02 40.54 99.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.408 HD21 ' HG2' ' A' ' 50' ' ' GLU . 85.5 mt -68.95 -47.18 66.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.94 32.0 61.91 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.662 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.934 ' O ' HD13 ' A' ' 55' ' ' LEU . 37.8 ttpt 178.19 130.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.6 mm? -135.75 133.63 38.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.94 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 p -119.69 135.96 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.144 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 6' ' ' LEU . 43.0 t . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 112.059 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 31.9 mtmm . . . . . 0 CA--C 1.529 0.15 0 CA-C-O 120.791 0.329 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.401 HG11 HG11 ' A' ' 57' ' ' VAL . 46.2 t -83.01 -36.91 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.677 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.484 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 60.2 tp -49.12 -46.84 76.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 97.0 Cg_exo -43.44 -33.0 3.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.649 2.233 . . . . 0.0 112.904 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.017 ' CD2' HD13 ' A' ' 43' ' ' LEU . 28.2 tp -82.25 -44.92 15.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.41 -36.05 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.311 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 20.4 pt-20 -68.26 -39.11 82.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.352 . . . . 0.0 110.514 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.78 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 0.0 110.529 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.853 HD13 HD23 ' A' ' 55' ' ' LEU . 30.3 mt -60.03 -51.0 71.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.058 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -58.23 -44.04 88.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.15 -41.85 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.452 ' NH1' HD22 ' A' ' 44' ' ' LEU . 99.1 mtt180 -83.64 15.54 3.13 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.68 37.16 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.36 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.9 t -99.2 132.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.685 0.279 . . . . 0.0 110.786 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 41.4 tp10 -62.61 133.02 54.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.86 0.362 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 81' ' ' LEU . 61.0 t -157.68 150.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.952 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -163.48 127.92 2.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.708 179.917 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.849 0.357 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.882 HG23 ' HG2' ' A' ' 54' ' ' LYS . 9.6 p -133.06 133.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.066 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.642 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -78.55 139.56 22.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.868 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.86 134.71 47.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.378 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.68 HD11 HD22 ' A' ' 43' ' ' LEU . 84.3 mt -117.91 137.45 52.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.097 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 8.6 p-10 -140.82 136.2 32.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.73 137.64 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.36 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.27 -44.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.227 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -178.65 105.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.751 0.31 . . . . 0.0 110.784 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . 45.57 30.35 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.281 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -165.86 143.3 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 54.1 mt -112.84 133.73 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.406 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.403 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -82.02 133.87 12.47 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.584 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 ' HG ' ' A' ' 31' ' ' LEU . 92.0 mt -105.11 130.26 53.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.856 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.48 149.06 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.669 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 59.2 t -146.96 127.97 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.151 0.5 . . . . 0.0 111.501 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.793 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.449 -0.451 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.217 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HG3' HG23 ' A' ' 17' ' ' VAL . 26.8 mmm180 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.657 0.265 . . . . 0.0 110.862 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.18 -138.38 2.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.825 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.413 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 5.3 p90 -179.72 140.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.748 0.309 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.651 ' HG ' HD11 ' A' ' 15' ' ' LEU . 80.7 mt -120.22 126.09 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.9 t -71.99 144.12 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.414 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 74.6 mtp180 -55.14 149.27 12.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.959 0.409 . . . . 0.0 111.319 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 61.6 mttm -150.49 -153.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.1 m -86.78 -158.6 0.44 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.5 pt? -81.54 -48.56 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.123 -0.36 . . . . 0.0 111.0 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 16.5 pt-20 -66.96 -38.98 87.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 4.1 mm-40 -60.57 -55.42 33.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.33 -48.0 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.499 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 36' ' ' LEU . 5.2 t -60.51 -54.82 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 109.791 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -53.79 -45.82 70.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.48 87.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.718 ' O ' HG23 ' A' ' 47' ' ' VAL . 97.4 mt -63.89 -44.19 93.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.268 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.0 mt -60.97 -47.58 85.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 110.527 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 48' ' ' ARG . 4.8 t70 -47.29 -41.76 19.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.739 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.1 t80 -75.06 -40.09 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 43' ' ' LEU . 60.3 t -63.01 -53.9 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 8.9 ptt85 -72.06 -62.86 1.28 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 49' ' ' ARG . 11.7 mtp-105 -47.9 -50.52 26.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -75.65 -6.47 50.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.369 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.29 39.45 94.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.666 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.739 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.1 mt -72.78 -53.26 12.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.39 42.52 83.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.882 ' HG2' HG23 ' A' ' 3' ' ' VAL . 83.3 tttt -178.3 127.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.011 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -141.54 135.96 30.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.786 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 4' ' ' GLY . 13.4 p -117.47 125.69 74.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 121.074 0.464 . . . . 0.0 111.647 -179.312 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.85 0.357 . . . . 0.0 111.029 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.1 -42.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.595 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 59.3 tp -55.93 -43.77 99.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.579 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.8 Cg_exo -46.72 -40.15 24.13 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 0.0 112.392 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.663 HD13 ' C ' ' A' ' 77' ' ' LEU . 2.5 tm? -71.44 -38.48 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.616 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.819 HG13 HG11 ' A' ' 88' ' ' VAL . 61.5 t -55.03 -36.24 37.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -67.09 -40.02 86.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.886 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.32 92.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.139 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.011 HD13 HD23 ' A' ' 55' ' ' LEU . 22.5 mt -59.78 -48.08 83.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -56.83 -41.26 77.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.005 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.14 75.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.194 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mtp85 -84.96 15.28 4.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.739 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.42 38.89 97.08 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.161 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -100.67 134.64 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.654 0.264 . . . . 0.0 111.046 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.41 ' C ' HG23 ' A' ' 88' ' ' VAL . 4.4 mm-40 -63.79 129.03 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.819 HG11 HG13 ' A' ' 78' ' ' VAL . 57.3 t -157.52 144.83 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.129 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' VAL . 16.1 pt-20 -168.08 131.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.344 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.898 HD12 ' O ' ' A' ' 90' ' ' LEU . 3.0 pp . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.339 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.72 ' NE ' HG12 ' A' ' 17' ' ' VAL . 9.6 tpt180 . . . . . 0 C--O 1.23 0.028 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.818 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.2 p -134.26 139.45 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.834 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.798 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -87.99 140.47 16.4 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.201 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -125.82 136.79 53.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.625 HD11 HD22 ' A' ' 43' ' ' LEU . 92.8 mt -125.43 142.49 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 10.9 p-10 -145.05 140.15 27.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.643 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 13' ' ' ILE . 35.1 m -112.42 134.17 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.27 132.97 2.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.873 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 57.16 49.46 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.235 0.54 . . . . 0.0 111.329 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 52.29 33.68 13.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.449 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.877 ' CZ ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -147.66 139.75 24.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.627 HG12 HG12 ' A' ' 8' ' ' VAL . 60.9 mt -106.56 128.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.623 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.76 131.89 10.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.824 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.623 HD21 HD22 ' A' ' 31' ' ' LEU . 92.7 mt -102.46 130.54 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -149.95 147.83 28.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.792 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.72 HG12 ' NE ' ' A' ' 2' ' ' ARG . 46.8 t -150.04 122.84 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.982 0.42 . . . . 0.0 111.063 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.818 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.351 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.238 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.838 0.351 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.77 -143.96 4.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 179.79 150.47 0.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 111.379 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.629 ' N ' HD23 ' A' ' 31' ' ' LEU . 1.6 pt? -142.67 135.6 28.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.691 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.877 HG22 ' CZ ' ' A' ' 12' ' ' ARG . 46.5 t -70.23 148.2 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 74.4 mtm180 -51.64 139.7 20.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.02 0.438 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HD3' ' HG3' ' A' ' 38' ' ' GLU . 66.5 mttm -128.05 -120.3 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.183 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.582 ' O ' ' N ' ' A' ' 38' ' ' GLU . 37.7 p -156.05 128.32 7.62 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.023 0.439 . . . . 0.0 112.113 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.835 HD12 ' H ' ' A' ' 36' ' ' LEU . 4.2 mp 0.08 -68.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' A' ' 38' ' ' GLU . 13.5 pm0 -67.13 -45.71 76.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.0 tp10 -59.86 -50.22 74.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.022 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 73' ' ' LYS . 55.3 m-20 -50.31 -38.82 43.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.6 t -59.11 -46.7 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 109.768 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -56.33 -48.34 76.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.005 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.998 0.428 . . . . 0.0 110.846 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.995 HD13 ' CD2' ' A' ' 77' ' ' LEU . 71.2 mt -63.13 -47.3 83.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.05 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.577 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 23.2 mt -59.76 -46.68 88.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 7.4 t70 -46.14 -42.04 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.647 ' CE2' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -81.17 -58.01 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.62 HG11 HD21 ' A' ' 55' ' ' LEU . 60.8 t -58.12 -48.87 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.07 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 31.5 tpt85 -65.25 -57.09 9.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 23.1 mmt85 -68.07 -43.43 78.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.4 tp10 -72.34 -3.23 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.661 0.267 . . . . 0.0 111.339 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.76 92.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.674 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.647 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.9 mt -71.5 -52.54 17.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.903 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.516 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 51.18 31.72 27.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.229 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.817 ' C ' HD22 ' A' ' 55' ' ' LEU . 61.5 mttp -162.63 131.02 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.599 0.238 . . . . 0.0 110.614 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.837 HD23 HD13 ' A' ' 81' ' ' LEU . 2.7 mm? -141.67 136.97 31.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.204 0.526 . . . . 0.0 111.445 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 4' ' ' GLY . 10.6 p -132.4 140.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.577 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.2 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-O 121.064 0.459 . . . . 0.0 111.56 -179.418 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 10.3 mtmp? . . . . . 0 CA--C 1.528 0.107 0 CA-C-O 120.739 0.304 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.27 -43.14 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.109 0.481 . . . . 0.0 110.968 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.678 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 51.5 tp -55.42 -48.8 95.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.2 Cg_endo -46.68 -39.45 23.41 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.471 2.114 . . . . 0.0 112.127 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.995 ' CD2' HD13 ' A' ' 43' ' ' LEU . 35.1 tp -66.19 -38.31 87.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.412 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -53.04 -36.94 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.683 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.8 -43.1 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.592 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -63.46 -48.09 79.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.837 HD13 HD23 ' A' ' 55' ' ' LEU . 26.4 mt -58.7 -47.57 84.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.989 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.72 -42.36 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.44 -46.61 76.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.933 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.619 HH12 ' HB1' ' A' ' 80' ' ' ALA . 68.6 mtm-85 -87.53 18.87 3.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.28 37.65 92.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.866 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.516 HG13 ' C ' ' A' ' 53' ' ' GLY . 57.7 t -89.17 131.12 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -62.73 132.15 51.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 81' ' ' LEU . 57.8 t -153.05 144.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.633 ' HG3' HG23 ' A' ' 56' ' ' VAL . 16.7 pt-20 -148.36 150.84 34.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.327 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.798 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.6 pt? . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.53 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 . . . . . 0 CA--C 1.526 0.052 0 CA-C-O 120.583 0.23 . . . . 0.0 110.629 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.934 HG12 ' O ' ' A' ' 18' ' ' GLY . 14.7 p -132.72 137.36 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.971 0.415 . . . . 0.0 111.188 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.77 126.06 7.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.107 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.28 130.57 49.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.613 HD11 HD22 ' A' ' 43' ' ' LEU . 92.8 mt -123.28 139.71 53.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.008 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.69 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.5 p-10 -147.64 139.17 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 p -113.99 133.51 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.1 126.31 1.27 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.899 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 8.4 mp0 55.85 45.53 23.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 10' ' ' GLU . . . 75.54 -52.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.669 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.66 140.17 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 7' ' ' ASP . 60.2 mt -111.23 130.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.835 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.45 140.06 22.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.253 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.828 HD11 HD22 ' A' ' 31' ' ' LEU . 74.5 mt -123.99 133.3 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.666 0.27 . . . . 0.0 110.522 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HA ' ' CG ' ' A' ' 28' ' ' ARG . . . -159.05 -162.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.333 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 16' ' ' ALA . 90.3 t -158.87 142.4 6.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.934 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.452 -0.242 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.982 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 28' ' ' ARG . 4.7 mmp_? . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.485 0.183 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.19 -139.87 5.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.172 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -179.98 151.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.659 0.266 . . . . 0.0 110.796 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 15' ' ' LEU . 1.5 pt? -133.91 136.17 44.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 33' ' ' ARG . 48.9 t -76.08 156.04 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.724 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 64.0 mtp180 -51.84 150.21 4.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.807 0.337 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 56.7 mttp -147.97 -155.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.26 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -97.13 -158.39 0.66 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.468 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.894 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.6 mm? -75.32 -55.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.607 0.241 . . . . 0.0 111.376 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.456 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.9 OUTLIER -70.36 -38.25 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.991 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 34' ' ' LYS . 7.3 mt-10 -57.74 -55.91 28.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 0.0 110.772 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -53.97 -42.31 68.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.794 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 36' ' ' LEU . 6.1 t -58.98 -55.99 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.415 0.626 . . . . 0.0 110.384 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.66 -46.89 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.422 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.28 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 47' ' ' VAL . 72.7 mt -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.379 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.608 ' CD1' HG12 ' A' ' 40' ' ' VAL . 76.3 mt -59.52 -48.4 81.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -50.23 -37.78 37.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.708 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.708 ' CE2' HD11 ' A' ' 52' ' ' LEU . 17.9 t80 -77.04 -44.1 32.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 43' ' ' LEU . 59.6 t -56.62 -53.77 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -70.78 -60.79 2.04 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -49.6 -50.46 42.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.72 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.6 tp10 -74.25 -10.97 60.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.618 0.247 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.44 39.62 97.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.561 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.708 HD11 ' CE2' ' A' ' 46' ' ' PHE . 89.4 mt -75.09 -49.37 19.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 54.86 26.5 40.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.381 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.844 ' O ' HD13 ' A' ' 55' ' ' LEU . 66.1 mttm -164.26 131.65 3.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.968 HD23 HD13 ' A' ' 81' ' ' LEU . 2.3 mm? -140.28 131.06 25.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 111.764 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 56' ' ' VAL . 10.8 p -118.64 124.24 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 90' ' ' LEU . 45.8 t . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.516 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.637 0.256 . . . . 0.0 110.901 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.2 t -100.4 -44.35 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.166 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.9 tm? -54.21 -49.67 88.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.622 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.8 Cg_endo -46.95 -40.27 25.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.565 2.177 . . . . 0.0 112.599 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.68 HD23 HG13 ' A' ' 40' ' ' VAL . 2.8 tm? -71.84 -37.86 70.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.617 HG13 HG11 ' A' ' 88' ' ' VAL . 57.4 t -55.7 -35.62 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.676 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.85 -40.02 91.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.892 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.74 91.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.968 HD13 HD23 ' A' ' 55' ' ' LEU . 27.1 mt -61.52 -47.43 85.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 3.6 mmm180 -59.12 -42.27 90.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.19 80.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.377 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -86.89 19.25 3.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.799 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.74 37.88 94.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.985 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 52.9 t -97.28 134.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 41.2 tp10 -65.4 128.09 34.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.947 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 78' ' ' VAL . 46.7 t -158.06 145.06 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.55 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -169.71 141.34 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.122 0.487 . . . . 0.0 111.824 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.692 HD13 ' HB ' ' A' ' 57' ' ' VAL . 2.6 mm? . . . . . 0 C--N 1.331 -0.228 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.411 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.723 0.297 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.912 HG23 ' HG3' ' A' ' 54' ' ' LYS . 14.7 p -124.78 132.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.863 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.87 124.08 6.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.879 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.313 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.676 HD11 HD22 ' A' ' 43' ' ' LEU . 99.0 mt -129.27 138.63 51.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 9.5 p-10 -146.33 138.92 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.524 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.6 t -105.5 135.11 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.74 130.41 1.65 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.743 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 17.5 tp10 55.81 52.06 11.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.18 0.514 . . . . 0.0 111.136 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . 50.5 35.11 10.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HD3' ' CG ' ' A' ' 30' ' ' TYR . 38.6 ttm180 -149.24 140.1 22.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.855 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -103.8 128.66 56.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -83.93 130.32 9.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.544 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.637 HD11 ' CD2' ' A' ' 31' ' ' LEU . 89.3 mt -105.11 131.58 52.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.51 147.01 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.901 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.3 t -143.5 119.34 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.197 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.908 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.36 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.3 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.855 0.359 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.22 -140.77 3.36 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.317 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.442 ' CG ' ' HD3' ' A' ' 12' ' ' ARG . 6.9 p90 179.95 140.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.383 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 15' ' ' LEU . 75.7 mt -106.14 123.02 47.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.546 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.8 t -72.68 148.99 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 81.6 mtm180 -47.08 148.32 1.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.334 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HD3' ' CG ' ' A' ' 38' ' ' GLU . 62.3 mttm -144.79 -121.94 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 38' ' ' GLU . 23.4 p -154.78 128.0 8.36 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.817 ' O ' HG23 ' A' ' 40' ' ' VAL . 83.5 mt 5.83 -69.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.4 pt-20 -67.8 -46.88 70.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 111.763 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.1 tp10 -58.55 -50.65 73.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.079 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.4 m-20 -48.67 -46.03 39.7 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.94 0.4 . . . . 0.0 110.315 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 36' ' ' LEU . 3.8 t -61.93 -50.22 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -52.91 -46.85 68.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.093 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.46 93.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.832 ' O ' HG23 ' A' ' 47' ' ' VAL . 94.7 mt -67.31 -42.0 84.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.639 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 70.0 mt -59.58 -56.21 24.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.694 0.283 . . . . 0.0 111.066 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -48.55 -38.02 19.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.812 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.686 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.2 t80 -73.49 -42.59 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 43' ' ' LEU . 59.5 t -63.31 -50.12 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -72.89 -62.84 1.32 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.8 mmm-85 -48.0 -51.8 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.074 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.1 tp10 -76.08 -4.88 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.343 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.08 40.68 91.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 46' ' ' PHE . 86.4 mt -68.22 -54.35 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.99 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.95 40.66 66.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.125 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.912 ' HG3' HG23 ' A' ' 3' ' ' VAL . 3.4 tppp? -178.36 128.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.02 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -141.32 133.2 27.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 111.776 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 89' ' ' GLU . 14.8 p -121.57 117.83 53.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.9 t . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.533 -179.428 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.747 ' HG2' HD23 ' A' ' 36' ' ' LEU . 36.6 mtmm . . . . . 0 CA--C 1.528 0.131 0 CA-C-O 120.77 0.319 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.01 -45.09 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.158 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.523 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 56.3 tp -56.71 -49.82 91.5 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 83.9 Cg_exo -44.06 -38.37 10.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.116 . . . . 0.0 112.38 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.689 HD23 HG13 ' A' ' 40' ' ' VAL . 2.3 tm? -70.5 -36.31 73.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.693 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.96 HG13 HG11 ' A' ' 88' ' ' VAL . 61.3 t -54.45 -36.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.959 0.409 . . . . 0.0 110.581 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.93 -39.9 83.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.846 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.91 85.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.02 HD13 HD23 ' A' ' 55' ' ' LEU . 23.6 mt -59.08 -45.29 91.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.026 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -58.3 -44.04 88.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.08 85.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.103 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -83.11 15.55 2.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 38.84 96.65 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.254 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.6 t -108.5 135.24 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.35 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -69.75 139.35 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.96 HG11 HG13 ' A' ' 78' ' ' VAL . 44.5 t -155.84 139.72 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -161.53 130.79 4.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.032 0.444 . . . . 0.0 111.61 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 90' ' ' LEU . 2.3 pp . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.758 0.313 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 54' ' ' LYS . 14.4 p -136.58 136.13 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -79.32 134.69 14.12 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.134 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -121.96 133.92 54.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 111.423 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.614 HD11 HD22 ' A' ' 43' ' ' LEU . 98.9 mt -126.43 139.45 53.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -143.77 139.35 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.31 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -106.71 128.45 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.867 0.365 . . . . 0.0 111.559 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.84 -135.46 6.63 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.79 -44.4 90.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.364 . . . . 0.0 110.746 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -168.15 32.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.708 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.495 ' CD ' HG22 ' A' ' 32' ' ' VAL . 23.6 mmt85 -147.92 144.21 27.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.482 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 55.3 mt -99.61 125.25 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.41 129.34 9.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.631 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.668 HD11 ' HG ' ' A' ' 31' ' ' LEU . 85.5 mt -104.81 127.13 52.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 110.937 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -147.29 148.94 31.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.432 HG22 ' HA2' ' A' ' 4' ' ' GLY . 55.6 t -151.1 133.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.005 0.431 . . . . 0.0 111.676 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.374 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.611 0.243 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.66 -151.41 10.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.856 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.426 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.4 p90 179.82 141.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.946 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HG ' HD11 ' A' ' 15' ' ' LEU . 67.0 mt -114.71 124.19 51.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.495 HG22 ' CD ' ' A' ' 12' ' ' ARG . 47.6 t -66.22 146.0 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.562 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 98.6 mtt180 -51.58 147.54 6.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.862 0.363 . . . . 0.0 111.465 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 35' ' ' THR . 52.1 mttp -147.17 -125.75 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.052 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 34' ' ' LYS . 16.1 p -157.69 134.79 10.14 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.842 HD12 ' H ' ' A' ' 36' ' ' LEU . 5.2 mp 5.27 -72.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -69.75 -48.15 60.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.0 tp10 -57.49 -50.27 73.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.942 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.413 ' OD2' ' CG ' ' A' ' 73' ' ' LYS . 45.5 m-20 -51.31 -42.38 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.6 t -60.84 -47.38 93.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.511 0.672 . . . . 0.0 109.779 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.74 -49.58 37.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.436 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.2 -44.3 59.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.257 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.994 ' CD1' HD22 ' A' ' 77' ' ' LEU . 27.7 mt -61.57 -48.12 82.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.934 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' HG12 ' A' ' 40' ' ' VAL . 57.9 mt -57.51 -50.76 72.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -45.28 -40.43 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.968 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CE2' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -77.45 -45.43 25.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.456 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' LEU . 65.8 t -57.1 -50.85 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 5.4 ptm180 -71.32 -62.77 1.28 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -51.42 -48.84 62.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.995 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -69.87 -13.41 62.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.547 0.213 . . . . 0.0 111.219 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.88 39.12 95.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.423 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.572 HD11 ' CE2' ' A' ' 46' ' ' PHE . 86.1 mt -74.1 -49.27 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.507 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 54.53 28.21 44.14 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.233 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.796 ' O ' HD13 ' A' ' 55' ' ' LEU . 67.5 mttm -164.14 129.96 2.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.268 0.227 . . . . 0.0 110.399 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 54' ' ' LYS . 2.6 mm? -140.25 121.02 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.6 p -99.3 113.93 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.88 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.475 HG13 ' CG1' ' A' ' 74' ' ' VAL . 48.1 t . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.735 -179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' ' 73' ' ' LYS . 2.7 mppt? . . . . . 0 CA--C 1.53 0.185 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.475 ' CG1' HG13 ' A' ' 57' ' ' VAL . 40.3 t -61.5 -53.28 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.61 HD13 ' O ' ' A' ' 75' ' ' LEU . 2.2 tm? -55.38 -50.4 86.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.503 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.2 Cg_exo -42.5 -39.9 7.04 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.494 2.13 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.994 HD22 ' CD1' ' A' ' 43' ' ' LEU . 42.6 tp -66.52 -41.31 88.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.717 HG13 HG11 ' A' ' 88' ' ' VAL . 22.0 t -53.99 -34.88 26.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.86 -43.17 93.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.21 91.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.635 HD13 HD23 ' A' ' 55' ' ' LEU . 31.7 mt -59.4 -41.18 88.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.366 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.692 ' NH1' HG12 ' A' ' 78' ' ' VAL . 62.1 mtt85 -57.11 -42.73 81.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.281 . . . . 0.0 111.219 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.76 -51.27 69.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.383 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -70.63 -27.3 63.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.99 43.41 4.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.346 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.507 HG13 ' C ' ' A' ' 53' ' ' GLY . 59.1 t -98.85 139.95 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.613 0.244 . . . . 0.0 110.754 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -60.43 130.15 45.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.717 HG11 HG13 ' A' ' 78' ' ' VAL . 60.9 t -151.86 145.2 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 56' ' ' VAL . 24.4 pt-20 -171.86 123.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.481 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.458 ' H ' ' CD2' ' A' ' 90' ' ' LEU . 1.8 pt? . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.902 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.402 ' HB3' ' CG1' ' A' ' 17' ' ' VAL . 99.2 mtt180 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.682 0.277 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 18' ' ' GLY . 13.0 p -126.32 132.42 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.08 126.93 7.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.012 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.723 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -109.37 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.696 -0.297 . . . . 0.0 111.098 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.657 HD11 HD22 ' A' ' 43' ' ' LEU . 95.0 mt -120.47 136.53 54.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.454 . . . . 0.0 111.249 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -146.97 139.43 24.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.165 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.492 HG12 HG12 ' A' ' 13' ' ' ILE . 35.0 m -108.73 134.23 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.61 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.01 131.52 1.78 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.958 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 40.4 tt0 56.8 53.47 8.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 48.85 35.92 7.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.467 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -151.69 140.97 21.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.68 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 61.8 mt -105.27 127.4 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 134.38 13.42 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.768 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.688 HD11 HD22 ' A' ' 31' ' ' LEU . 88.0 mt -113.59 133.72 55.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 0.0 110.912 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.723 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.38 148.95 29.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 28' ' ' ARG . 48.0 t -140.43 121.96 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.289 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.826 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.341 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' A' ' 17' ' ' VAL . 27.1 mmm180 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.98 -137.58 2.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.67 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -179.93 150.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.927 0.394 . . . . 0.0 110.86 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.688 HD22 HD11 ' A' ' 15' ' ' LEU . 1.3 pt? -134.67 135.33 41.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.21 145.07 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 66.1 mtm180 -54.26 151.59 7.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.168 0.509 . . . . 0.0 111.326 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.433 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 64.1 mttm -146.61 -122.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.699 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 38' ' ' GLU . 38.4 p -148.58 139.72 23.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.728 0.299 . . . . 0.0 110.903 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.021 HD22 ' N ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -21.96 -43.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 1.021 ' N ' HD22 ' A' ' 36' ' ' LEU . 11.9 pt-20 -73.46 -48.88 30.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HG2' ' OG1' ' A' ' 35' ' ' THR . 13.6 mm-40 -61.79 -48.31 81.21 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 23.0 m-20 -45.93 -40.96 10.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.74 -52.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.185 0.517 . . . . 0.0 110.363 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.09 -51.92 66.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.94 93.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.006 HD13 ' CD2' ' A' ' 77' ' ' LEU . 74.0 mt -65.22 -50.31 66.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.457 ' HB3' ' NH1' ' A' ' 48' ' ' ARG . 61.5 mt -59.1 -48.08 82.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -49.35 -38.91 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 52' ' ' LEU . 17.9 t80 -77.04 -43.69 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.236 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 43' ' ' LEU . 99.9 t -58.06 -51.81 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 44' ' ' LEU . 1.5 ptt-85 -67.81 -63.18 1.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.6 mtp85 -51.35 -49.75 60.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.881 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -72.05 -10.23 59.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.263 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.8 97.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.465 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 46' ' ' PHE . 88.9 mt -72.36 -52.81 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 53.84 36.18 54.77 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.257 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.915 ' O ' HD13 ' A' ' 55' ' ' LEU . 37.3 ttpt 178.21 131.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.111 HD23 HD13 ' A' ' 81' ' ' LEU . 1.6 mm? -137.8 137.45 38.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.748 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 3' ' ' VAL . 15.0 p -128.19 132.79 68.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.11 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 90' ' ' LEU . 14.8 t . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.752 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 37.3 mtmm . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.805 0.336 . . . . 0.0 111.383 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.22 -41.15 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 61.2 tp -54.5 -52.0 73.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.3 Cg_exo -43.94 -40.16 11.52 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.348 2.032 . . . . 0.0 112.219 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.006 ' CD2' HD13 ' A' ' 43' ' ' LEU . 32.0 tp -63.19 -42.79 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.6 t -52.01 -35.49 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.77 -42.81 94.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.06 66.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.111 HD13 HD23 ' A' ' 55' ' ' LEU . 24.5 mt -57.94 -50.91 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -58.44 -38.4 77.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.42 -43.74 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.427 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.425 HH22 HD23 ' A' ' 81' ' ' LEU . 68.0 mtm-85 -89.69 20.04 4.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.505 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 39.82 98.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.501 HG13 ' C ' ' A' ' 53' ' ' GLY . 50.1 t -95.52 132.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.85 130.22 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.679 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 81' ' ' LEU . 65.9 t -155.91 144.48 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.96 0.41 . . . . 0.0 111.301 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.5 pt-20 -172.02 129.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.29 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 90' ' ' LEU . 2.5 pp . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.693 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.677 0.275 . . . . 0.0 110.672 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.889 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.7 p -121.49 131.56 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.48 117.56 4.76 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.951 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -97.22 133.3 42.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.226 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.785 HD11 HD22 ' A' ' 43' ' ' LEU . 83.8 mt -123.73 138.37 54.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -145.34 144.39 30.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.106 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.06 141.18 45.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 111.531 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.78 133.5 2.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.756 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 66.04 -67.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.344 0.257 . . . . 0.0 111.522 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . -176.19 36.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.844 0.354 . . . . 0.0 111.354 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -156.46 143.9 19.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.3 mt -104.09 130.44 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.708 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.13 138.12 17.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.009 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 31' ' ' LEU . 52.4 mt -115.39 132.8 56.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -154.68 145.46 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.058 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 28' ' ' ARG . 57.5 t -136.96 125.6 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.115 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.889 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.143 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.635 ' HG3' HG23 ' A' ' 17' ' ' VAL . 4.5 mmp_? . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.73 -139.4 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.378 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 5.7 p90 -179.81 143.06 0.17 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 111.311 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 15' ' ' LEU . 1.3 mp -111.81 127.97 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.029 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 55.2 t -70.61 143.35 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.468 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 mtt180 -50.58 140.23 14.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.824 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 50.3 mttp -138.53 -140.75 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.641 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.736 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.2 m -106.16 -158.98 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.5 pt? -77.17 -49.65 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.148 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.49 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 15.4 pt-20 -70.59 -40.13 73.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.602 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 1.7 mm-40 -55.42 -57.03 13.56 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.333 0.587 . . . . 0.0 110.351 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.6 -44.75 62.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.759 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 36' ' ' LEU . 3.6 t -60.51 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.428 0.633 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -53.51 -45.52 69.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.128 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' HD23 ' A' ' 31' ' ' LEU . . . -60.68 -47.02 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.774 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.785 HD22 HD11 ' A' ' 6' ' ' LEU . 92.1 mt -65.86 -45.14 83.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.683 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 22.3 mt -59.29 -57.47 12.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.526 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.823 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 65.8 t0 -43.95 -42.1 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 15.9 t80 -71.05 -42.39 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.152 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 43' ' ' LEU . 83.5 t -67.32 -44.57 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.8 ptm180 -64.43 -67.53 0.43 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 45' ' ' ASP . 39.7 ptt85 -56.19 -47.75 77.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.0 tp10 -65.35 -16.06 63.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 111.258 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 36.86 90.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.454 HD21 ' HG2' ' A' ' 50' ' ' GLU . 89.8 mt -68.15 -50.64 53.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.74 40.06 69.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.439 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.833 ' O ' HD13 ' A' ' 55' ' ' LEU . 59.7 tttp -177.87 125.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.476 0.179 . . . . 0.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.037 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -140.39 131.68 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.446 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 56' ' ' VAL . 10.2 p -111.18 120.05 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.59 HG21 ' CG2' ' A' ' 78' ' ' VAL . 33.2 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.479 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 53.8 mtmt . . . . . 0 CA--C 1.529 0.135 0 CA-C-O 120.624 0.249 . . . . 0.0 111.576 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.31 -45.25 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 75' ' ' LEU . 2.0 tm? -52.34 -50.12 81.39 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 96.0 Cg_exo -40.85 -33.32 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.834 2.356 . . . . 0.0 112.895 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.664 HD13 ' C ' ' A' ' 77' ' ' LEU . 2.7 tm? -80.8 -39.42 26.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG2' HG21 ' A' ' 57' ' ' VAL . 47.3 t -53.64 -36.8 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 21.3 pt-20 -73.56 -33.91 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.734 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -59.12 -45.11 91.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.157 0.503 . . . . 0.0 110.692 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.037 HD13 HD23 ' A' ' 55' ' ' LEU . 22.9 mt -60.7 -47.84 84.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.81 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -57.83 -39.59 78.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.94 72.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.376 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -88.19 21.21 2.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.724 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.99 92.73 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.966 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.53 135.78 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.703 0.287 . . . . 0.0 111.063 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 65.5 mm-40 -64.57 125.84 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.792 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.563 HG11 HG13 ' A' ' 78' ' ' VAL . 57.7 t -158.78 145.97 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -166.92 131.92 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.095 0.474 . . . . 0.0 111.624 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.568 HD23 ' C ' ' A' ' 90' ' ' LEU . 6.1 tt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.278 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.689 0.281 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 18' ' ' GLY . 11.9 p -119.42 136.23 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.281 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.465 ' HA3' HD13 ' A' ' 55' ' ' LEU . . . -81.47 131.18 10.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.094 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -113.87 130.76 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.663 HD11 HD22 ' A' ' 43' ' ' LEU . 96.5 mt -123.37 135.95 54.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.041 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 2.9 p30 -140.3 134.86 31.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.625 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -98.95 129.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.637 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.98 -135.48 5.69 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.285 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -62.92 -42.85 99.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . -171.57 39.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -155.33 146.61 22.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -98.95 127.03 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.484 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.47 126.63 7.7 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.447 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.658 HD11 ' CD2' ' A' ' 31' ' ' LEU . 86.0 mt -99.42 130.41 45.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.918 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.52 145.84 26.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.52 124.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.72 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.449 -0.478 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.505 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.93 0.395 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.81 -135.59 1.88 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.252 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 7.2 p90 -178.9 138.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.658 ' CD2' HD11 ' A' ' 15' ' ' LEU . 80.0 mt -106.43 125.63 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.669 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.23 133.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 52.4 mtp85 -56.94 124.98 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.461 . . . . 0.0 111.048 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.842 ' O ' HG23 ' A' ' 35' ' ' THR . 96.6 mttt -109.09 -96.96 0.39 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -176.03 127.3 0.22 Allowed 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 40' ' ' VAL . 62.4 tp 16.59 -76.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -67.55 -44.93 77.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 34' ' ' LYS . 4.6 mm-40 -57.69 -51.72 68.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.269 0.557 . . . . 0.0 110.324 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.9 m-20 -49.06 -42.8 39.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.243 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.696 HG13 HD23 ' A' ' 77' ' ' LEU . 3.2 t -58.86 -54.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 110.514 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.417 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -52.76 -49.53 65.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.346 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.22 89.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.948 0.404 . . . . 0.0 111.201 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 47' ' ' VAL . 84.2 mt -65.25 -46.09 81.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.391 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.512 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 72.7 mt -60.58 -52.8 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -48.55 -38.41 20.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -73.09 -42.09 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 43' ' ' LEU . 69.8 t -65.04 -51.94 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -70.79 -62.72 1.29 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -47.61 -51.0 22.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.959 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 5.4 tp10 -77.0 -4.04 42.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 111.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.49 38.55 91.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.657 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 46' ' ' PHE . 88.0 mt -72.59 -55.55 6.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . 53.0 33.22 43.76 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.841 ' C ' HD22 ' A' ' 55' ' ' LEU . 34.2 mmtp -161.91 128.1 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.225 0.21 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.952 HD23 HD13 ' A' ' 81' ' ' LEU . 2.8 mm? -143.16 133.05 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.367 0.603 . . . . 0.0 111.65 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 56' ' ' VAL . 11.1 p -131.02 122.44 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.2 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 25.0 t . . . . . 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.589 -179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 pttt . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.824 0.345 . . . . 0.0 111.287 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.4 -43.17 10.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.074 0.464 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 59.7 tp -53.5 -48.86 91.42 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 1.4 Cg_endo -43.19 -39.78 8.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.767 2.311 . . . . 0.0 112.718 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.696 HD23 HG13 ' A' ' 40' ' ' VAL . 2.5 tm? -76.07 -36.87 58.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.814 HG13 HG11 ' A' ' 88' ' ' VAL . 58.5 t -55.44 -36.18 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.678 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -66.23 -39.55 89.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.51 -44.9 93.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.952 HD13 HD23 ' A' ' 55' ' ' LEU . 24.1 mt -60.15 -48.39 81.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.056 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -58.81 -43.57 90.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.667 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.7 82.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -84.08 17.84 2.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.659 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 37.16 94.15 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.318 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.2 t -106.93 133.38 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 0.0 110.942 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 51.0 mm-40 -67.89 132.2 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.814 HG11 HG13 ' A' ' 78' ' ' VAL . 43.0 t -157.44 143.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.619 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.95 139.43 6.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.086 0.47 . . . . 0.0 112.054 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 90' ' ' LEU . 1.8 mm? . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.994 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 . . . . . 0 C--O 1.23 0.036 0 CA-C-O 120.827 0.346 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 18' ' ' GLY . 13.3 p -136.67 141.66 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . 0.468 ' HA3' HD13 ' A' ' 55' ' ' LEU . . . -73.97 131.84 14.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.448 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -121.75 137.32 54.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.85 ' O ' HG13 ' A' ' 57' ' ' VAL . 94.5 mt -132.17 141.07 48.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.126 0.488 . . . . 0.0 111.609 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 11.6 p-10 -146.2 137.94 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.677 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 8' ' ' VAL . 14.7 p -103.52 124.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.723 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.56 -136.76 9.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.675 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.1 -42.72 72.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.7 0.286 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.408 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -158.89 40.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.24 0.543 . . . . 0.0 110.899 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -167.59 173.4 8.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 52.1 mt -126.41 134.15 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.74 133.55 11.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.008 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.641 HD21 ' CD1' ' A' ' 31' ' ' LEU . 86.0 mt -98.61 131.65 44.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.608 0.242 . . . . 0.0 110.546 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -145.64 143.8 30.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.775 0.321 . . . . 0.0 111.051 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.8 t -135.79 123.83 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.168 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.9 ' O ' HG12 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.444 ' N ' ' O ' ' A' ' 15' ' ' LEU . 29.5 tpt180 . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 121.067 0.46 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' C ' ' CD1' ' A' ' 30' ' ' TYR . . . -163.0 -154.19 7.53 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.041 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 29' ' ' GLY . 75.0 m-85 -161.05 135.62 7.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.899 0.35 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.641 ' CD1' HD21 ' A' ' 15' ' ' LEU . 80.7 mt -121.92 122.28 39.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.117 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.5 t -67.1 145.95 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.513 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 99.2 mtt180 -52.64 147.26 8.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.018 0.437 . . . . 0.0 111.28 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HD3' ' HG2' ' A' ' 38' ' ' GLU . 66.7 mttm -147.92 -125.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.118 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 38' ' ' GLU . 42.6 p -145.9 136.31 24.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.026 0.441 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.713 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -18.28 -53.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 38' ' ' GLU . 16.5 pt-20 -72.01 -48.83 41.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.356 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HG2' ' HD3' ' A' ' 34' ' ' LYS . 81.4 tt0 -60.73 -48.97 79.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -49.69 -39.99 38.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.075 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -56.25 -48.52 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.359 0.6 . . . . 0.0 109.867 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.436 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -52.41 -47.73 66.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.277 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.1 73.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.017 HD13 ' CD2' ' A' ' 77' ' ' LEU . 61.0 mt -65.05 -47.35 77.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.773 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 61.7 mt -60.33 -49.8 76.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.602 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.2 -39.49 14.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.771 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.727 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.8 t80 -78.61 -43.86 25.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.244 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 43' ' ' LEU . 62.1 t -55.58 -53.39 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 4.8 ptm180 -69.69 -61.85 1.62 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -51.52 -49.04 62.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.874 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.9 tp10 -73.22 -12.62 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.43 40.66 99.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.436 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.727 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.0 mt -74.51 -52.37 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.965 0.412 . . . . 0.0 111.098 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 53.69 29.3 40.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.212 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.82 ' O ' HD13 ' A' ' 55' ' ' LEU . 97.3 mttt -163.62 135.08 4.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.516 0.198 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.936 HD23 HD13 ' A' ' 81' ' ' LEU . 2.7 mm? -139.82 139.64 36.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 89' ' ' GLU . 12.4 p -149.66 143.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.962 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.6 t . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 111.969 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 76' ' ' PRO . 36.5 mtmm . . . . . 0 CA--C 1.536 0.439 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.28 -41.31 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.533 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.65 ' C ' HD13 ' A' ' 75' ' ' LEU . 3.0 tm? -54.06 -53.93 53.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.9 Cg_endo -48.79 -35.67 31.34 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.296 1.998 . . . . 0.0 112.069 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.017 ' CD2' HD13 ' A' ' 43' ' ' LEU . 29.0 tp -61.62 -44.07 97.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 110.713 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 41.1 t -55.01 -34.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.432 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -56.58 -43.97 80.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.467 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -62.3 -47.38 84.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.936 HD13 HD23 ' A' ' 55' ' ' LEU . 33.5 mt -62.8 -42.83 99.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.383 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 78' ' ' VAL . 25.2 mmm180 -56.22 -43.92 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.693 0.282 . . . . 0.0 111.192 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.77 86.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.915 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . 0.467 HH12 ' HB1' ' A' ' 80' ' ' ALA . 65.9 mtt85 -70.77 -30.5 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.929 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.15 42.92 4.2 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.16 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.42 142.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.687 0.28 . . . . 0.0 110.718 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.74 128.7 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.761 0.315 . . . . 0.0 110.63 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 81' ' ' LEU . 62.8 t -152.91 140.08 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.6 pm0 -165.42 132.03 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 C--O 1.23 0.032 0 CA-C-O 120.909 0.385 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.48 ' HD3' ' H ' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -101.08 134.53 43.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.832 179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.1 p -140.0 137.88 38.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.833 0.349 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.14 130.89 10.1 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.442 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -117.57 133.26 56.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.844 0.354 . . . . 0.0 110.79 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.58 ' HB2' HG22 ' A' ' 57' ' ' VAL . 89.9 mt -120.38 138.92 53.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 111.194 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 13' ' ' ILE . 10.1 p-10 -149.9 149.8 30.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.306 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' O ' HG13 ' A' ' 8' ' ' VAL . 9.0 p -149.86 126.62 2.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -86.84 -55.81 2.34 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.991 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 11' ' ' ALA . 0.5 OUTLIER 178.16 34.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.727 0.299 . . . . 0.0 110.826 179.634 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 10' ' ' GLU . . . 168.53 -48.04 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.084 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.4 ttp180 -105.25 140.41 38.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.43 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.505 HG23 ' O ' ' A' ' 7' ' ' ASP . 53.5 mt -107.94 128.97 62.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.493 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.98 141.73 18.69 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.552 -0.833 . . . . 0.0 112.988 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.61 HD21 HD22 ' A' ' 31' ' ' LEU . 82.7 mt -118.05 129.71 55.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.887 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -138.75 147.41 42.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.995 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.616 HG21 ' CZ ' ' A' ' 46' ' ' PHE . 60.4 t -147.24 117.41 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.123 0.487 . . . . 0.0 111.472 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.37 -149.88 9.01 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.091 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' HG3' ' O ' ' A' ' 21' ' ' GLY . 11.7 pt-20 -77.54 148.28 35.33 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.585 0.231 . . . . 0.0 110.433 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -46.1 -55.38 7.06 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.241 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.455 ' O ' ' HG3' ' A' ' 19' ' ' GLU . . . -85.72 130.55 9.95 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.195 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 26' ' ' SER . 58.9 t -150.2 126.08 5.04 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.619 0.247 . . . . 0.0 111.044 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -79.83 -47.28 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.582 2.188 . . . . 0.0 112.961 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.614 ' C ' HD13 ' A' ' 24' ' ' LEU . 2.8 tm? -64.52 -70.98 0.19 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.898 -179.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 24' ' ' LEU . . . 170.66 -42.17 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.34 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 25' ' ' ALA . 88.6 p 60.19 137.66 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.819 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 16' ' ' ALA . . . -148.62 -152.66 5.76 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.632 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 21.5 tpp180 179.17 -43.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 0.0 110.903 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.96 -138.28 2.53 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.638 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 p90 179.96 150.05 0.36 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.732 0.301 . . . . 0.0 110.997 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.685 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.7 pt? -137.18 136.44 38.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.961 0.41 . . . . 0.0 111.154 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.448 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.0 t -74.28 147.45 8.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.413 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 83.2 mtm180 -54.73 140.96 34.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.837 0.351 . . . . 0.0 111.118 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 60.1 mttm -137.23 -149.79 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.109 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.875 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.9 m -87.94 -163.48 0.96 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 121.232 -0.187 . . . . 0.0 110.572 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.875 ' H ' HG22 ' A' ' 35' ' ' THR . 3.9 mp -78.64 -61.03 2.14 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.968 0.413 . . . . 0.0 110.523 179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -64.1 -37.17 86.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.82 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.437 ' HG3' ' CD ' ' A' ' 34' ' ' LYS . 5.3 tp10 -57.0 -54.12 50.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.292 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.423 ' OD2' ' O ' ' A' ' 35' ' ' THR . 46.3 m-20 -52.12 -41.46 62.51 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-O 120.713 0.292 . . . . 0.0 110.631 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.38 -46.12 92.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.408 0.623 . . . . 0.0 109.457 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -55.75 -47.63 76.66 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.894 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -65.96 -44.29 85.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.913 0.387 . . . . 0.0 110.533 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.017 HD13 ' CD2' ' A' ' 77' ' ' LEU . 36.8 mt -63.34 -50.03 71.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.341 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.592 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 22.1 mt -56.9 -49.88 74.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.695 0.283 . . . . 0.0 111.003 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 37.0 t70 -46.9 -42.07 16.96 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.69 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.616 ' CZ ' HG21 ' A' ' 17' ' ' VAL . 17.2 t80 -83.75 -57.73 3.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.525 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.55 HG11 HD21 ' A' ' 55' ' ' LEU . 59.5 t -56.05 -47.58 80.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.91 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.592 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 13.9 tpp85 -65.85 -53.95 33.22 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 58.5 mmt-85 -71.41 -43.45 66.76 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 46' ' ' PHE . 40.6 tp10 -63.81 -14.9 56.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.567 0.222 . . . . 0.0 111.37 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 63.02 40.54 99.42 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.636 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.408 HD21 ' HG2' ' A' ' 50' ' ' GLU . 85.5 mt -68.95 -47.18 66.3 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.017 0.437 . . . . 0.0 110.573 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 56.94 32.0 61.91 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.662 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.934 ' O ' HD13 ' A' ' 55' ' ' LEU . 37.8 ttpt 178.19 130.97 0.07 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.453 -0.202 . . . . 0.0 110.453 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.6 mm? -135.75 133.63 38.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.171 0.51 . . . . 0.0 111.94 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.0 p -119.69 135.96 58.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.144 179.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.58 HG22 ' HB2' ' A' ' 6' ' ' LEU . 43.0 t -148.84 130.48 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.999 0.428 . . . . 0.0 112.059 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.512 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -94.8 136.63 13.05 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.32 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.512 HD23 ' O ' ' A' ' 58' ' ' GLY . 96.5 mt -159.59 138.83 8.18 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 120.5 0.19 . . . . 0.0 110.624 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -58.66 -47.14 19.91 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.27 1.98 . . . . 0.0 112.138 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 60.3 tp 62.0 126.99 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.172 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 46.3 ttt85 -75.92 -34.0 59.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.683 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 60.5 m 69.19 126.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.061 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 t0 178.48 138.37 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.547 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.8 mt -56.35 -56.55 19.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.003 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.499 ' HD3' ' N ' ' A' ' 66' ' ' LYS . 2.5 mppt? -89.07 131.35 35.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.669 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 61.92 145.81 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.918 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 99.3 p -162.6 -150.73 0.18 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.509 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.874 ' HB2' ' CD2' ' A' ' 75' ' ' LEU . . . 58.36 40.13 24.66 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.919 0.39 . . . . 0.0 110.809 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -66.83 128.37 36.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.251 0.548 . . . . 0.0 111.37 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 60.76 135.38 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.875 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.28 131.67 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.923 -0.58 . . . . 0.0 113.139 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 34' ' ' LYS . 31.9 mtmm -86.82 49.38 1.8 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.791 0.329 . . . . 0.0 110.932 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.401 HG11 HG11 ' A' ' 57' ' ' VAL . 46.2 t -83.01 -36.91 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.677 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.874 ' CD2' ' HB2' ' A' ' 69' ' ' ALA . 60.2 tp -49.12 -46.84 76.29 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 97.0 Cg_exo -43.44 -33.0 3.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.649 2.233 . . . . 0.0 112.904 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.017 ' CD2' HD13 ' A' ' 43' ' ' LEU . 28.2 tp -82.25 -44.92 15.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.395 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 21.5 t -50.41 -36.05 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.311 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 20.4 pt-20 -68.26 -39.11 82.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.84 0.352 . . . . 0.0 110.514 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.89 -47.78 79.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.135 0.493 . . . . 0.0 110.529 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.853 HD13 HD23 ' A' ' 55' ' ' LEU . 30.3 mt -60.03 -51.0 71.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.058 -179.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -58.23 -44.04 88.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.932 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.15 -41.85 99.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.613 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.452 ' NH1' HD22 ' A' ' 44' ' ' LEU . 99.1 mtt180 -83.64 15.54 3.13 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.222 0.452 . . . . 0.0 112.222 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 62.68 37.16 94.33 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.36 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.9 t -99.2 132.28 44.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.685 0.279 . . . . 0.0 110.786 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.438 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 41.4 tp10 -62.61 133.02 54.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.86 0.362 . . . . 0.0 110.964 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.468 HG21 ' CB ' ' A' ' 81' ' ' LEU . 61.0 t -157.68 150.16 8.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.952 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -163.48 127.92 2.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 85.7 mt -75.24 125.25 28.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.708 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 19.2 t-105 -76.88 126.49 31.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.884 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -71.1 -149.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.413 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -64.54 135.14 55.71 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.936 0.398 . . . . 0.0 110.783 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -63.33 -55.35 25.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.983 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -85.28 138.04 32.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.863 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.0 t -176.04 129.3 0.23 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.844 0.354 . . . . 0.0 111.342 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.8 m -71.57 136.31 47.39 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.058 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 56.0 tptt . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.839 179.907 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.9 tpp . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.815 0.34 . . . . 0.0 110.945 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 23.7 ptt-85 -104.15 137.52 41.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.157 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.882 HG23 ' HG2' ' A' ' 54' ' ' LYS . 9.6 p -133.06 133.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.066 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.642 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -78.55 139.56 22.47 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.868 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.86 134.71 47.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.895 0.378 . . . . 0.0 111.639 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.68 HD11 HD22 ' A' ' 43' ' ' LEU . 84.3 mt -117.91 137.45 52.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.097 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 8.6 p-10 -140.82 136.2 32.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.905 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.2 t -104.73 137.64 33.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.36 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.27 -44.78 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.227 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -178.65 105.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.751 0.31 . . . . 0.0 110.784 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . 45.57 30.35 0.76 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.281 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 49.4 ttm-85 -165.86 143.3 5.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.051 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 54.1 mt -112.84 133.73 57.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.406 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.403 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -82.02 133.87 12.47 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.328 -0.939 . . . . 0.0 112.584 -179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.651 HD11 ' HG ' ' A' ' 31' ' ' LEU . 92.0 mt -105.11 130.26 53.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.936 0.398 . . . . 0.0 110.856 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -148.48 149.06 31.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.669 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 59.2 t -146.96 127.97 5.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.151 0.5 . . . . 0.0 111.501 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.793 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.72 -149.82 8.88 Favored Glycine 0 N--CA 1.449 -0.451 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.217 179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -84.87 142.17 29.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.799 0.333 . . . . 0.0 110.645 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -51.49 133.44 29.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.86 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.39 53.44 41.92 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.312 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 53.4 t -59.67 127.56 85.19 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.479 0.181 . . . . 0.0 111.015 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.505 ' O ' HD23 ' A' ' 24' ' ' LEU . 24.6 Cg_exo -63.05 -45.36 12.81 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 122.385 2.057 . . . . 0.0 112.31 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.545 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 96.7 mt -159.34 151.99 21.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.029 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 24' ' ' LEU . . . 76.52 135.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.668 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.7 p 179.76 131.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.311 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 177.62 145.38 5.83 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.672 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.412 ' HG3' HG23 ' A' ' 17' ' ' VAL . 26.8 mmm180 -155.33 -44.12 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.657 0.265 . . . . 0.0 110.862 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -177.18 -138.38 2.96 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.825 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.413 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 5.3 p90 -179.72 140.92 0.14 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.748 0.309 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.651 ' HG ' HD11 ' A' ' 15' ' ' LEU . 80.7 mt -120.22 126.09 49.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.946 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.441 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.9 t -71.99 144.12 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.414 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 74.6 mtp180 -55.14 149.27 12.57 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.959 0.409 . . . . 0.0 111.319 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HB2' ' HB2' ' A' ' 38' ' ' GLU . 61.6 mttm -150.49 -153.21 0.48 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.075 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.698 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.1 m -86.78 -158.6 0.44 Allowed 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.9 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.5 pt? -81.54 -48.56 11.64 Favored 'General case' 0 C--N 1.329 -0.291 0 O-C-N 122.123 -0.36 . . . . 0.0 111.0 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.487 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 16.5 pt-20 -66.96 -38.98 87.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.323 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 4.1 mm-40 -60.57 -55.42 33.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.117 0.484 . . . . 0.0 110.401 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.33 -48.0 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.499 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.9 HG23 ' O ' ' A' ' 36' ' ' LEU . 5.2 t -60.51 -54.82 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 109.791 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 tp10 -53.79 -45.82 70.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.81 -46.48 87.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.718 ' O ' HG23 ' A' ' 47' ' ' VAL . 97.4 mt -63.89 -44.19 93.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.268 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.0 mt -60.97 -47.58 85.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.843 0.354 . . . . 0.0 110.527 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.425 ' HA ' ' CZ ' ' A' ' 48' ' ' ARG . 4.8 t70 -47.29 -41.76 19.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.739 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.1 t80 -75.06 -40.09 60.5 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 43' ' ' LEU . 60.3 t -63.01 -53.9 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 -178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 8.9 ptt85 -72.06 -62.86 1.28 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.445 ' CZ ' ' HB3' ' A' ' 49' ' ' ARG . 11.7 mtp-105 -47.9 -50.52 26.45 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.514 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -75.65 -6.47 50.6 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.68 0.276 . . . . 0.0 111.369 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.29 39.45 94.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.666 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.739 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.1 mt -72.78 -53.26 12.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.39 42.52 83.47 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.43 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.882 ' HG2' HG23 ' A' ' 3' ' ' VAL . 83.3 tttt -178.3 127.05 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.011 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -141.54 135.96 30.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.786 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.642 HG12 ' O ' ' A' ' 4' ' ' GLY . 13.4 p -117.47 125.69 74.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.596 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.409 HG12 ' N ' ' A' ' 58' ' ' GLY . 21.9 t -78.45 153.0 5.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.074 0.464 . . . . 0.0 111.647 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.641 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -159.46 130.14 2.39 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.578 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 58' ' ' GLY . 75.0 mt -153.2 136.94 10.3 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.639 0.257 . . . . 0.0 111.222 -179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.41 141.18 45.95 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.556 2.171 . . . . 0.0 112.108 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.8 tp -55.88 128.16 33.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.927 0.394 . . . . 0.0 111.046 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.3 mmm180 -72.65 134.56 45.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 71.1 p -67.2 130.96 44.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.225 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 p30 45.35 -170.75 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.502 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.715 ' O ' HD23 ' A' ' 65' ' ' LEU . 5.2 tt -80.44 -43.89 20.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.665 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 67' ' ' GLU . 7.8 tmtm? -56.79 137.02 55.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.852 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.469 ' N ' ' HD3' ' A' ' 66' ' ' LYS . 50.8 mt-10 -153.69 132.22 12.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.75 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.1 p -64.8 -58.37 6.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.989 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.24 124.72 34.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.12 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -82.4 126.67 32.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.178 0.513 . . . . 0.0 110.914 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 53.2 -135.1 1.56 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.077 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.52 -136.85 2.16 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.217 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -158.79 31.87 0.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.029 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.6 t -100.1 -42.03 9.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.595 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.503 ' N ' ' CD ' ' A' ' 76' ' ' PRO . 59.3 tp -55.93 -43.77 99.37 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.579 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.503 ' CD ' ' N ' ' A' ' 75' ' ' LEU . 85.8 Cg_exo -46.72 -40.15 24.13 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.329 2.02 . . . . 0.0 112.392 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.663 HD13 ' C ' ' A' ' 77' ' ' LEU . 2.5 tm? -71.44 -38.48 71.35 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.616 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.819 HG13 HG11 ' A' ' 88' ' ' VAL . 61.5 t -55.03 -36.24 37.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.559 179.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -67.09 -40.02 86.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.886 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.2 -44.32 92.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.139 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.011 HD13 HD23 ' A' ' 55' ' ' LEU . 22.5 mt -59.78 -48.08 83.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.23 -179.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 53.9 mtp85 -56.83 -41.26 77.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.005 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.45 -41.14 75.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.194 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.5 mtp85 -84.96 15.28 4.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.739 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.42 38.89 97.08 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.161 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -100.67 134.64 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.654 0.264 . . . . 0.0 111.046 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.41 ' C ' HG23 ' A' ' 88' ' ' VAL . 4.4 mm-40 -63.79 129.03 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.819 HG11 HG13 ' A' ' 78' ' ' VAL . 57.3 t -157.52 144.83 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.129 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' VAL . 16.1 pt-20 -168.08 131.33 1.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.344 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.898 HD12 ' O ' ' A' ' 90' ' ' LEU . 3.0 pp -82.12 142.63 32.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.339 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.46 ' CD1' ' CG2' ' A' ' 56' ' ' VAL . 11.4 m0 -110.98 137.72 48.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.983 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -174.35 36.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.658 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -85.49 132.22 34.24 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.057 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 53.0 mtp85 -156.55 37.27 0.32 Allowed 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.049 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 60.34 131.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.211 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.411 ' O ' ' CG2' ' A' ' 97' ' ' THR . 8.7 t -68.46 131.55 45.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.96 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.411 ' CG2' ' O ' ' A' ' 96' ' ' THR . 10.2 t 44.39 44.65 7.01 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.602 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.9 tttp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.891 -179.925 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.881 0.372 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.72 ' NE ' HG12 ' A' ' 17' ' ' VAL . 9.6 tpt180 -88.68 131.93 34.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.065 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.818 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.2 p -134.26 139.45 48.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.073 0.463 . . . . 0.0 111.834 -179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.798 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -87.99 140.47 16.4 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.201 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -125.82 136.79 53.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.625 HD11 HD22 ' A' ' 43' ' ' LEU . 92.8 mt -125.43 142.49 51.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.131 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 10.9 p-10 -145.05 140.15 27.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.643 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.627 HG12 HG12 ' A' ' 13' ' ' ILE . 35.1 m -112.42 134.17 55.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.39 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.27 132.97 2.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.873 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 57.16 49.46 13.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.235 0.54 . . . . 0.0 111.329 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.441 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 52.29 33.68 13.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.449 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.877 ' CZ ' HG22 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -147.66 139.75 24.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.588 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.627 HG12 HG12 ' A' ' 8' ' ' VAL . 60.9 mt -106.56 128.93 60.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.623 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.76 131.89 10.82 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.824 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.623 HD21 HD22 ' A' ' 31' ' ' LEU . 92.7 mt -102.46 130.54 49.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.867 0.365 . . . . 0.0 110.865 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.445 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -149.95 147.83 28.36 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.792 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.72 HG12 ' NE ' ' A' ' 2' ' ' ARG . 46.8 t -150.04 122.84 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.982 0.42 . . . . 0.0 111.063 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.818 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.56 -149.57 8.76 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.238 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -79.71 151.09 30.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.665 0.269 . . . . 0.0 110.563 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -46.58 140.41 4.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.205 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.14 46.43 13.1 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.248 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 91.0 t -59.88 126.31 82.95 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 120.543 0.211 . . . . 0.0 111.263 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.94 128.6 17.03 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.389 2.059 . . . . 0.0 111.901 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.4 tp 61.8 127.29 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.001 0.429 . . . . 0.0 110.81 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -69.33 148.31 49.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.351 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 40.0 t 66.71 137.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.191 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -176.21 -47.44 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.259 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -68.61 -41.02 80.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 110.758 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.77 -143.96 4.28 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.481 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 179.79 150.47 0.36 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.763 0.316 . . . . 0.0 111.379 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.629 ' N ' HD23 ' A' ' 31' ' ' LEU . 1.6 pt? -142.67 135.6 28.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.691 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.877 HG22 ' CZ ' ' A' ' 12' ' ' ARG . 46.5 t -70.23 148.2 11.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.825 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.441 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 74.4 mtm180 -51.64 139.7 20.24 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.02 0.438 . . . . 0.0 111.129 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HD3' ' HG3' ' A' ' 38' ' ' GLU . 66.5 mttm -128.05 -120.3 0.24 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.183 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.582 ' O ' ' N ' ' A' ' 38' ' ' GLU . 37.7 p -156.05 128.32 7.62 Favored 'General case' 0 C--O 1.226 -0.183 0 CA-C-O 121.023 0.439 . . . . 0.0 112.113 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.835 HD12 ' H ' ' A' ' 36' ' ' LEU . 4.2 mp 0.08 -68.83 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.48 ' HG2' ' N ' ' A' ' 38' ' ' GLU . 13.5 pm0 -67.13 -45.71 76.3 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.914 0.387 . . . . 0.0 111.535 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.582 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.0 tp10 -59.86 -50.22 74.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.022 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.401 ' OD2' ' HD2' ' A' ' 73' ' ' LYS . 55.3 m-20 -50.31 -38.82 43.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.138 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.6 t -59.11 -46.7 91.75 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-O 121.287 0.565 . . . . 0.0 109.768 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -56.33 -48.34 76.94 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.005 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.28 77.4 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.998 0.428 . . . . 0.0 110.846 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.995 HD13 ' CD2' ' A' ' 77' ' ' LEU . 71.2 mt -63.13 -47.3 83.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.05 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.577 ' O ' ' HB3' ' A' ' 48' ' ' ARG . 23.2 mt -59.76 -46.68 88.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.788 0.328 . . . . 0.0 110.484 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 49' ' ' ARG . 7.4 t70 -46.14 -42.04 13.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.647 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.647 ' CE2' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -81.17 -58.01 3.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.487 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.62 HG11 HD21 ' A' ' 55' ' ' LEU . 60.8 t -58.12 -48.87 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.438 . . . . 0.0 112.07 -179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.577 ' HB3' ' O ' ' A' ' 44' ' ' LEU . 31.5 tpt85 -65.25 -57.09 9.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' A' ' 45' ' ' ASP . 23.1 mmt85 -68.07 -43.43 78.62 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.4 tp10 -72.34 -3.23 22.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.661 0.267 . . . . 0.0 111.339 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 37.76 92.27 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.674 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.647 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.9 mt -71.5 -52.54 17.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.821 0.343 . . . . 0.0 110.903 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.516 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 51.18 31.72 27.18 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.229 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.817 ' C ' HD22 ' A' ' 55' ' ' LEU . 61.5 mttp -162.63 131.02 3.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.599 0.238 . . . . 0.0 110.614 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.837 HD23 HD13 ' A' ' 81' ' ' LEU . 2.7 mm? -141.67 136.97 31.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.204 0.526 . . . . 0.0 111.445 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.798 HG12 ' O ' ' A' ' 4' ' ' GLY . 10.6 p -132.4 140.57 47.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.577 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 43.2 t -153.56 148.67 13.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.064 0.459 . . . . 0.0 111.56 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.549 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -149.35 141.25 8.74 Favored Glycine 0 N--CA 1.451 -0.338 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.921 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.549 HD23 ' O ' ' A' ' 58' ' ' GLY . 87.2 mt -144.81 147.6 36.03 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.784 0.326 . . . . 0.0 111.227 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -56.11 144.08 81.49 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.756 2.304 . . . . 0.0 112.155 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 61' ' ' LEU . 6.9 mp -57.81 129.79 43.52 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.131 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 61.7 mtm-85 -68.19 134.61 50.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.91 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.76 HG22 HD21 ' A' ' 65' ' ' LEU . 9.8 t -82.2 46.11 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.703 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 59.36 52.92 5.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.756 0.312 . . . . 0.0 111.475 179.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.76 HD21 HG22 ' A' ' 63' ' ' THR . 2.6 mm? -80.53 46.69 0.88 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.406 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -95.63 31.54 2.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.71 0.291 . . . . 0.0 111.124 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -80.44 -45.06 18.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.017 0.437 . . . . 0.0 110.616 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.5 p -177.79 -46.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.417 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.9 140.33 58.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.774 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -171.34 134.5 0.89 Allowed 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.271 0.558 . . . . 0.0 111.208 -179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -153.26 134.41 14.1 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.19 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -175.75 143.39 6.57 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.154 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HB2' ' NZ ' ' A' ' 73' ' ' LYS . 10.3 mtmp? -154.46 28.91 0.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.739 0.304 . . . . 0.0 111.211 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.27 -43.14 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.109 0.481 . . . . 0.0 110.968 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.678 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 51.5 tp -55.42 -48.8 95.5 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.616 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.678 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.2 Cg_endo -46.68 -39.45 23.41 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.471 2.114 . . . . 0.0 112.127 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.995 ' CD2' HD13 ' A' ' 43' ' ' LEU . 35.1 tp -66.19 -38.31 87.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.96 0.41 . . . . 0.0 110.412 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 44.6 t -53.04 -36.94 25.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.683 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.8 -43.1 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.592 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.619 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -63.46 -48.09 79.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.809 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.837 HD13 HD23 ' A' ' 55' ' ' LEU . 26.4 mt -58.7 -47.57 84.09 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.989 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -59.72 -42.36 92.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.995 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.44 -46.61 76.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.933 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.619 HH12 ' HB1' ' A' ' 80' ' ' ALA . 68.6 mtm-85 -87.53 18.87 3.62 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 59.28 37.65 92.18 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.556 -0.831 . . . . 0.0 111.866 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.516 HG13 ' C ' ' A' ' 53' ' ' GLY . 57.7 t -89.17 131.12 37.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.57 -0.315 . . . . 0.0 110.883 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -62.73 132.15 51.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.147 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.484 HG21 HD12 ' A' ' 81' ' ' LEU . 57.8 t -153.05 144.36 15.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.597 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.633 ' HG3' HG23 ' A' ' 56' ' ' VAL . 16.7 pt-20 -148.36 150.84 34.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.327 -179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.798 ' H ' HD23 ' A' ' 90' ' ' LEU . 1.6 pt? -129.6 157.55 41.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.53 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.447 ' CZ3' ' CD1' ' A' ' 61' ' ' LEU . 23.8 t90 -59.32 144.26 47.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.022 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 68.03 126.34 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.787 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -73.09 133.61 44.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.206 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' NH2' ' CZ ' ' A' ' 95' ' ' PHE . 29.6 tpt180 -72.69 134.7 45.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.826 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CZ ' ' NH2' ' A' ' 94' ' ' ARG . 5.4 p90 -60.37 142.36 54.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.412 ' O ' ' HB ' ' A' ' 97' ' ' THR . 71.0 m -165.89 -41.87 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.412 ' HB ' ' O ' ' A' ' 96' ' ' THR . 51.6 m 72.26 -54.27 0.69 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.622 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 57.4 tptt . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.763 0.316 . . . . 0.0 110.925 -179.99 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.882 0.372 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -88.5 133.13 34.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.629 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.934 HG12 ' O ' ' A' ' 18' ' ' GLY . 14.7 p -132.72 137.36 54.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.971 0.415 . . . . 0.0 111.188 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -84.77 126.06 7.48 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.107 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -102.28 130.57 49.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.349 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.613 HD11 HD22 ' A' ' 43' ' ' LEU . 92.8 mt -123.28 139.71 53.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.008 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.69 ' O ' HG23 ' A' ' 13' ' ' ILE . 8.5 p-10 -147.64 139.17 23.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.1 p -113.99 133.51 59.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.291 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.1 126.31 1.27 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 121.032 -0.604 . . . . 0.0 111.899 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 8.4 mp0 55.85 45.53 23.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.156 0.503 . . . . 0.0 110.47 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.502 ' HB3' ' O ' ' A' ' 10' ' ' GLU . . . 75.54 -52.85 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.669 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -64.66 140.17 58.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.04 0.448 . . . . 0.0 111.408 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.69 HG23 ' O ' ' A' ' 7' ' ' ASP . 60.2 mt -111.23 130.74 64.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.835 179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -79.45 140.06 22.35 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.517 -0.849 . . . . 0.0 113.253 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.828 HD11 HD22 ' A' ' 31' ' ' LEU . 74.5 mt -123.99 133.3 53.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.666 0.27 . . . . 0.0 110.522 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' HA ' ' CG ' ' A' ' 28' ' ' ARG . . . -159.05 -162.87 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.333 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.415 ' CG2' ' O ' ' A' ' 16' ' ' ALA . 90.3 t -158.87 142.4 6.0 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.784 -179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.934 ' O ' HG12 ' A' ' 3' ' ' VAL . . . -171.65 -148.87 6.29 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.957 -0.639 . . . . 0.0 111.982 -179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -123.58 116.75 23.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.042 0.449 . . . . 0.0 110.905 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mm-40 47.67 46.75 18.08 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.832 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' C ' HG23 ' A' ' 22' ' ' VAL . . . 62.62 142.09 0.01 OUTLIER Glycine 0 C--N 1.33 0.197 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.794 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.476 HG13 ' HD2' ' A' ' 23' ' ' PRO . 51.9 t -157.01 137.21 8.86 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 120.468 0.175 . . . . 0.0 110.877 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.476 ' HD2' HG13 ' A' ' 22' ' ' VAL . 19.3 Cg_endo -60.0 129.71 31.52 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.449 2.099 . . . . 0.0 112.372 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.46 ' O ' ' HB2' ' A' ' 25' ' ' ALA . 86.1 mt 60.89 125.63 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.192 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 24' ' ' LEU . . . 175.45 40.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.127 179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 52.8 m -75.66 134.53 40.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.713 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 179.81 -45.28 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.294 -0.955 . . . . 0.0 113.287 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.457 ' NE ' ' HA ' ' A' ' 28' ' ' ARG . 4.7 mmp_? -58.34 -55.38 35.75 Favored 'General case' 0 C--N 1.33 -0.246 0 O-C-N 122.843 -0.21 . . . . 0.0 111.355 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.19 -139.87 5.84 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.172 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -179.98 151.65 0.43 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.659 0.266 . . . . 0.0 110.796 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.828 HD22 HD11 ' A' ' 15' ' ' LEU . 1.5 pt? -133.91 136.17 44.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.998 0.428 . . . . 0.0 111.334 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.443 HG12 ' N ' ' A' ' 33' ' ' ARG . 48.9 t -76.08 156.04 5.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.724 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 64.0 mtp180 -51.84 150.21 4.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.807 0.337 . . . . 0.0 111.231 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 38' ' ' GLU . 56.7 mttp -147.97 -155.41 0.63 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.26 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.715 HG22 ' H ' ' A' ' 36' ' ' LEU . 0.6 OUTLIER -97.13 -158.39 0.66 Allowed 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 121.082 -0.247 . . . . 0.0 110.468 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.894 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.6 mm? -75.32 -55.47 5.68 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 120.607 0.241 . . . . 0.0 111.376 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.456 ' OE2' ' HB ' ' A' ' 35' ' ' THR . 0.9 OUTLIER -70.36 -38.25 74.76 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.991 -178.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 34' ' ' LYS . 7.3 mt-10 -57.74 -55.91 28.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.019 0.437 . . . . 0.0 110.772 -179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -53.97 -42.31 68.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.794 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.894 HG23 ' O ' ' A' ' 36' ' ' LEU . 6.1 t -58.98 -55.99 19.84 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.287 0 CA-C-O 121.415 0.626 . . . . 0.0 110.384 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -51.66 -46.89 63.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.422 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.74 -48.28 79.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.422 . . . . 0.0 111.098 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.677 ' O ' HG23 ' A' ' 47' ' ' VAL . 72.7 mt -65.54 -47.07 77.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.379 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.608 ' CD1' HG12 ' A' ' 40' ' ' VAL . 76.3 mt -59.52 -48.4 81.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.931 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -50.23 -37.78 37.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.708 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.708 ' CE2' HD11 ' A' ' 52' ' ' LEU . 17.9 t80 -77.04 -44.1 32.07 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.371 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.677 HG23 ' O ' ' A' ' 43' ' ' LEU . 59.6 t -56.62 -53.77 37.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 112.122 0.415 . . . . 0.0 112.122 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.44 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -70.78 -60.79 2.04 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 27.0 mmm180 -49.6 -50.46 42.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.72 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.6 tp10 -74.25 -10.97 60.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.618 0.247 . . . . 0.0 111.347 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.44 39.62 97.54 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.561 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.708 HD11 ' CE2' ' A' ' 46' ' ' PHE . 89.4 mt -75.09 -49.37 19.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.85 0.357 . . . . 0.0 111.026 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.455 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 54.86 26.5 40.9 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.381 -179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.844 ' O ' HD13 ' A' ' 55' ' ' LEU . 66.1 mttm -164.26 131.65 3.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.968 HD23 HD13 ' A' ' 81' ' ' LEU . 2.3 mm? -140.28 131.06 25.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.131 0.491 . . . . 0.0 111.764 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 56' ' ' VAL . 10.8 p -118.64 124.24 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.488 179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 90' ' ' LEU . 45.8 t -78.71 128.49 38.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.516 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.524 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -85.69 139.95 17.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.002 -0.618 . . . . 0.0 112.192 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 58' ' ' GLY . 97.5 mt -157.28 129.52 4.13 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.588 0.232 . . . . 0.0 110.943 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.65 -161.16 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.494 2.129 . . . . 0.0 112.234 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 85.5 mt -72.29 134.43 45.55 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.797 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -64.47 127.37 31.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.887 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 77.2 p -75.56 -52.39 10.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.173 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.2 t70 179.5 130.61 0.09 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.65 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.1 mt -71.62 128.01 34.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.109 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.47 ' NZ ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER 178.54 120.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.625 179.668 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 66' ' ' LYS . 66.4 mm-40 59.93 132.85 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.982 179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 80.2 p -62.68 120.05 10.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.781 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.55 132.96 35.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.01 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -64.86 131.65 47.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.001 0.429 . . . . 0.0 110.784 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.8 134.98 53.24 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.247 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -76.46 51.03 2.92 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.748 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER 59.32 20.95 9.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.637 0.256 . . . . 0.0 110.901 -179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.2 t -100.4 -44.35 11.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.904 0.383 . . . . 0.0 111.166 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 2.9 tm? -54.21 -49.67 88.95 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.622 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.8 Cg_endo -46.95 -40.27 25.45 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.565 2.177 . . . . 0.0 112.599 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.68 HD23 HG13 ' A' ' 40' ' ' VAL . 2.8 tm? -71.84 -37.86 70.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.765 0.317 . . . . 0.0 110.916 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.617 HG13 HG11 ' A' ' 88' ' ' VAL . 57.4 t -55.7 -35.62 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.972 0.415 . . . . 0.0 110.676 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -65.85 -40.02 91.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.892 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.74 91.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.101 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.968 HD13 HD23 ' A' ' 55' ' ' LEU . 27.1 mt -61.52 -47.43 85.63 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.153 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.5 ' HB3' ' NH1' ' A' ' 82' ' ' ARG . 3.6 mmm180 -59.12 -42.27 90.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.886 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -57.63 -41.19 80.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.377 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 64.5 mtt85 -86.89 19.25 3.08 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.799 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.74 37.88 94.28 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.985 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 52.9 t -97.28 134.98 33.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 54' ' ' LYS . 41.2 tp10 -65.4 128.09 34.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.947 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 78' ' ' VAL . 46.7 t -158.06 145.06 8.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.55 -179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -169.71 141.34 2.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.122 0.487 . . . . 0.0 111.824 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.692 HD13 ' HB ' ' A' ' 57' ' ' VAL . 2.6 mm? -66.46 139.72 57.98 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.411 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -135.19 136.42 41.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.978 0.418 . . . . 0.0 110.903 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 93' ' ' GLU . 9.9 t70 -62.55 -118.12 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.451 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.514 ' O ' ' O ' ' A' ' 94' ' ' ARG . 17.7 tp10 -176.85 138.74 0.27 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.893 0.378 . . . . 0.0 110.991 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.514 ' O ' ' O ' ' A' ' 93' ' ' GLU . 14.1 ptp180 51.7 138.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.135 -179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -56.22 139.96 46.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.93 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 84.3 m -165.75 -41.63 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.062 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t -169.15 135.9 1.75 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.221 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.899 -179.938 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.84 0.352 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 22.1 mmt85 -101.29 134.92 43.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.154 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.912 HG23 ' HG3' ' A' ' 54' ' ' LYS . 14.7 p -124.78 132.56 71.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.863 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.87 124.08 6.88 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.879 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.702 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -111.63 134.37 53.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.807 0.337 . . . . 0.0 111.313 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.676 HD11 HD22 ' A' ' 43' ' ' LEU . 99.0 mt -129.27 138.63 51.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.092 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.586 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 9.5 p-10 -146.33 138.92 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.524 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.6 t -105.5 135.11 44.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 111.351 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.74 130.41 1.65 Allowed Glycine 0 CA--C 1.518 0.275 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.743 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 10' ' ' GLU . 17.5 tp10 55.81 52.06 11.37 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.18 0.514 . . . . 0.0 111.136 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.429 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . 50.5 35.11 10.52 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.289 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HD3' ' CG ' ' A' ' 30' ' ' TYR . 38.6 ttm180 -149.24 140.1 22.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.855 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.586 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -103.8 128.66 56.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.642 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.401 ' HA3' ' OD1' ' A' ' 7' ' ' ASP . . . -83.93 130.32 9.68 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.259 -0.972 . . . . 0.0 112.544 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.637 HD11 ' CD2' ' A' ' 31' ' ' LEU . 89.3 mt -105.11 131.58 52.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.874 0.368 . . . . 0.0 110.935 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.93 ' HB2' ' HA ' ' A' ' 26' ' ' SER . . . -150.51 147.01 26.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.901 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.3 t -143.5 119.34 4.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.197 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.908 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.44 -149.53 8.76 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.3 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.0 pm0 -69.36 145.87 52.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.765 0.317 . . . . 0.0 110.6 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.76 ' OE1' HG21 ' A' ' 3' ' ' VAL . 48.3 mm-40 -52.24 133.14 34.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.033 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 62.72 52.47 48.32 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.809 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.461 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 47.1 t -59.86 127.36 85.31 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 120.485 0.183 . . . . 0.0 111.014 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 22' ' ' VAL . 13.2 Cg_exo -69.39 54.97 1.08 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.794 2.329 . . . . 0.0 112.606 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.716 ' O ' HD23 ' A' ' 24' ' ' LEU . 5.6 tt -175.93 -41.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.825 0.345 . . . . 0.0 110.579 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.439 ' O ' HD23 ' A' ' 24' ' ' LEU . . . 64.97 137.3 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.168 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.93 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 48.8 m 63.91 130.88 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.899 -179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 174.88 45.33 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.5 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.3 mmm-85 -157.32 -45.23 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.855 0.359 . . . . 0.0 110.791 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -174.22 -140.77 3.36 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.317 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.442 ' CG ' ' HD3' ' A' ' 12' ' ' ARG . 6.9 p90 179.95 140.35 0.13 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.903 0.383 . . . . 0.0 111.267 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.637 ' CD2' HD11 ' A' ' 15' ' ' LEU . 75.7 mt -106.14 123.02 47.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.546 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.48 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 49.8 t -72.68 148.99 8.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.343 179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.429 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 81.6 mtm180 -47.08 148.32 1.18 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.865 0.364 . . . . 0.0 111.334 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HD3' ' CG ' ' A' ' 38' ' ' GLU . 62.3 mttm -144.79 -121.94 0.08 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.278 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 38' ' ' GLU . 23.4 p -154.78 128.0 8.36 Favored 'General case' 0 C--O 1.225 -0.21 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.817 ' O ' HG23 ' A' ' 40' ' ' VAL . 83.5 mt 5.83 -69.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.467 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.4 pt-20 -67.8 -46.88 70.67 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.846 0.355 . . . . 0.0 111.763 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.525 ' N ' ' O ' ' A' ' 35' ' ' THR . 5.1 tp10 -58.55 -50.65 73.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.079 -179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.4 m-20 -48.67 -46.03 39.7 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 120.94 0.4 . . . . 0.0 110.315 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 36' ' ' LEU . 3.8 t -61.93 -50.22 81.03 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -52.91 -46.85 68.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.308 -1.314 . . . . 0.0 111.093 179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -63.59 -44.46 93.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.943 0.402 . . . . 0.0 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.832 ' O ' HG23 ' A' ' 47' ' ' VAL . 94.7 mt -67.31 -42.0 84.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.639 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.51 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 70.0 mt -59.58 -56.21 24.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.694 0.283 . . . . 0.0 111.066 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -48.55 -38.02 19.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.887 0.375 . . . . 0.0 110.812 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.686 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.2 t80 -73.49 -42.59 61.65 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.102 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.832 HG23 ' O ' ' A' ' 43' ' ' LEU . 59.5 t -63.31 -50.12 80.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -72.89 -62.84 1.32 Allowed 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.319 0.488 . . . . 0.0 112.319 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 46.8 mmm-85 -48.0 -51.8 22.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.32 -0.4 . . . . 0.0 112.074 -178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.1 tp10 -76.08 -4.88 43.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.665 -0.243 . . . . 0.0 111.343 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 57.08 40.68 91.81 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.508 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.686 HD11 ' CE2' ' A' ' 46' ' ' PHE . 86.4 mt -68.22 -54.35 18.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.99 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.95 40.66 66.04 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.125 -179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.912 ' HG3' HG23 ' A' ' 3' ' ' VAL . 3.4 tppp? -178.36 128.82 0.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 -179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.02 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -141.32 133.2 27.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.366 0.603 . . . . 0.0 111.776 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.517 HG22 ' CD1' ' A' ' 91' ' ' TRP . 14.8 p -121.57 117.83 53.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.341 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.23 145.42 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.533 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -143.6 125.62 2.57 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.903 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.581 HD23 ' O ' ' A' ' 58' ' ' GLY . 88.5 mt -158.47 134.5 6.19 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 120.579 0.228 . . . . 0.0 110.747 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.49 129.36 17.75 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.289 1.993 . . . . 0.0 112.123 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.569 HD13 ' N ' ' A' ' 62' ' ' ARG . 0.6 OUTLIER 62.3 121.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.307 179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.724 ' NH2' HD22 ' A' ' 90' ' ' LEU . 19.8 tpp180 -86.38 -40.73 15.12 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 111.949 0.352 . . . . 0.0 111.949 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.505 ' CG2' ' O ' ' A' ' 62' ' ' ARG . 8.2 t 50.53 -133.28 1.72 Allowed 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.107 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -47.49 126.71 10.2 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.935 0.398 . . . . 0.0 111.298 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 tp -77.92 -39.9 41.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.366 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -159.63 151.33 20.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.028 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -158.59 -40.16 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.963 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.4 t 65.82 -145.97 0.2 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.611 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 59.53 46.63 11.89 Favored 'General case' 0 N--CA 1.457 -0.113 0 CA-C-O 120.908 0.385 . . . . 0.0 110.727 -179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 63.63 103.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.666 -179.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 178.74 142.4 0.11 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.117 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 68.04 131.21 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.591 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.747 ' HG2' HD23 ' A' ' 36' ' ' LEU . 36.6 mtmm -109.64 -29.17 8.49 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.77 0.319 . . . . 0.0 110.988 -179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.01 -45.09 65.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.158 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.523 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 56.3 tp -56.71 -49.82 91.5 Favored Pre-proline 0 CA--C 1.531 0.226 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 83.9 Cg_exo -44.06 -38.37 10.44 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.475 2.116 . . . . 0.0 112.38 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.689 HD23 HG13 ' A' ' 40' ' ' VAL . 2.3 tm? -70.5 -36.31 73.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.693 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.96 HG13 HG11 ' A' ' 88' ' ' VAL . 61.3 t -54.45 -36.99 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.959 0.409 . . . . 0.0 110.581 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -67.93 -39.9 83.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.846 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.75 -43.91 85.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.145 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.02 HD13 HD23 ' A' ' 55' ' ' LEU . 23.6 mt -59.08 -45.29 91.22 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.026 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.1 mmm-85 -58.3 -44.04 88.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.52 -40.08 85.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.103 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 75.3 mtt-85 -83.11 15.55 2.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.72 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.94 38.84 96.65 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.254 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.415 ' HB ' ' HB3' ' A' ' 81' ' ' LEU . 59.6 t -108.5 135.24 47.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 120.836 0.35 . . . . 0.0 111.021 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -69.75 139.35 53.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.166 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.96 HG11 HG13 ' A' ' 78' ' ' VAL . 44.5 t -155.84 139.72 8.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.515 ' O ' HG23 ' A' ' 56' ' ' VAL . 0.4 OUTLIER -161.53 130.79 4.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.032 0.444 . . . . 0.0 111.61 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 90' ' ' LEU . 2.3 pp -83.02 146.81 28.53 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.479 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.517 ' CD1' HG22 ' A' ' 56' ' ' VAL . 12.5 m0 -59.89 151.99 24.48 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.369 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.1 t0 67.05 135.52 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.196 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -178.28 127.11 0.12 Allowed 'General case' 0 CA--C 1.516 -0.358 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.458 ' O ' ' HG3' ' A' ' 94' ' ' ARG . 21.6 tpp180 -172.36 40.04 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.713 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 17.9 t80 -75.33 -48.05 24.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.762 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t 178.18 136.54 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.887 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 72.3 p -58.12 133.74 55.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.163 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HD2' ' C ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.318 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.6 mtt . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.779 0.323 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 49.2 mmt-85 -93.68 133.31 37.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.794 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 54' ' ' LYS . 14.4 p -136.58 136.13 48.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.031 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.468 ' O ' HG12 ' A' ' 56' ' ' VAL . . . -79.32 134.69 14.12 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.134 179.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -121.96 133.92 54.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.895 0.378 . . . . 0.0 111.423 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.614 HD11 HD22 ' A' ' 43' ' ' LEU . 98.9 mt -126.43 139.45 53.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.13 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -143.77 139.35 29.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.31 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.8 t -106.71 128.45 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.867 0.365 . . . . 0.0 111.559 -179.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -111.84 -135.46 6.63 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.207 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -64.79 -44.4 90.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.863 0.364 . . . . 0.0 110.746 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -168.15 32.85 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.708 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.495 ' CD ' HG22 ' A' ' 32' ' ' VAL . 23.6 mmt85 -147.92 144.21 27.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.482 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 55.3 mt -99.61 125.25 53.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.58 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.41 129.34 9.01 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.631 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.668 HD11 ' HG ' ' A' ' 31' ' ' LEU . 85.5 mt -104.81 127.13 52.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.006 0.431 . . . . 0.0 110.937 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -147.29 148.94 31.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.588 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.432 HG22 ' HA2' ' A' ' 4' ' ' GLY . 55.6 t -151.1 133.87 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.005 0.431 . . . . 0.0 111.676 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.454 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.89 -149.89 8.87 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.374 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -98.62 164.88 12.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.699 0.285 . . . . 0.0 110.973 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -48.75 -45.44 39.75 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.907 0.384 . . . . 0.0 110.906 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -76.13 54.72 3.12 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.508 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 43.3 t -59.95 134.61 90.05 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.608 0.242 . . . . 0.0 111.026 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -61.21 -41.15 44.67 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.646 2.23 . . . . 0.0 112.271 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 58.3 tp -168.83 -42.07 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.017 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.91 -42.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.245 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 47.2 t 63.44 127.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.962 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.03 146.82 34.02 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.682 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.7 tpp85 -158.03 -47.59 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.611 0.243 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 178.66 -151.41 10.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.401 -0.904 . . . . 0.0 112.856 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.426 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 6.4 p90 179.82 141.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.946 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.668 ' HG ' HD11 ' A' ' 15' ' ' LEU . 67.0 mt -114.71 124.19 51.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.517 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.495 HG22 ' CD ' ' A' ' 12' ' ' ARG . 47.6 t -66.22 146.0 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.562 179.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.418 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 98.6 mtt180 -51.58 147.54 6.23 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.862 0.363 . . . . 0.0 111.465 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' O ' HG23 ' A' ' 35' ' ' THR . 52.1 mttp -147.17 -125.75 0.06 Allowed 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.052 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.542 HG23 ' O ' ' A' ' 34' ' ' LYS . 16.1 p -157.69 134.79 10.14 Favored 'General case' 0 N--CA 1.461 0.11 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.842 HD12 ' H ' ' A' ' 36' ' ' LEU . 5.2 mp 5.27 -72.02 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -69.75 -48.15 60.44 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.49 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.0 tp10 -57.49 -50.27 73.6 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.942 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.413 ' OD2' ' CG ' ' A' ' 73' ' ' LYS . 45.5 m-20 -51.31 -42.38 61.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.248 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.6 t -60.84 -47.38 93.55 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.511 0.672 . . . . 0.0 109.779 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.74 -49.58 37.65 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.955 -1.02 . . . . 0.0 111.436 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -73.2 -44.3 59.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.952 0.406 . . . . 0.0 111.257 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.994 ' CD1' HD22 ' A' ' 77' ' ' LEU . 27.7 mt -61.57 -48.12 82.41 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.934 -179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.583 ' HG ' HG12 ' A' ' 40' ' ' VAL . 57.9 mt -57.51 -50.76 72.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.931 0.396 . . . . 0.0 110.684 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -45.28 -40.43 7.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.968 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.572 ' CE2' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -77.45 -45.43 25.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.456 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 43' ' ' LEU . 65.8 t -57.1 -50.85 75.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 5.4 ptm180 -71.32 -62.77 1.28 Allowed 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -51.42 -48.84 62.53 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.995 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -69.87 -13.41 62.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.547 0.213 . . . . 0.0 111.219 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.88 39.12 95.06 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.423 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.572 HD11 ' CE2' ' A' ' 46' ' ' PHE . 86.1 mt -74.1 -49.27 24.66 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.877 0.37 . . . . 0.0 110.99 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.507 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 54.53 28.21 44.14 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.233 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.796 ' O ' HD13 ' A' ' 55' ' ' LEU . 67.5 mttm -164.14 129.96 2.97 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.268 0.227 . . . . 0.0 110.399 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.796 HD13 ' O ' ' A' ' 54' ' ' LYS . 2.6 mm? -140.25 121.02 14.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.12 0.486 . . . . 0.0 111.525 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.507 ' O ' HG13 ' A' ' 56' ' ' VAL . 8.6 p -99.3 113.93 35.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.88 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 58' ' ' GLY . 48.1 t -73.62 157.92 6.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.735 -179.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.581 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -155.02 129.82 2.66 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.657 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.698 HD21 HG21 ' A' ' 74' ' ' VAL . 91.8 mt -157.58 146.09 14.4 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.603 0.24 . . . . 0.0 110.928 -179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.1 -26.58 76.34 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.551 2.167 . . . . 0.0 112.148 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.408 ' HG ' ' O ' ' A' ' 59' ' ' LEU . 67.8 mt 69.83 -157.2 0.15 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.404 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 44.6 -153.78 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 120.35 0.119 . . . . 0.0 110.758 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 63' ' ' THR . 42.1 m 53.34 48.7 21.39 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-O 120.923 0.392 . . . . 0.0 111.031 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -76.55 48.03 0.52 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.676 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.577 ' N ' HD12 ' A' ' 65' ' ' LEU . 5.0 mp -88.47 140.38 29.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.727 0.299 . . . . 0.0 110.825 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -54.76 -41.43 70.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.001 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -59.2 -50.75 72.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.895 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 53.0 m -70.14 131.23 43.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.712 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.71 130.12 38.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.293 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 16.0 mp0 -73.25 133.8 44.06 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.215 0.531 . . . . 0.0 110.987 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.913 ' HB1' ' HB2' ' A' ' 75' ' ' LEU . . . 70.13 -55.98 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.678 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 81.31 -138.78 19.61 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.282 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' N ' ' HD3' ' A' ' 73' ' ' LYS . 2.7 mppt? -81.73 -28.62 33.29 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.208 0.448 . . . . 0.0 112.208 -179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.698 HG21 HD21 ' A' ' 59' ' ' LEU . 40.3 t -61.5 -53.28 50.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.913 ' HB2' ' HB1' ' A' ' 71' ' ' ALA . 2.2 tm? -55.38 -50.4 86.95 Favored Pre-proline 0 C--N 1.329 -0.295 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.503 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.2 Cg_exo -42.5 -39.9 7.04 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.494 2.13 . . . . 0.0 112.467 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.994 HD22 ' CD1' ' A' ' 43' ' ' LEU . 42.6 tp -66.52 -41.31 88.97 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.717 HG13 HG11 ' A' ' 88' ' ' VAL . 22.0 t -53.99 -34.88 26.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.783 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -64.86 -43.17 93.86 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.961 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.96 -45.21 91.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.131 0.491 . . . . 0.0 111.113 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.635 HD13 HD23 ' A' ' 55' ' ' LEU . 31.7 mt -59.4 -41.18 88.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.366 -179.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.692 ' NH1' HG12 ' A' ' 78' ' ' VAL . 62.1 mtt85 -57.11 -42.73 81.39 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.691 0.281 . . . . 0.0 111.219 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.76 -51.27 69.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.383 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 79.0 mtm180 -70.63 -27.3 63.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.953 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.99 43.41 4.12 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.346 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.507 HG13 ' C ' ' A' ' 53' ' ' GLY . 59.1 t -98.85 139.95 19.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.613 0.244 . . . . 0.0 110.754 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -60.43 130.15 45.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.614 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.717 HG11 HG13 ' A' ' 78' ' ' VAL . 60.9 t -151.86 145.2 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.191 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 56' ' ' VAL . 24.4 pt-20 -171.86 123.7 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.481 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.458 ' H ' ' CD2' ' A' ' 90' ' ' LEU . 1.8 pt? -75.68 130.66 39.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.476 ' CZ2' ' HA3' ' A' ' 58' ' ' GLY . 1.5 p90 -77.31 143.1 39.06 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 110.573 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -178.13 133.83 0.15 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.795 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 56.64 47.27 18.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.963 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.453 ' NH2' ' CE1' ' A' ' 95' ' ' PHE . 8.4 ptm180 -177.45 134.04 0.18 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.946 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.453 ' CE1' ' NH2' ' A' ' 94' ' ' ARG . 2.0 m-85 63.01 137.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.008 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.1 t -57.45 139.0 54.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.313 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.6 p -158.47 135.1 9.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.016 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.2 mttm . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.961 -179.865 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HG2' ' O ' ' A' ' 1' ' ' MET . 49.6 ttm . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.822 0.344 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.402 ' HB3' ' CG1' ' A' ' 17' ' ' VAL . 99.2 mtt180 -96.38 132.3 42.04 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.917 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.826 HG12 ' O ' ' A' ' 18' ' ' GLY . 13.0 p -126.32 132.42 70.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.998 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.08 126.93 7.67 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.012 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.723 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -109.37 130.46 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.696 -0.297 . . . . 0.0 111.098 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.657 HD11 HD22 ' A' ' 43' ' ' LEU . 95.0 mt -120.47 136.53 54.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.052 0.454 . . . . 0.0 111.249 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.554 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -146.97 139.43 24.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.165 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.492 HG12 HG12 ' A' ' 13' ' ' ILE . 35.0 m -108.73 134.23 51.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.759 0.314 . . . . 0.0 111.61 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -178.01 131.52 1.78 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.958 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 10' ' ' GLU . 40.4 tt0 56.8 53.47 8.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.144 0.497 . . . . 0.0 111.413 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.463 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . 48.85 35.92 7.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.467 179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -151.69 140.97 21.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.68 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 61.8 mt -105.27 127.4 60.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.877 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -80.27 134.38 13.42 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.768 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.688 HD11 HD22 ' A' ' 31' ' ' LEU . 88.0 mt -113.59 133.72 55.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.934 0.397 . . . . 0.0 110.912 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.723 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.38 148.95 29.41 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.999 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.439 HG23 ' HG3' ' A' ' 28' ' ' ARG . 48.0 t -140.43 121.96 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.289 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.826 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.63 -149.59 8.75 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.341 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.881 ' O ' HG23 ' A' ' 22' ' ' VAL . 56.2 mt-10 -65.77 154.79 38.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.724 0.297 . . . . 0.0 110.747 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.588 ' HA ' HG11 ' A' ' 3' ' ' VAL . 4.1 tm-20 -65.47 126.84 29.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.964 0.411 . . . . 0.0 111.055 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.67 48.06 86.84 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.975 -0.557 . . . . 0.0 113.712 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.881 HG23 ' O ' ' A' ' 19' ' ' GLU . 59.3 t -71.52 132.72 85.36 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 117.095 0.448 . . . . 0.0 110.827 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.492 ' O ' HD23 ' A' ' 24' ' ' LEU . 92.3 Cg_endo -83.75 37.72 0.66 Allowed 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.641 2.227 . . . . 0.0 112.732 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.492 HD23 ' O ' ' A' ' 23' ' ' PRO . 94.9 mt -161.8 -42.6 0.04 OUTLIER 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.931 0.396 . . . . 0.0 110.6 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 24' ' ' LEU . . . 69.46 125.98 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.095 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 81.0 p -73.09 -37.49 66.74 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.105 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.34 138.79 1.37 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.328 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.439 ' HG3' HG23 ' A' ' 17' ' ' VAL . 27.1 mmm180 -132.08 -43.37 0.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.98 -137.58 2.37 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.67 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -179.93 150.77 0.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.927 0.394 . . . . 0.0 110.86 -179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.688 HD22 HD11 ' A' ' 15' ' ' LEU . 1.3 pt? -134.67 135.33 41.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.878 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.9 t -63.21 145.07 13.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.912 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 66.1 mtm180 -54.26 151.59 7.16 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.168 0.509 . . . . 0.0 111.326 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.433 ' HB2' ' OD1' ' A' ' 39' ' ' ASP . 64.1 mttm -146.61 -122.55 0.07 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.699 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.487 ' OG1' ' HG2' ' A' ' 38' ' ' GLU . 38.4 p -148.58 139.72 23.19 Favored 'General case' 0 N--CA 1.457 -0.087 0 CA-C-O 120.728 0.299 . . . . 0.0 110.903 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.021 HD22 ' N ' ' A' ' 37' ' ' GLU . 0.0 OUTLIER -21.96 -43.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 1.021 ' N ' HD22 ' A' ' 36' ' ' LEU . 11.9 pt-20 -73.46 -48.88 30.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 117.929 0.331 . . . . 0.0 111.469 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HG2' ' OG1' ' A' ' 35' ' ' THR . 13.6 mm-40 -61.79 -48.31 81.21 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.433 ' OD1' ' HB2' ' A' ' 34' ' ' LYS . 23.0 m-20 -45.93 -40.96 10.92 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.808 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -59.74 -52.03 65.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.185 0.517 . . . . 0.0 110.363 179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -56.09 -51.92 66.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.346 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.13 -43.94 93.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.954 0.407 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.006 HD13 ' CD2' ' A' ' 77' ' ' LEU . 74.0 mt -65.22 -50.31 66.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.457 ' HB3' ' NH1' ' A' ' 48' ' ' ARG . 61.5 mt -59.1 -48.08 82.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.804 0.335 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -49.35 -38.91 29.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.587 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.705 ' CE2' HD11 ' A' ' 52' ' ' LEU . 17.9 t80 -77.04 -43.69 33.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.236 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 43' ' ' LEU . 99.9 t -58.06 -51.81 66.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 44' ' ' LEU . 1.5 ptt-85 -67.81 -63.18 1.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 53.6 mtp85 -51.35 -49.75 60.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.881 -178.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 17.5 tp10 -72.05 -10.23 59.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.263 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 61.02 39.8 97.59 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.465 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.705 HD11 ' CE2' ' A' ' 46' ' ' PHE . 88.9 mt -72.36 -52.81 14.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.776 0.322 . . . . 0.0 110.897 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.501 ' C ' HG13 ' A' ' 86' ' ' VAL . . . 53.84 36.18 54.77 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.257 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.915 ' O ' HD13 ' A' ' 55' ' ' LEU . 37.3 ttpt 178.21 131.42 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 110.28 -0.267 . . . . 0.0 110.28 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.111 HD23 HD13 ' A' ' 81' ' ' LEU . 1.6 mm? -137.8 137.45 38.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.067 0.461 . . . . 0.0 111.748 -179.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.581 HG12 HG22 ' A' ' 3' ' ' VAL . 15.0 p -128.19 132.79 68.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.11 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' HB ' ' HA ' ' A' ' 90' ' ' LEU . 14.8 t -77.91 141.91 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.471 -0.332 . . . . 0.0 110.752 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.733 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -152.48 133.93 4.3 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.195 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 58' ' ' GLY . 65.1 mt -149.56 114.07 3.5 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 120.536 0.208 . . . . 0.0 110.584 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -72.54 -57.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.409 2.073 . . . . 0.0 112.458 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 58.3 tp -77.27 127.21 32.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.372 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -83.15 133.95 35.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.655 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.5 p -61.44 127.45 31.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.904 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -73.59 -57.92 3.67 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.451 ' N ' HD23 ' A' ' 65' ' ' LEU . 1.8 pt? -66.03 125.61 25.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.47 ' NZ ' ' HB3' ' A' ' 66' ' ' LYS . 0.3 OUTLIER -84.35 133.92 34.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.763 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 68' ' ' SER . 12.6 pt-20 -177.62 -163.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.674 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 67' ' ' GLU . 91.6 p 56.33 130.84 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.056 0.455 . . . . 0.0 111.547 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.77 -43.74 98.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -178.24 130.83 0.14 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.271 0.558 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.48 -144.15 0.56 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.946 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' O ' ' CD ' ' A' ' 76' ' ' PRO . . . -179.64 -135.44 2.43 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.413 -0.898 . . . . 0.0 112.374 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.469 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 37.3 mtmm -64.22 -25.26 67.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.805 0.336 . . . . 0.0 111.383 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.0 t -68.22 -41.15 83.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.577 ' HB3' ' HD3' ' A' ' 76' ' ' PRO . 61.2 tp -54.5 -52.0 73.42 Favored Pre-proline 0 CA--C 1.533 0.291 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.577 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 88.3 Cg_exo -43.94 -40.16 11.52 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.348 2.032 . . . . 0.0 112.219 179.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.006 ' CD2' HD13 ' A' ' 43' ' ' LEU . 32.0 tp -63.19 -42.79 99.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.669 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 26.6 t -52.01 -35.49 18.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.693 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -59.77 -42.81 94.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.549 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.97 -49.06 66.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.952 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.111 HD13 HD23 ' A' ' 55' ' ' LEU . 24.5 mt -57.94 -50.91 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.088 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -58.44 -38.4 77.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -53.42 -43.74 68.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.427 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.425 HH22 HD23 ' A' ' 81' ' ' LEU . 68.0 mtm-85 -89.69 20.04 4.3 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.505 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 61.97 39.82 98.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.614 -0.803 . . . . 0.0 111.878 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.501 HG13 ' C ' ' A' ' 53' ' ' GLY . 50.1 t -95.52 132.26 40.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.785 0.326 . . . . 0.0 111.081 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 65.2 mm-40 -64.85 130.22 42.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.679 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 81' ' ' LEU . 65.9 t -155.91 144.48 12.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.96 0.41 . . . . 0.0 111.301 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.505 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.5 pt-20 -172.02 129.66 0.62 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.29 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.815 HD12 ' O ' ' A' ' 90' ' ' LEU . 2.5 pp -78.0 149.61 34.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.693 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -157.87 137.55 12.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.069 0.461 . . . . 0.0 111.602 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.421 ' OD1' ' HG3' ' A' ' 93' ' ' GLU . 2.8 p30 -177.96 -40.37 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.314 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.421 ' HG3' ' OD1' ' A' ' 92' ' ' ASP . 52.7 mt-10 -70.2 132.74 46.22 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.771 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.6 tpt180 -164.41 -47.87 0.03 OUTLIER 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.332 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -177.99 130.13 0.14 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.728 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 96' ' ' THR . 37.7 m -91.11 42.83 1.12 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.277 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.447 ' O ' ' O ' ' A' ' 96' ' ' THR . 65.7 p 56.33 133.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.767 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.33 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.985 0.422 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.505 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 1.0 OUTLIER -87.59 135.91 33.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.672 179.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.889 HG12 ' O ' ' A' ' 18' ' ' GLY . 12.7 p -121.49 131.56 72.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.092 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.48 117.56 4.76 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.951 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -97.22 133.3 42.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.901 0.381 . . . . 0.0 111.226 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.785 HD11 HD22 ' A' ' 43' ' ' LEU . 83.8 mt -123.73 138.37 54.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.967 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.585 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 3.0 p30 -145.34 144.39 30.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.106 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.8 p -125.06 141.18 45.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.829 0.347 . . . . 0.0 111.531 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -169.78 133.5 2.85 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.756 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 66.04 -67.98 0.14 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 122.344 0.257 . . . . 0.0 111.522 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.468 ' HA ' ' CD ' ' A' ' 33' ' ' ARG . . . -176.19 36.3 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.844 0.354 . . . . 0.0 111.354 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 84.1 mtm180 -156.46 143.9 19.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.3 mt -104.09 130.44 54.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.708 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.13 138.12 17.46 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.009 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 31' ' ' LEU . 52.4 mt -115.39 132.8 56.5 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.873 0.368 . . . . 0.0 111.442 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.881 ' HB2' ' HA ' ' A' ' 26' ' ' SER . . . -154.68 145.46 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.058 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.635 HG23 ' HG3' ' A' ' 28' ' ' ARG . 57.5 t -136.96 125.6 34.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.115 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.889 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.63 -149.42 8.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.143 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.886 ' O ' HG23 ' A' ' 22' ' ' VAL . 42.2 tp10 -73.56 160.02 32.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.811 0.338 . . . . 0.0 110.53 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -67.7 130.08 41.89 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.944 0.402 . . . . 0.0 111.402 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 61.02 46.06 95.35 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 121.182 -0.532 . . . . 0.0 113.767 179.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.886 HG23 ' O ' ' A' ' 19' ' ' GLU . 94.7 t -80.14 133.49 57.39 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.896 0.348 . . . . 0.0 110.979 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.05 134.39 29.36 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.482 2.121 . . . . 0.0 111.767 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.614 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.5 mm? 60.22 52.85 4.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.863 0.363 . . . . 0.0 110.343 -179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.436 ' O ' ' OG ' ' A' ' 26' ' ' SER . . . -60.17 -138.63 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.608 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.881 ' HA ' ' HB2' ' A' ' 16' ' ' ALA . 97.8 p 58.45 122.62 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.967 0.413 . . . . 0.0 111.017 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 166.91 51.55 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.67 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.635 ' HG3' HG23 ' A' ' 17' ' ' VAL . 4.5 mmp_? -151.39 -50.66 0.12 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.724 0.297 . . . . 0.0 110.847 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 174.73 -139.4 4.84 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.378 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 13' ' ' ILE . 5.7 p90 -179.81 143.06 0.17 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.815 0.34 . . . . 0.0 111.311 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.845 HD11 HD11 ' A' ' 15' ' ' LEU . 1.3 mp -111.81 127.97 55.97 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.029 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.499 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 55.2 t -70.61 143.35 14.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.468 ' CD ' ' HA ' ' A' ' 11' ' ' ALA . 97.7 mtt180 -50.58 140.23 14.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 111.824 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 32' ' ' VAL . 50.3 mttp -138.53 -140.75 0.15 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.641 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.736 HG22 ' H ' ' A' ' 36' ' ' LEU . 1.2 m -106.16 -158.98 0.68 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 179.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.842 ' O ' HG23 ' A' ' 40' ' ' VAL . 2.5 pt? -77.17 -49.65 14.7 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.148 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.49 ' N ' ' HG ' ' A' ' 36' ' ' LEU . 15.4 pt-20 -70.59 -40.13 73.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.602 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . 1.7 mm-40 -55.42 -57.03 13.56 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.333 0.587 . . . . 0.0 110.351 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.6 -44.75 62.96 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.759 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.842 HG23 ' O ' ' A' ' 36' ' ' LEU . 3.6 t -60.51 -56.47 17.51 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.428 0.633 . . . . 0.0 110.377 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -53.51 -45.52 69.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.128 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.437 ' HB1' HD23 ' A' ' 31' ' ' LEU . . . -60.68 -47.02 88.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.774 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.785 HD22 HD11 ' A' ' 6' ' ' LEU . 92.1 mt -65.86 -45.14 83.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.002 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.683 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 22.3 mt -59.29 -57.47 12.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.526 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.823 ' O ' ' HG2' ' A' ' 49' ' ' ARG . 65.8 t0 -43.95 -42.1 5.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.697 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.499 ' O ' ' HB3' ' A' ' 50' ' ' GLU . 15.9 t80 -71.05 -42.39 69.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.152 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 43' ' ' LEU . 83.5 t -67.32 -44.57 87.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.683 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.8 ptm180 -64.43 -67.53 0.43 Allowed 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 45' ' ' ASP . 39.7 ptt85 -56.19 -47.75 77.73 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 40.0 tp10 -65.35 -16.06 63.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.711 0.291 . . . . 0.0 111.258 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 59.23 36.86 90.6 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.382 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.454 HD21 ' HG2' ' A' ' 50' ' ' GLU . 89.8 mt -68.15 -50.64 53.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.961 0.41 . . . . 0.0 110.691 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 54.74 40.06 69.85 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.439 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.833 ' O ' HD13 ' A' ' 55' ' ' LEU . 59.7 tttp -177.87 125.23 0.12 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.476 0.179 . . . . 0.0 110.718 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.037 HD23 HD13 ' A' ' 81' ' ' LEU . 2.4 mm? -140.39 131.68 26.66 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.988 0.423 . . . . 0.0 111.446 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.477 ' O ' HG13 ' A' ' 56' ' ' VAL . 10.2 p -111.18 120.05 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.842 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.59 HG21 ' CG2' ' A' ' 78' ' ' VAL . 33.2 t -92.27 153.73 3.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.597 ' O ' HD23 ' A' ' 59' ' ' LEU . . . -152.31 130.72 3.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.003 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.597 HD23 ' O ' ' A' ' 58' ' ' GLY . 93.1 mt -156.83 138.15 9.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.643 0.258 . . . . 0.0 110.993 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.96 149.05 82.9 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.703 2.268 . . . . 0.0 112.312 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 82.9 mt 68.13 139.93 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.149 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -55.47 138.78 45.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.082 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.6 t -58.35 134.34 56.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.301 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.99 141.65 58.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.989 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.5 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.3 mm? -59.94 137.0 58.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.753 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt 63.48 136.23 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.719 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -62.0 121.56 13.31 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.779 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 79.8 p -81.76 134.9 35.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.87 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.15 -49.08 78.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.955 0.407 . . . . 0.0 110.781 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -70.2 132.31 45.56 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.287 0.565 . . . . 0.0 110.83 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . 59.25 -146.9 0.5 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.801 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.405 ' O ' ' CD ' ' A' ' 76' ' ' PRO . . . 54.94 43.04 82.18 Favored Glycine 0 C--N 1.334 0.472 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.302 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.479 ' C ' ' HD2' ' A' ' 76' ' ' PRO . 53.8 mtmt -76.96 -25.31 52.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.624 0.249 . . . . 0.0 111.576 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 52.5 t -69.31 -45.25 79.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 112.359 0.503 . . . . 0.0 112.359 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.625 HD13 ' O ' ' A' ' 75' ' ' LEU . 2.0 tm? -52.34 -50.12 81.39 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 75' ' ' LEU . 96.0 Cg_exo -40.85 -33.32 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.834 2.356 . . . . 0.0 112.895 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.664 HD13 ' C ' ' A' ' 77' ' ' LEU . 2.7 tm? -80.8 -39.42 26.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.858 0.361 . . . . 0.0 110.859 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.59 ' CG2' HG21 ' A' ' 57' ' ' VAL . 47.3 t -53.64 -36.8 29.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.876 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 76' ' ' PRO . 21.3 pt-20 -73.56 -33.91 64.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.734 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' A' ' 77' ' ' LEU . . . -59.12 -45.11 91.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.157 0.503 . . . . 0.0 110.692 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.037 HD13 HD23 ' A' ' 55' ' ' LEU . 22.9 mt -60.7 -47.84 84.47 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.81 -179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -57.83 -39.59 78.01 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.892 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.28 -41.94 72.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.376 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 80.1 mtm180 -88.19 21.21 2.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.724 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 60.64 36.99 92.73 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.966 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.5 t -94.53 135.78 27.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.703 0.287 . . . . 0.0 111.063 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 54' ' ' LYS . 65.5 mm-40 -64.57 125.84 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.792 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.563 HG11 HG13 ' A' ' 78' ' ' VAL . 57.7 t -158.78 145.97 7.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.706 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -166.92 131.92 2.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.095 0.474 . . . . 0.0 111.624 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.899 HD23 ' N ' ' A' ' 91' ' ' TRP . 6.1 tt -72.27 142.38 48.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.278 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.899 ' N ' HD23 ' A' ' 90' ' ' LEU . 21.0 t-105 -146.86 141.99 27.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.886 0.374 . . . . 0.0 111.042 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -164.28 -43.71 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.761 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -175.21 127.32 0.27 Allowed 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.185 0.516 . . . . 0.0 111.121 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.476 ' NE ' ' HA ' ' A' ' 94' ' ' ARG . 3.0 tpm_? -91.74 -44.2 9.12 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.923 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -71.47 57.82 0.27 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.503 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 81.2 m -62.51 -43.46 98.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.899 0.381 . . . . 0.0 110.796 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.683 HG22 ' HG2' ' A' ' 98' ' ' LYS . 77.6 m 63.72 132.26 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.052 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.683 ' HG2' HG22 ' A' ' 97' ' ' THR . 47.0 mmtm . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 C--O 1.23 0.061 0 CA-C-O 121.029 0.443 . . . . 0.0 111.496 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 59.1 mmt-85 -104.74 140.26 38.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.782 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.547 HG12 ' O ' ' A' ' 18' ' ' GLY . 11.9 p -119.42 136.23 57.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.957 0.408 . . . . 0.0 111.281 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.465 ' HA3' HD13 ' A' ' 55' ' ' LEU . . . -81.47 131.18 10.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.094 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -113.87 130.76 56.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.886 0.374 . . . . 0.0 111.112 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.663 HD11 HD22 ' A' ' 43' ' ' LEU . 96.5 mt -123.37 135.95 54.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.041 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 2.9 p30 -140.3 134.86 31.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.625 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 34.3 m -98.95 129.41 49.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.637 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -115.98 -135.48 5.69 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.285 179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -62.92 -42.85 99.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.894 0.378 . . . . 0.0 110.799 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 33' ' ' ARG . . . -171.57 39.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.796 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -155.33 146.61 22.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.913 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 56.5 mt -98.95 127.03 52.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.484 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -78.47 126.63 7.7 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.447 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.658 HD11 ' CD2' ' A' ' 31' ' ' LEU . 86.0 mt -99.42 130.41 45.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.716 0.293 . . . . 0.0 110.918 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.933 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -150.52 145.84 26.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.16 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -146.52 124.91 4.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.72 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.547 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.64 151.67 10.05 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.505 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -59.86 148.59 34.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.637 0.256 . . . . 0.0 110.404 179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -42.07 134.98 2.6 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.537 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 70.29 45.97 52.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.455 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 46.3 t -64.29 127.53 92.2 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 120.519 0.199 . . . . 0.0 111.102 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.436 ' O ' ' HB3' ' A' ' 24' ' ' LEU . 23.6 Cg_exo -63.91 134.38 43.08 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.358 2.039 . . . . 0.0 111.699 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.473 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 54.8 tp 69.69 -51.54 0.62 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.533 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 24' ' ' LEU . . . 71.1 137.55 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.981 0.419 . . . . 0.0 111.256 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 79.7 p -173.71 129.92 0.42 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.623 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -68.44 132.77 27.67 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.789 -179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -65.52 -35.63 81.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 110.676 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.81 -135.59 1.88 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.252 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.434 ' O ' ' CD1' ' A' ' 30' ' ' TYR . 7.2 p90 -178.9 138.99 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.911 0.386 . . . . 0.0 111.166 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.658 ' CD2' HD11 ' A' ' 15' ' ' LEU . 80.0 mt -106.43 125.63 51.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.669 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 49.4 t -67.23 133.19 31.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 11' ' ' ALA . 52.4 mtp85 -56.94 124.98 20.51 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.069 0.461 . . . . 0.0 111.048 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.842 ' O ' HG23 ' A' ' 35' ' ' THR . 96.6 mttt -109.09 -96.96 0.39 Allowed 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.527 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.842 HG23 ' O ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -176.03 127.3 0.22 Allowed 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 179.21 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.688 ' O ' HG23 ' A' ' 40' ' ' VAL . 62.4 tp 16.59 -76.03 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.496 ' N ' ' O ' ' A' ' 35' ' ' THR . 16.5 pt-20 -67.55 -44.93 77.1 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 34' ' ' LYS . 4.6 mm-40 -57.69 -51.72 68.37 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.269 0.557 . . . . 0.0 110.324 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 35' ' ' THR . 1.9 m-20 -49.06 -42.8 39.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.243 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.696 HG13 HD23 ' A' ' 77' ' ' LEU . 3.2 t -58.86 -54.37 34.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.281 0.562 . . . . 0.0 110.514 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.417 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 0.2 OUTLIER -52.76 -49.53 65.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.346 -179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.22 89.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.948 0.404 . . . . 0.0 111.201 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.666 ' O ' HG23 ' A' ' 47' ' ' VAL . 84.2 mt -65.25 -46.09 81.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.391 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.512 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 72.7 mt -60.58 -52.8 63.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.826 0.346 . . . . 0.0 110.703 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 -48.55 -38.41 20.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.798 179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.543 ' CZ ' HD11 ' A' ' 52' ' ' LEU . 18.0 t80 -73.09 -42.09 63.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.22 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 ' O ' ' A' ' 43' ' ' LEU . 69.8 t -65.04 -51.94 59.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 7.6 ptt180 -70.79 -62.72 1.29 Allowed 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -47.61 -51.0 22.78 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.959 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 5.4 tp10 -77.0 -4.04 42.06 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.685 0.279 . . . . 0.0 111.449 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 58.49 38.55 91.32 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.657 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.543 HD11 ' CZ ' ' A' ' 46' ' ' PHE . 88.0 mt -72.59 -55.55 6.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.838 0.351 . . . . 0.0 110.923 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.4 ' O ' ' HG2' ' A' ' 54' ' ' LYS . . . 53.0 33.22 43.76 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.313 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.841 ' C ' HD22 ' A' ' 55' ' ' LEU . 34.2 mmtp -161.91 128.1 3.67 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 122.225 0.21 . . . . 0.0 110.462 -179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.952 HD23 HD13 ' A' ' 81' ' ' LEU . 2.8 mm? -143.16 133.05 24.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.367 0.603 . . . . 0.0 111.65 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 56' ' ' VAL . 11.1 p -131.02 122.44 51.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.2 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' HB ' ' CD1' ' A' ' 90' ' ' LEU . 25.0 t -97.23 141.76 15.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.589 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -140.44 109.99 0.65 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.983 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.42 131.37 84.84 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.525 0.203 . . . . 0.0 110.898 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.4 42.03 1.26 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.586 2.191 . . . . 0.0 112.862 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 61' ' ' LEU . 1.5 pt? 179.67 129.2 0.08 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.758 0.314 . . . . 0.0 110.864 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 29.5 tpt180 -71.85 -51.45 22.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.744 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -76.5 142.16 41.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.245 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.49 ' C ' HD13 ' A' ' 65' ' ' LEU . 2.7 p30 -169.68 132.22 1.17 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.692 HD13 ' N ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -171.24 41.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.237 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm 64.75 146.27 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.675 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -154.52 -42.65 0.09 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.28 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.5 t -169.13 135.01 1.64 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.932 0.396 . . . . 0.0 111.261 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . 62.25 126.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.42 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -75.3 136.05 40.89 Favored 'General case' 0 CA--C 1.513 -0.451 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.97 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -154.33 127.85 8.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.441 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.64 129.5 1.09 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.127 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 51.4 pttt -179.39 34.18 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.824 0.345 . . . . 0.0 111.287 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.8 t -100.4 -43.17 10.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 121.074 0.464 . . . . 0.0 111.072 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 76' ' ' PRO . 59.7 tp -53.5 -48.86 91.42 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.964 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 1.4 Cg_endo -43.19 -39.78 8.76 Favored 'Trans proline' 0 C--N 1.348 0.534 0 C-N-CA 122.767 2.311 . . . . 0.0 112.718 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.696 HD23 HG13 ' A' ' 40' ' ' VAL . 2.5 tm? -76.07 -36.87 58.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.777 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.814 HG13 HG11 ' A' ' 88' ' ' VAL . 58.5 t -55.44 -36.18 40.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.678 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -66.23 -39.55 89.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.834 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.51 -44.9 93.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.127 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.952 HD13 HD23 ' A' ' 55' ' ' LEU . 24.1 mt -60.15 -48.39 81.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.056 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 54.2 mtp85 -58.81 -43.57 90.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.667 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -38.7 82.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.058 179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.2 mtp85 -84.08 17.84 2.32 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.659 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.22 37.16 94.15 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.318 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 49.2 t -106.93 133.38 51.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.769 0.319 . . . . 0.0 110.942 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 54' ' ' LYS . 51.0 mm-40 -67.89 132.2 46.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.927 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.814 HG11 HG13 ' A' ' 78' ' ' VAL . 43.0 t -157.44 143.12 8.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.619 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.95 139.43 6.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.086 0.47 . . . . 0.0 112.054 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.637 HD22 ' N ' ' A' ' 90' ' ' LEU . 1.8 mm? -80.56 119.9 23.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.994 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.457 ' CZ2' ' HB2' ' A' ' 93' ' ' GLU . 15.3 t-105 179.9 159.35 0.78 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.7 0.286 . . . . 0.0 110.972 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -151.73 -44.23 0.11 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.574 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.457 ' HB2' ' CZ2' ' A' ' 91' ' ' TRP . 65.9 mm-40 -58.37 128.89 39.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.231 0.539 . . . . 0.0 111.195 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 94' ' ' ARG . 2.8 ptp180 -84.79 145.53 27.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.384 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.415 ' CE2' ' CZ2' ' A' ' 91' ' ' TRP . 0.0 OUTLIER -166.01 45.39 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.348 179.636 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.8 t -177.49 -143.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.887 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 73.7 m 64.07 133.96 0.02 OUTLIER 'General case' 0 C--O 1.231 0.108 0 CA-C-O 120.909 0.385 . . . . 0.0 111.004 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.4 pttm . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.854 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 ttm . . . . . 0 CA--C 1.527 0.071 0 CA-C-O 120.981 0.42 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -119.18 142.18 48.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.896 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.9 HG12 ' O ' ' A' ' 18' ' ' GLY . 13.3 p -136.67 141.66 40.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.468 ' HA3' HD13 ' A' ' 55' ' ' LEU . . . -73.97 131.84 14.51 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.448 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 16' ' ' ALA . . . -121.75 137.32 54.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.762 0.315 . . . . 0.0 111.132 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.85 ' O ' HG13 ' A' ' 57' ' ' VAL . 94.5 mt -132.17 141.07 48.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.126 0.488 . . . . 0.0 111.609 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.623 ' O ' ' HA ' ' A' ' 13' ' ' ILE . 11.6 p-10 -146.2 137.94 24.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.677 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 8' ' ' VAL . 14.7 p -103.52 124.81 58.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.899 0.381 . . . . 0.0 111.723 -179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -97.56 -136.76 9.29 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.675 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -70.1 -42.72 72.32 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.7 0.286 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . . . -158.89 40.01 0.23 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.24 0.543 . . . . 0.0 110.899 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -167.59 173.4 8.61 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.623 ' HA ' ' O ' ' A' ' 7' ' ' ASP . 52.1 mt -126.41 134.15 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.96 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.74 133.55 11.88 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.008 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.641 HD21 ' CD1' ' A' ' 31' ' ' LEU . 86.0 mt -98.61 131.65 44.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.608 0.242 . . . . 0.0 110.546 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.775 ' HB3' ' HB3' ' A' ' 5' ' ' ALA . . . -145.64 143.8 30.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.775 0.321 . . . . 0.0 111.051 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.8 t -135.79 123.83 36.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.168 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.9 ' O ' HG12 ' A' ' 3' ' ' VAL . . . 179.64 -149.41 8.63 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.254 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -64.99 145.22 56.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.724 0.297 . . . . 0.0 110.535 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.884 ' HA ' HG11 ' A' ' 3' ' ' VAL . 44.6 tt0 -46.14 133.43 9.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.89 0.376 . . . . 0.0 111.245 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 68.84 47.72 53.39 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.631 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 49.1 t -62.25 129.6 92.38 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.538 0.208 . . . . 0.0 110.978 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -84.5 41.21 0.95 Allowed 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 122.663 2.242 . . . . 0.0 112.582 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 24' ' ' LEU . 33.4 tp 56.5 44.42 24.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.999 0.428 . . . . 0.0 110.785 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -61.01 -40.41 93.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.951 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 55.1 m -165.42 127.4 2.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.462 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -73.77 124.6 8.69 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.137 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' N ' ' O ' ' A' ' 15' ' ' LEU . 29.5 tpt180 -75.29 -37.79 60.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.067 0.46 . . . . 0.0 110.155 179.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' C ' ' CD1' ' A' ' 30' ' ' TYR . . . -163.0 -154.19 7.53 Favored Glycine 0 N--CA 1.451 -0.312 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.041 179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.452 ' CD1' ' C ' ' A' ' 29' ' ' GLY . 75.0 m-85 -161.05 135.62 7.28 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.899 0.35 . . . . 0.0 111.143 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.641 ' CD1' HD21 ' A' ' 15' ' ' LEU . 80.7 mt -121.92 122.28 39.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.117 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.465 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 48.5 t -67.1 145.95 13.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.576 -0.284 . . . . 0.0 110.513 179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.408 ' NE ' ' HA ' ' A' ' 11' ' ' ALA . 99.2 mtt180 -52.64 147.26 8.83 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 121.018 0.437 . . . . 0.0 111.28 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.488 ' HD3' ' HG2' ' A' ' 38' ' ' GLU . 66.7 mttm -147.92 -125.23 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.118 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' N ' ' A' ' 38' ' ' GLU . 42.6 p -145.9 136.31 24.0 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.026 0.441 . . . . 0.0 111.755 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.713 ' O ' HG23 ' A' ' 40' ' ' VAL . 1.0 OUTLIER -18.28 -53.9 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.414 ' HG3' ' N ' ' A' ' 38' ' ' GLU . 16.5 pt-20 -72.01 -48.83 41.87 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.025 0.44 . . . . 0.0 111.356 -179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' HG2' ' HD3' ' A' ' 34' ' ' LYS . 81.4 tt0 -60.73 -48.97 79.39 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.535 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.2 m-20 -49.69 -39.99 38.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.075 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 36' ' ' LEU . 2.7 t -56.25 -48.52 79.36 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.359 0.6 . . . . 0.0 109.867 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' N ' ' OE1' ' A' ' 41' ' ' GLU . 0.3 OUTLIER -52.41 -47.73 66.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.277 -179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -68.47 -45.1 73.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.096 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.017 HD13 ' CD2' ' A' ' 77' ' ' LEU . 61.0 mt -65.05 -47.35 77.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.773 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.509 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 61.7 mt -60.33 -49.8 76.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.828 0.347 . . . . 0.0 110.602 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -47.2 -39.49 14.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.771 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.727 ' CE2' HD11 ' A' ' 52' ' ' LEU . 16.8 t80 -78.61 -43.86 25.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.244 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 43' ' ' LEU . 62.1 t -55.58 -53.39 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 44' ' ' LEU . 4.8 ptm180 -69.69 -61.85 1.62 Allowed 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 80.4 mtt-85 -51.52 -49.04 62.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.874 -179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 46' ' ' PHE . 39.9 tp10 -73.22 -12.62 60.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.573 0.225 . . . . 0.0 111.177 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.43 40.66 99.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.436 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.727 HD11 ' CE2' ' A' ' 46' ' ' PHE . 87.0 mt -74.51 -52.37 12.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.965 0.412 . . . . 0.0 111.098 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.442 ' O ' ' CG ' ' A' ' 54' ' ' LYS . . . 53.69 29.3 40.57 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.212 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.82 ' O ' HD13 ' A' ' 55' ' ' LEU . 97.3 mttt -163.62 135.08 4.78 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.516 0.198 . . . . 0.0 110.677 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.936 HD23 HD13 ' A' ' 81' ' ' LEU . 2.7 mm? -139.82 139.64 36.42 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.982 0.42 . . . . 0.0 111.172 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 89' ' ' GLU . 12.4 p -149.66 143.36 17.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.962 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 6' ' ' LEU . 21.6 t -144.86 129.73 13.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.914 0.388 . . . . 0.0 111.969 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.06 108.31 3.46 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.787 -0.72 . . . . 0.0 111.341 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.644 HD22 ' N ' ' A' ' 59' ' ' LEU . 2.3 mm? -85.49 138.6 35.98 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.731 0.3 . . . . 0.0 111.493 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 59' ' ' LEU . 25.3 Cg_exo -62.51 -40.84 35.97 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.643 2.229 . . . . 0.0 112.822 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.479 HD13 ' CH2' ' A' ' 91' ' ' TRP . 65.1 tp 65.64 159.64 0.12 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.809 0.337 . . . . 0.0 110.82 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 27.8 tpt180 76.1 42.55 0.19 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.633 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 8.0 t -74.4 144.14 44.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.761 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -51.95 126.16 17.47 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.876 0.369 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.55 134.13 48.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.194 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' NZ ' ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -178.14 -68.0 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 179.53 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 66' ' ' LYS . 73.5 mm-40 -161.3 -54.82 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.02 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 69' ' ' ALA . 80.0 p -71.07 132.97 45.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.185 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 68' ' ' SER . . . 175.76 -49.73 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.249 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.414 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 13.7 mp0 -83.74 52.34 2.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.628 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 70' ' ' GLN . . . 179.4 137.28 0.1 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.793 0.33 . . . . 0.0 111.647 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' C ' ' H ' ' A' ' 74' ' ' VAL . . . -168.51 25.66 0.12 Allowed Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.84 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.451 ' O ' ' HG2' ' A' ' 76' ' ' PRO . 36.5 mtmm 66.56 -19.55 0.11 Allowed 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 72' ' ' GLY . 48.9 t -79.28 -41.31 22.66 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 O-C-N 122.196 -0.315 . . . . 0.0 111.533 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.65 ' C ' HD13 ' A' ' 75' ' ' LEU . 3.0 tm? -54.06 -53.93 53.03 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.317 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 75' ' ' LEU . 3.9 Cg_endo -48.79 -35.67 31.34 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.296 1.998 . . . . 0.0 112.069 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.017 ' CD2' HD13 ' A' ' 43' ' ' LEU . 29.0 tp -61.62 -44.07 97.68 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.937 0.399 . . . . 0.0 110.713 179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.418 ' O ' ' HG2' ' A' ' 82' ' ' ARG . 41.1 t -55.01 -34.59 32.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.432 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -56.58 -43.97 80.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.467 ' HB1' HH12 ' A' ' 84' ' ' ARG . . . -62.3 -47.38 84.54 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.109 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.936 HD13 HD23 ' A' ' 55' ' ' LEU . 33.5 mt -62.8 -42.83 99.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.383 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . 0.418 ' HG2' ' O ' ' A' ' 78' ' ' VAL . 25.2 mmm180 -56.22 -43.92 79.03 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.693 0.282 . . . . 0.0 111.192 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.77 86.11 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.869 0.366 . . . . 0.0 110.915 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . 0.467 HH12 ' HB1' ' A' ' 80' ' ' ALA . 65.9 mtt85 -70.77 -30.5 67.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.929 179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 93.15 42.92 4.2 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.16 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 52.0 t -100.42 142.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.687 0.28 . . . . 0.0 110.718 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -59.74 128.7 38.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.761 0.315 . . . . 0.0 110.63 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.579 HG21 HD12 ' A' ' 81' ' ' LEU . 62.8 t -152.91 140.08 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.009 0.433 . . . . 0.0 111.238 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 56' ' ' VAL . 12.6 pm0 -165.42 132.03 2.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.427 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.668 ' N ' HD23 ' A' ' 90' ' ' LEU . 1.3 pt? -154.47 124.44 6.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.057 0.456 . . . . 0.0 110.879 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TRP . . . . . 0.479 ' CH2' HD13 ' A' ' 61' ' ' LEU . 31.3 t-105 -179.23 148.45 0.37 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.01 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 61' ' ' LEU . 64.0 t0 -47.11 132.17 12.33 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.847 0.356 . . . . 0.0 110.745 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 15.4 pt-20 -57.6 114.12 2.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.201 0.524 . . . . 0.0 111.507 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 93' ' ' GLU . 22.5 mmt85 -161.02 32.7 0.14 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.49 179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.426 ' O ' ' CG ' ' A' ' 95' ' ' PHE . 17.2 t80 52.33 39.11 26.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.915 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 73.0 m -68.46 127.99 34.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.007 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.487 HG23 ' N ' ' A' ' 98' ' ' LYS . 9.1 t -74.1 -46.06 45.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.142 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.487 ' N ' HG23 ' A' ' 97' ' ' THR . 39.8 ttmt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.945 179.962 . . . . . . . . 1 1 . 1 stop_ save_